Genetic dissection of regulatory domains and signalling interactions of PRL1 WD-protein in Arabidopsis by Szakonyi, Dóra
 
 
 
 
 
 
 
 
 
 
 
Genetic dissection of regulatory domains and 
signalling interactions of PRL1 WD-protein in 
Arabidopsis 
 
 
 
 
 
 
 
 
Inaugural-Dissertation 
zur 
Erlangung des Doktorgrades 
der Mathematisch-Naturwissenschaftlichen Fakultät 
der Universität zu Köln 
 
 
 
 
 
vorgelegt von 
 
Dóra Szakonyi 
aus Kecskemét 
 
 
 
 
 
 
 
KÖLN 2006 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Berichterstatter:  Prof. Dr. George Coupland 
    Prof. Dr. Martin Hülskamp 
    Prof. Dr. Karin Schnetz 
 
 
 
 
 
Tag der mündlichen Prüfung: 06. 07. 2006 
 
 
 
 
 
 
 
 
 
 
 
 
CONTENTS   I  
CONTENTS 
 FIGURES AND TABLES........................................................................................................... IVI
 ABBREVIATIONS AND SYMBOLES.................................................................................. VIIII
 SUMMARY - ZUSAMMENFASSUNG...................................................................................... IX 
1. INTRODUCTION ......................................................................................................................... 1 
1.1. SUGAR SIGNALLING IN PLANTS ..................................................................................................... 1 
1.2. IDENTIFICATION AND CHARACTERIZATION OF THE PRL1 MUTANT............................................... 3 
1.3. THE ARABIDOPSIS PRL1 GENE AND PRL1 ORTHOLOGS ................................................................ 4 
1.4. CONSERVED WD-REPEAT PROTEINS............................................................................................. 5 
1.5. PRL1 FAMILY MEMBERS ARE SUBUNITS OF CONSERVED SPLICING-ASSOCIATED COMPLEXES .... 6 
1.5.1. Prp19.......................................................................................................................................... 6 
1.5.2. CDC5 ......................................................................................................................................... 9 
1.5.3. Crooked neck (CRN) proteins ................................................................................................. 10 
1.6. FUNCTION OF THE PRP19-ASSOCIATED COMPLEX IN SPLICING................................................... 11 
1.7. PRL1 INTERACTS WITH SNF1 RELATED PROTEIN KINASES OF AMP-ACTIVATED (AMPK) 
 KINASE FAMILY ........................................................................................................................... 13 
1.8. ARABIDOPSIS SNRK1Α KINASES ARE FOUND IN ASSOCIATION WITH THE PROTEASOME............. 14 
1.9. AIMS OF THE PRESENT WORK...................................................................................................... 15 
2. MATERIALS AND METHODS .......................................................................................................... 17 
2.1. MATERIALS ................................................................................................................................. 17 
2.1.1. Chemicals, enzymes and laboratory supplies .......................................................................... 17 
2.1.2. Bacterial Strains....................................................................................................................... 19 
2.1.2.1. E. coli strains......................................................................................................................... 19 
2.1.2.2. Agrobacterium tumefaciens strains....................................................................................... 20 
2.1.2.3. Yeast strains .......................................................................................................................... 20 
2.1.3. Plant material ........................................................................................................................... 20 
2.1.4. Plasmids vectors and constructs............................................................................................... 21 
2.1.4.1. Plasmid vectors ..................................................................................................................... 21 
2.1.4.2. Plasmid constructs ................................................................................................................ 21 
2.1.5. Arabidopsis yeast two hybrid cDNA library............................................................................ 23 
2.1.6. Oligonucleotides ...................................................................................................................... 24 
2.1.6.1. Oligonucleotides for DNA sequencing ................................................................................. 24 
2.1.6.2. Oligonucleotides for cloning................................................................................................. 24 
2.1.6.3. Oligonucleotides for site-directed mutagenesis .................................................................... 24 
2.1.6.4. Oligonucleotides to screen for T-DNA insertion mutants in Arabidopsis ............................ 25 
2.2. GENERAL BUFFERS, STOCK SOLUTIONS AND GROWTH MEDIA.................................................... 25 
2.2.1.1. Solutions ............................................................................................................................... 25 
2.2.2. Antibiotics................................................................................................................................ 26 
2.2.3. Plant hormones ........................................................................................................................ 26 
2.2.4. Culture media........................................................................................................................... 26 
2.2.4.1. Bacterial media ..................................................................................................................... 26 
2.2.4.2. Yeast media........................................................................................................................... 27 
2.2.4.3. Plant media ........................................................................................................................... 27 
2.2.5. Antibodies................................................................................................................................ 28 
2.2.5.1. Primary antibodies ................................................................................................................ 28 
2.2.5.2. Secondary antibodies ............................................................................................................ 29 
2.2.6. Bioinformatic Resources.......................................................................................................... 29 
2.2.6.1. Softwares .............................................................................................................................. 29 
2.2.6.2. Databases .............................................................................................................................. 29 
2.3. METHODS ................................................................................................................................. 30 
2.3.1. General molecular biology methods ........................................................................................ 30 
2.3.1.1. Preparation of plasmid DNA by alkaline lysis (modified from Birnboim and Doly, 1979). 30 
2.3.1.2. DNA sequencing................................................................................................................... 31 
2.3.1.3. Phenol/Chloroform extraction .............................................................................................. 31 
CONTENTS   II  
2.3.1.4. DNA precipitation................................................................................................................. 31 
2.3.1.5. Agarose gel electrophoresis .................................................................................................. 31 
2.3.1.6. Purification of DNA fragments from agarose gels ............................................................... 32 
2.3.1.7. Measurement of nucleic acid concentration.......................................................................... 32 
2.3.1.8. Digestion with restriction endonucleases.............................................................................. 32 
2.3.1.9. Generating blunt ends of digested DNA fragments .............................................................. 32 
2.3.1.10. Dephosphorylation of DNA ends........................................................................................ 32 
2.3.1.11. DNA ligation....................................................................................................................... 33 
2.3.1.12. Gateway® LR cloning reaction .......................................................................................... 33 
2.3.1.13. PCR amplification............................................................................................................... 33 
2.3.1.14. Site-directed mutagenesis of plasmids................................................................................ 34 
2.3.1.15. Isolation of plasmid DNA from Agrobacterium tumefaciens............................................. 35 
2.3.1.16. Transformation of bacterial cells ........................................................................................ 36 
2.3.1.17. Transformation of E.coli cells by the heat-shock method................................................... 36 
2.3.1.18. Electroporation of bacterial cells ........................................................................................ 36 
2.3.2. Protein biochemical methods................................................................................................... 36 
2.3.2.1. Preparation of protein extracts from plant material .............................................................. 36 
2.3.2.2. Determination of protein concentration ................................................................................ 37 
2.3.2.3. Electrophoretic separation of proteins .................................................................................. 37 
2.3.2.4. Western blotting.................................................................................................................... 38 
2.3.2.5. Size separation of protein complexes on linear glycerol gradient ........................................ 39 
2.3.2.6. Immunoprecipitation of protein complexes .......................................................................... 39 
2.3.3. Yeast molecular biology methods............................................................................................ 40 
2.3.3.1. Small scale transformation of yeast cells using the lithium acetate method......................... 40 
2.3.3.2. Plasmid isolation from yeast ................................................................................................. 40 
2.3.3.3. β-galactosidase filter lift assay.............................................................................................. 41 
2.3.3.4. Yeast one-hybrid assay ......................................................................................................... 41 
2.3.4. Plant tissue culture and transformation.................................................................................... 41 
2.3.4.1. Plant growth conditions in the greenhouse ........................................................................... 41 
2.3.4.2. In vitro cultivation of A. thaliana seedlings.......................................................................... 41 
2.3.4.3. Maintenance of Arabidopsis cell suspensions ...................................................................... 42 
2.3.4.4. Sterilization of A. thaliana seeds .......................................................................................... 42 
2.3.4.5. Agrobacterium-mediated transformation of A. thaliana plants by the floral dip method ..... 42 
2.3.4.6. Agrobacterium-mediated transformation of A. thaliana cell suspensions ............................ 42 
2.3.4.7. Selecting for transformed plants ........................................................................................... 43 
2.3.4.8. Crosses of Arabidopsis plants ............................................................................................... 43 
2.3.4.9. Measurement of flowering time............................................................................................ 43 
2.3.4.10. DNA extraction from plant material ................................................................................... 43 
2.3.4.11. Histochemical assay of β-glucuronidase (uidA) reporter enzyme activity in planta .......... 44 
2.3.4.12. Isolation of plant cell nuclei................................................................................................ 44 
2.3.5. Cell biological methods ........................................................................................................... 45 
2.3.5.1. Light microscopy .................................................................................................................. 45 
2.3.5.2. Indirect immunofluorescence microscopy ............................................................................ 45 
2.3.5.3. Confocal laser scanning microscopy .................................................................................... 45 
3. RESULTS ........................................................................................................................................ 46 
3.1. ANALYSIS OF PRL1 GENE EXPRESSION PATTERN AND IDENTIFICATION OF ESSENTIAL 
 TRANSCRIPTION REGULATORY REGIONS..................................................................................... 46 
3.1.1. Overexpression of PRL1 cDNA............................................................................................... 46 
3.1.2. Genetic complementation assay using an estradiol-inducible PRL1 genomic construct ......... 47 
3.1.3. Testing the stringency of estradiol induction of pER8 vector using a GUS reporter gene ...... 48 
3.1.4. Characterization of an estradiol-inducible PRL1 cDNA construct .......................................... 49 
3.1.5. Characterization of the prl1-5 (SAIL_1276G04) mutant allele............................................... 52 
3.1.6. Search for putative regulatory elements in the PRL1 promoter sequence ............................... 53 
3.1.7. Construction of a PRL1 promoter-driven GUS reporter gene.................................................. 54 
3.1.8. Characterization of PRL1 promoter activity in planta............................................................. 54 
3.1.9. Construction of GUS reporter lines with PRL1 promoter deletions ........................................ 56 
3.1.10. Comparison of activity of PRL1 promoter-GUS constructs .................................................. 56 
CONTENTS   III  
3.1.11. Elimination of candidate regulatory regions from the second intron..................................... 59 
3.1.12. Confirmation of importance of intragenic PRL1 regulatory sequences by genetic 
 complementation assays......................................................................................................... 60 
3.1.13. Western blot analysis of PRL1 complementation constructs................................................. 62 
3.1.14. PRL1-HA expression in different tissues of complemented lines ......................................... 63 
3.1.15. Complementation studies using heterologous promoters ...................................................... 64 
3.1.16. Phenotypic analysis of PRL1 misexpressing plants............................................................... 65 
3.2. YEAST-ONE-HYBRID SCREENING FOR TRANSCRIPTION FACTORS BINDING TO INTRAGENIC PRL1 
 PROMOTER SEQUENCES............................................................................................................... 67 
3.2.1. Construction of promoter testing vectors and selection of test strains for yeast-one-hybrid 
 assay......................................................................................................................................... 67 
3.2.2. Isolation of a cDNA encoding a PRL1 intron 2 binding factor................................................ 68 
3.3. ANALYSIS OF EXPRESSION PATTERN AND CELLULAR LOCALIZATION OF PRL1 PROTEIN .......... 70 
3.3.1. Construction of a vector for expression of a PRL1-GFP fusion protein.................................. 70 
3.3.2. Localization of PRL1-GFP fusion protein in planta................................................................ 70 
3.3.3. Subcellular immunolocalization of PRL1-HA protein ............................................................ 70 
3.3.4. Effects of plant hormone treatments on PRL1 protein level.................................................... 72 
3.3.5. Regulation of PRL1 mRNA levels by hormones..................................................................... 73 
3.4. POSTTRANSCRIPTIONAL REGULATION OF PRL1......................................................................... 74 
3.4.1. Comparison of PRL1 transcript and protein levels in different plant organs .......................... 74 
3.4.2. Analysis of PRL1 protein stability........................................................................................... 75 
3.4.3. Degradation of PRL1 is inhibited by the proteasome inhibitor MG132.................................. 76 
3.4.4. Identification and site-specific mutagenesis of a putative destruction-box motif in PRL1 ..... 77 
3.4.4.1. Site-directed mutagenesis of the putative PRL1 D box ........................................................ 78 
3.4.4.2. Assay of stability of D-box mutant PRL1-GFP protein in cell suspension .......................... 78 
3.4.4.3. Immunodetection of stabilized PRL1-GFP in wild type plants ............................................ 79 
3.5. CHARACTERIZATION OF PRL1 PROTEIN INTERACTIONS............................................................. 80 
3.5.1. Yeast two hybrid assay with AtCDC5 ..................................................................................... 80 
3.5.2. Detection of PRL1-AtCDC5 interaction in vivo ...................................................................... 81 
3.5.3. AtCDC5-HA is associated with the components of the protein degradation system............... 82 
3.5.4. Size fractionation of AtCDC5 complex on glycerol gradient.................................................. 83 
3.5.5. Distribution of AtCDC5 in nuclear and cytoplasmic fractions................................................ 84 
3.5.6. Search for protein interactions with the N-terminal domain of PRL1 ..................................... 85 
3.6. GENETIC APPROACHES TO FUNCTIONAL CHARACTERIZATION OF PRL1 AND ITS PUTATIVE 
 INTERACTING PARTNERS ............................................................................................................. 88 
3.6.1. Isolation of new prl1 insertion mutant alleles.......................................................................... 88 
3.6.1.1. PCR genotyping of the prl1-2 SALK_008466 line............................................................... 88 
3.6.1.2. PCR genotyping of prl1-3 SALK_096289 and prl1-4 SALK_039427 lines ........................ 89 
3.6.2. Isolation of prl2 T-DNA insertion mutations .......................................................................... 92 
3.6.2.1. PCR genotyping of the prl2-1 KONCZ16136 line ............................................................... 92 
3.6.2.2. PCR genotyping of the prl-2-2 GABI 228D02 mutant line .................................................. 93 
3.6.2.3. Segregation analysis of prl2-1 and prl2-2 mutants ............................................................... 95 
3.6.3. Generation of prl1 double mutants with mutations in genes coding for putative PRL1 
 interacting partners .................................................................................................................. 95 
3.6.4. Isolation of point mutations in the PRL1 coding region .......................................................... 97 
3.6.4.1. Screening for EMS-induced point mutations by TILLING .................................................. 97 
3.6.4.2. Site-directed mutagenesis of the PRL1 gene ........................................................................ 99 
4. DISCUSSION ................................................................................................................................. 102 
4.1. CHARACTERIZATION OF PRL1 GENE EXPRESSION.................................................................... 102 
4.2. PRL1 GENE EXPRESSION IS REGULATED BY INTRAGENIC REGIONS .......................................... 103 
4.3. PRL1 PROTEIN IS A POTENTIAL PROTEASOME SUBSTRATE....................................................... 106 
4.4. PRL1 IS PRESENT IN AN ATCDC5-ASSOCIATED PROTEIN COMPLEX ........................................ 108 
4.5. GENETIC APPROACHES TO FUNCTIONAL CHARACTERIZATION OF PRL1 INTERACTIONS.......... 109 
5. REFERENCES ............................................................................................................................... 112 
 
 
 
FIGURES  IV 
FIGURES 
Figure 1. Simplified model of glucose signalling 2 
Figure 2. Phenotype of the prl1 mutant. 3 
Figure 3. Three dimensional structure of WD40 proteins 5 
Figure 4. The Prp19-associated complex 8 
Figure 5. Role of Ntc Prp19-complex in splicing 12 
Figure 6. Proteasomal complexes of SnRK1α AMPK kinases 14 
Figure 7. Genetic complementation assay with the CaMV35S:PRL1-HiA construct 46 
Figure 8. Analysis of estradiol inducible PRL1-HA synthesis in transgenic plants carrying the 
 pER8(Km)-PRL1genomic-HA construct 48 
Figure 9. Histochemical assay of GUS reporter enzyme activity of pER8-iGUS seedlings in the 
 absence and presence of estradiol 49 
Figure 10. Analysis of plants carrying the estradiol-inducible pER8(Km)-PRL1-cDNA-HA 
 construct 50 
Figure 11. Genetic complementation analysis with the estradiol-inducible pER8(Km)-PRL1-
cDNA- HA construct. 51 
Figure 12. Immunodetection of PRL1-HA protein in seedlings displaying full or partial 
 complememtation of prl1 root elongation defect by the eastradiol-inducible  
 pER8(Km)-PRL1-cDNA-HA construct in the presence of estradiol. 51 
Figure 13. Localization of the T-DNA insertion in the prl1-5 (SAIL_1276 G04) mutant 52 
Figure 14. Putative transcription regulatory sequences in the PRL1 promoter sequence 53 
Figure 15. Histochemical analysis of PRL1::GUS expression pattern 55 
Figure 16. GUS histochemical assay of activities of PRL1 promoter deletion constructs in cell 
 suspensions 57 
Figure 17. Histochemical staining of GUS reporter enzyme activity controlled by the short  
 PRL1 promoter construct pPCV812-PRL1-PROM-XhoI-BmgBI 58 
Figure 18. Histochemical assay of promoter-GUS constructs carrying deletions of TC-rich  
 repeat sequences. 59 
Figure 19. Phenotypic analysis of PRL1 complementation constructs 62 
Figure 20. Immunodetection of PRL1-HA protein in prl1 lines complemented with different  
 PRL1 gene constructs 63 
Figure 21. Immunodetection of PRL1-HA protein in various organs of complemented lines 64 
Figure 22. Genetic complementation assays using misexpression of the PRL1 cDNA from 
 different heterologous promoters 66 
Figure 23. Selection of pHISi-1 reporter strain 67 
Figure 24. Yeast one-hybrid assay 68 
Figure 25. Domain structure, binding site and regulation of expression of AtNAM 69 
Figure 26. Analysis of PRL1-GFP expression pattern in planta by confocal laser scanning 
 microscopy 71 
Figure 27. Cellular localization of PRL1-HA in a complemented prl1 mutant 72 
Figure 28. Effects of hormone treatments on PRL1 protein levels 73 
Figure 29. Immunodetection of PRL1 protein in seedlings treated with 50mM salicylic acid 73 
Figure 30. Genevestigator microarray data on changes of PRL1 transcript levels in response 
 hormone treatments 74 
Figure 31. Comparison of PRL1 mRNA and protein levels in plant organs 75 
Figure 32. Analysis of PRL1 protein stability 76 
Figure 33. Estradiol induced accumulation of PRL1 protein is enhanced by MG132 proteasome 
 inhibitor treatment 76 
Figure 34. Inhibition of translation by cycloheximide does not affect the kinetics of PRL1 
 degradation 77 
Figure 35. Identification of putative D-box motif in the PRL1 protein sequence 78 
Figure 36. Assay of levels of wild type and D-box mutant PRL1-GFP proteins in cell suspension 79 
Figure 37. Immunodetection of wild type and D-box mutant PRL1-GFP proteins in planta 80 
Figure 38. Yeast two hybrid assays using AtCDC5 as prey 81 
Figure 39. AtCDC5-HA immunoprecipitates PRL1 from protein extracts prepared from 
 Arabidopsis cell suspension. 82 
FIGURES  V 
Figure 40. Detection of subunits proteasome, SCF and COP9 complexes in the AtCDC5-HA 
 immunoprecipitated protein fraction. 83 
Figure 41. Size fractionation of AtCDC5 complex on glycerol density gradient 84 
Figure 42. Biochemical assay of subcellular localization of AtCDC5-HA protein. 84 
Figure 43. Assay of PRL1 co-immunoprecipitation with AKIN11-HA, UFD1-HA and PAM1-
 cMyc baits 85 
Figure 44. Assay of co-immunoprecipitation of PRL1-HA with SnRK1α and ATAM1 amidase 
 proteins. 86 
Figure 45. Size fractionation of PRL1-HA complexes from nuclear and whole cell protein  
 extracts 87 
Figure 46. Size separation of protein complexes containing putative PRL1 interacting partner 
 proteins 87 
Figure 47. PCR analysis of prl1-2 SALK_008466 allele 89 
Figure 48. PCR genotyping of prl1-3 SALK_039427 lines 90 
Figure 49. PCR genotyping of the prl1-4 SALK_096289 allele 91 
Figure 50. Root elongation phenotype of seedlings carrying the prl1-2 to prl1-4 mutant alleles 91 
Figure 51. Comparison of PRL1 and PRL2 gene expression patterns based on microarray data in 
 the Genevestigator database. 92 
Figure 52. PCR analysis of the prl2-1 Koncz16136 (#4) mutant 93 
Figure 53. PCR analysis of prl2-2 GABI 228D02 insertion line 94 
Figure 54. Map positions of PIP genes in the Arabidopsis chromosomes 96 
Figure 55. Genetic complementation assays with G77E mutation 99 
Figure 56. Cytological analysis of prl1 root structure 100 
Figure 57. Histochemical staining of prl1 and wild type plants carrying the CycB1;1::GUS reporter 
 gene. 101 
 
TABLES 
Table 1. Components of the yeast Prp19-associated protein complexes and their potential 
 orthologs in Arabidopsis 7 
Table 2. Segregation analysis of prl2 mutant lines 94 
Table 3. List of PIP genes, in which insertion mutations were isolated and used in crosses  
 with the prl1 mutant. 95 
Table 4. List of crosses performed between prl1 and pip mutants 96 
Table 5. Identification of EMS-induced mutations in the 5’ coding region of the PRL1 gene  
 by TILLING. 98 
Table 6. Site-directed mutagenesis of the PRL1 gene 100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABBREVIATIONS   VI 
I ABBREVIATIONS AND SYMBOLES 
A    adenine 
ABA    abscisic acid 
Ac     acetate 
ADP     adenosine 5’-diphosphate  
AMP    adenosine 5’-monophosphate 
APC    Anaphase Promoting Complex/Cyclosome E3 ligase 
A. thaliana   Arabidopsis thaliana  
ATP    adenosine 5’-triphosphate 
ATPase   adenosine 5’-triphosphatase 
 
bp     base pair 
BSA     bovine serum albumin  
 
C    cytosine 
°C    grad Celsius 
CaMV    Cauliflower Mosaic Virus 
cDNA     complementary DNA 
CSM    A. thaliana Cell Suspension culture Medium 
CS    A. thaliana Cell Suspension culture  
C-terminal   carboxyterminal 
C-terminus   carboxyl terminus 
CTAB    cetyltrimethylammonium bromide 
 
2,4-D    2,4-Dichlorophenoxy acetic acid 
DAPI    4,6-diamine-2-phenylindole dihydrochloride 
DMSO    dimethyl sulfoxide 
DNA    Deoxyribonucleic acid 
dNTP    deoxyribonucleotide triphosphate 
DTT    dithiotreitol 
 
E. coli    Escherichia coli 
EDTA    ethylenediaminetetraacetic acid 
EtBr    ethidium bromide 
EtOH    ethanol 
 
G    guanine 
GA    gibberellin 
g    gram 
g    relative centrifugal field unit 
GST    glutathione-S-transferase 
GTC    guanidium thiocyanate 
 
h    hour 
HIS3    imidazole-glycerol-phosphate-dehydratase gene 
 
IAA    indole-3-acetic acid 
IGEPAL   (octylphenoxy)polyethoxyethanol 
IgG    immunoglobuline G 
IP    immunoprecipitation 
 
kb    kilobase 
kDa    kilo Dalton (1,000 Da) 
 
l    liter 
lacZ    E. coli β-galactosidase gene 
ABBREVIATIONS   VII 
 
M    Molar 
µg    microgram 
µl    microliter 
µM    micromolar 
mA    milliampere 
mg    milligram 
min.    minute 
ml    milliliter 
mM    millimolar 
mRNA    messenger RNA 
 
nt    nucleotide 
N-terminal   amino terminal 
N-terminus   amino terminus 
 
OD    optical density 
O/N    overnight 
 
PAGE    polyacrylamide gel electrophoresis 
POD    peroxidase 
PCR    polymerase chain reaction 
PEG    polyethylene glycol 
pH    negative logarithm of the proton concentration 
PMSF    phenylmethylsulfonyl fluoride 
PRL1    PLEIOTROPIC REGULATORY LOCUS 1 
PVDF    polyvinylidene difluoride 
 
RNA    ribonucleic acid  
RNase    ribonuclease 
rpm    revolution per minute 
RT    room temperature 
 
S. cerevisiae   Saccharomyces cerevisiae 
SDS    sodium dodecylsulfate  
sec.    second 
 
T    thymine 
T    Total 
TAE    Tris-acetate (40 mM); EDTA (1mM) 
TCA    trichloroacetic acid 
TE    Tris.HCl (10mM); EDTA (1mM) 
TEMED   N,N,N’,N’ tetramethylenethylendiamine 
Tris    Tris(hydroxymethyl) aminomethane 
 
U    unit 
Ub    ubiquitin 
UTR    untranslated region 
UV    ultraviolet light 
 
V    Volt 
vol.    volume 
X-Gal    5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
X-Gluc    5-bromo-4-chloro-3-indolyl-β-D-glucuronic acid 
 
wt    wild type 
 
ABBREVIATIONS   VIII 
Aminoacids 
A  Ala  Alanine 
C  Cys  Cysteine 
D  Asp  Aspartic acid 
E  Glu  Glutamic acid 
F  Phe  Phenylalanine 
G  Gly  Glycine 
H  His  Histidine 
I  Ile  Isoleucine 
K  Lys  Lysine 
L  Leu  Leucine 
M  Met  Methionine 
N  Asn  Asparagine 
P  Pro  Proline 
Q  Gln  Glutamine 
R  Arg  Arginine 
S  Ser  Serine 
T  Thr  Threonine 
V  Val  Valine 
W  Trp  Trptophan 
Y  Tyr  Tyrosine 
X    any amino acid 
 
 
 
 
 
 
SUMMARY-ZUSAMMENFASSUNG   IX 
II SUMMARY - ZUSAMMENFASSUNG 
 
Der Arabidopsis PLEITROPIC LOCUS (PRL1) kodiert für ein nukleares WD40-Protein. Pflanzen, die 
eine PRL1-Insertionsmutation tragen, sind kleiner als der Wildtyp, haben kürzere Wurzeln, Blätter mit 
gesägten Blatträndern und kürzere Petiolen. In photosynthetisch aktiven Geweben der prl1-Mutante 
lassen sich erhöhte Mengen an Glukose, Saccharose, Fruktose, Stärke, Anthozyanin und Chlorophyll 
nachweisen. Der Verlust der PRL1-Funktion führt zur Hypersensitivität gegenüber Glukose, 
Saccharose und Pflanzenhormonen, einschliesslich Cytokinin, Ethylen, Abscisinsäure und Auxin.   
 Für die Analyse der regulatorischen Funktion von PRL1 entwickelten wir zunächst molekulare 
Werkzeuge um die PRL1-Genexpression zu charakterisieren. Ein Volllängen- (4.2 kb) PRL1-
Promotor, der die Expression des β-Glukuronidase (GUS)-Reportergens als Fusion mit den ersten 69 
Aminosäuren der kodierenden Sequenz des PRL1-Proteins steuert, liess sich in den meisten Geweben 
als exprimiert beobachten. Zur Identifizierung der regulatorischen Bereiche des PRL1-Gens wurde 
eine Anzahl von Promotordeletionen erzeugt und sowohl in Gewebekultur als auch in planta 
propagiert. Unsere Ergebnisse zeigten, dass intergenische Regionen entscheidend für eine korrekte 
Genexpression sind, da PRL1-Konstrukte, denen das zweite Intron fehlt, nur eine geringe Aktivität 
aufweisen. Ein kurzer Promotor, der eine alternative TATA-Box, 5´-UTR und einen 0.5 kb grossen 
kodierenden Bereich einschliesslich der ersten beiden Introns von PRL1 enthält, zeigt eine GUS-
Aktivität ähnlich der des zuvor charakterisierten Volllängenpromotors. Während stromaufwärts 
gelegene regulatorische Sequenzen (~ 3.5 kb) allein nicht für eine korrekte mRNA-Expression 
ausreichend sind, konnten Konstrukte die das zweite Intron tragen, in genetischen 
Komplementationsversuchen vor dem prl1-Mutantenhintergrund als funktional nachgewiesen werden. 
Die Sequenzanalyse legte die Bedeutung einer TC-reichen Region im zweiten Intron nahe. Die 
Deletion dieser Region führte jedoch nicht zu einer dramatischen Veränderung der Genexpression. Als 
PRL1 mit dem grünen fluoreszierenden Protein (GFP) markiert wurde, ließ es sich in den meisten 
Zelltypen als exprimiert und hauptsächlich als im Nukleus lokalisiert nachweisen. Zur Unterscheidung 
der Rolle des PRL1-Proteins in der Organentwicklung, wurden ein genomisches PRL1-Fragment und 
die cDNA hinter den heterologen Promotoren der AtKNAT1; AtSTM; AtUFO; AtAS1; AtSUC2 und 
TobRB7 Gene exprimiert. Während die genomischen Konstrukte in allen Fällen den prl1-Phänotyp 
komplementierten, konnten nur cDNA-Konstrukte, die von den AtAS- und AtSUC2-Promotoren 
angetrieben werden, den Blattphänotyp der prl1-Mutante komplementieren.  
 Aufgrund unseres Befundes, dass das Protein instabil ist, wurde eine posttranslationale 
Regulation für PRL1 postuliert. Der reversible Proteasominhibitor MG132 stabilisiert PRL1 und so 
liegt die Vermutung nahe, dass PRL1 in einer Proteasom-abhängigen Weise abgebaut wird. Im N-
terminalen Bereich von PRL1 konnte ein Zerstörungs- (destruction, D-) Boxmotiv identifiziert 
werden, welches ein mögliches Degron für den „Anaphase Promoting Complex / Cyclosome E3 
Ligase (APC) Komplex“ darstellt. Entsprechende Punktmutationen wurden eingeführt um die D-Box-
Konsensussequenz zu unterbrechen, mit der Zielsetzung so das PRL1-Protein zu stabilisieren. In 
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Zellsuspension konnte ein höheres Niveau von GFP-markiertem PRL1-Protein als mögliches Ergebnis 
der stabilisierenden Mutationen nachgewiesen werden, aber in drei Wochen alten Keimlingen war dies 
nicht der Fall. Aus diesem Grund sind weitere Untersuchungen für ein volles Verständnis der 
Kontrolle des PRL1-Abbaus erforderlich.  
 Biochemische Studien belegten die Anwesenheit von PRL1 in einem grossen nuklearen 
Proteinkomplex assoziiert mit dem Spliceosomkomponenten AtCDC5 Protein. Unsere Daten zeigen, 
dass AtCDC5 mit verschiedenen Komponenten des Proteindegradationssystems interagiert, wie z.B. 
mit den 20S Kern- und den 19S Deckelpartikeln des Proteasoms, der CSN5 Untereinheit des COP9-
Signalosoms und der SCF E3-Ubiquitinligaseuntereinheit Cullin1. Ausserdem lassen sich 
ubiquitinylierte Proteine in „pull-down“ Versuchen mit AtCDC5 nachweisen, was vermuten lässt, dass 
Substrate, die für das Proteasom bestimmt sind, möglicherweise mit diesem Komplex assoziiert sind.  
 Diese Ergebnisse deuten aufgrund seiner Interaktion mit AtCDC5 auf mögliche Rollen für 
PRL1 beim mRNA-Spleissen und beim Proteasom-abhängigen Proteinabbau hin. Fortlaufende 
Projekte mit der Zielsetzung eines erweiterten Verständnisses der PRL1-Funktion bedienen sich 
genetischer Ansätze und ortspezifischer Mutagenese. 
The Arabidopsis PLEIOTROPIC REGULATORY LOCUS 1 (PRL1) encodes a nuclear WD40 protein. 
Plants carrying a prl1 insertion mutation are smaller than wild type, have shorter roots, leaves with 
serrated leaf margins and shorter petioles. In photosynthetic tissues of the prl1 mutant elevated 
glucose, sucrose, fructose, starch, anthocyanin and chlorophyll levels are detected. Loss of the PRL1 
function results in hypersensitivity to glucose, sucrose and plant hormones, including cytokinin, 
ethylene, abscisic acid and auxin.  
 
*** 
To study the regulatory function of PRL1, we first developed molecular tools for characterization of 
PRL1 gene expression. A full length (4.2 kb) PRL1 promoter driving the expression of β-
glucuronidase (GUS) reporter gene in fusion with coding sequences for the first 69 amino acids of 
PRL1 protein was found to be expressed in most tissues. To identify regulatory regions in the PRL1 
gene, a set of promoter deletions was generated and propagated in cell suspension and in planta. Our 
results demonstrated that intragenic sequences are crucial for correct gene expression as PRL1 
constructs lacking the second intron showed only low activity. A short promoter containing an 
alternative TATA-box, 5’-UTR and 0.5 kb coding region with the first two introns of PRL1 showed 
GUS activity similar to the previously characterized full-length promoter. Whereas upstream 
regulatory sequences (~3.5 kb) alone were not sufficient for correct mRNA expression, constructs 
containing the second intron proved to be fully functional in genetic complementation assays in the 
prl1 mutant background. Sequence analysis suggested the importance of a TC-rich region in the 
second intron. However, deletion of this sequence did not affect gene expression dramatically. When 
PRL1 was tagged with green fluorescent protein (GFP), it was found to be expressed in most cell types 
and localized mainly in the nucleus. To differentiate the role of PRL1 protein in organ development, a 
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PRL1 genomic fragment and cDNA were misexpressed using the heterologous promoters of 
AtKNAT1; AtSTM; AtUFO; AtAS1; AtSUC2, At4CL1 and TobRB7 genes. Whereas genomic constructs 
complemented the prl1 phenotype in all cases, only cDNA construct driven by the AtAS1 and AtSUC2 
promoters were able to complement the prl1 mutant leaf phenotype. 
 Posttranslational regulation for PRL1 was suggested by our result indicating that the protein is 
unstable. The reversible proteasome inhibitor MG132 stabilized PRL1 suggesting that PRL1 is 
degraded in a proteasome-dependent manner. In the N-terminal region of PRL1, a destruction box (D 
box) motif was identified, which represents a putative degron for the Anaphase Promoting 
Complex/Cyclosome (APC) E3 ligase complex. Point mutations were introduced to disrupt the D box 
consensus sequence, in order to stabilize PRL1 protein. In cell suspension higher level of GFP-tagged 
PRL1 protein could be detected as potential result of stabilizing mutations, but this was not the case in 
three-week-old seedlings. Therefore, full understanding the control of PRL1 degradation requires 
further investigations.  
 Biochemical studies revealed that PRL1 is present in a large nuclear protein complex 
associated with the spliceosome component AtCDC5 protein. Our data indicate that AtCDC5 interacts 
with various elements of the protein degradation system, such as the 20S core and 19S lid particles of 
the proteasome, the CSN5 subunit of the COP9 signalosome and the SCF E3 ubiqutin ligase subunit 
CULLIN 1. In addition, ubiquitinated proteins were detected in pull-down assays with AtCDC5 
suggesting that substrates targeted to the proteasome are potentially also associated to this complex. 
These results indicate potential roles for PRL1 through its interaction with AtCDC5 in mRNA splicing 
and proteasome-dependent protein degradation. Ongoing projects aim at further understanding of the 
PRL1 function using genetic and site-specific mutagenesis approaches. 
 
. 
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1. INTRODUCTION 
1.1. Sugar signalling in plants 
In plant research, a vastly growing interest focuses on the understanding of potential regulatory roles 
of sugar molecules. Sugars derived from glucose play well-defined roles in various metabolic 
reactions. For example, oxidation of sugars provides energy for all the life functions and sugar-derived 
metabolites are used as building blocks in amino acid and fatty acid synthesis and in biosynthetic 
pathways of secondary metabolites (Lea and Leagold, 1993). The excess of sugars is turned into 
storage compounds, such as starch, to build reserves in seeds or for starvation conditions. Plants 
possess a distinctive feature that after a short heterotrophic period can synthesize sugars through 
photosynthetic pathways. Mature leaf mesophyll cells function as source of photosynthesis-derived 
sugar compounds and carbohydrates are transported through the vascular system to sink organs, 
including roots, developing leaves, flowers and seeds that require energy import (Lemoine, 2000).  
In plants, carbohydrates play also a pivotal role in development (for review see: Paul and Pellny, 
2003; Gibson, 2005). High concentrations of externally provided glucose and sucrose are thus known 
to delay seed germination; but the germination rate remains apparently unaffected by internal increase 
of sugar concentrations (Dekkers et al., 2004). A contradictory role of carbohydrates was shown in 
combination with abscisic acid (ABA) as exogenously provided sugars alleviate the inhibitory effect 
of ABA on seed germination (Finkelstein and Lynch, 2000). During seedling development, 6% 
glucose in combination with continuous light conditions inhibits greening and expansion of 
cotyledons, rosette leaf initiation, root and hypocotyl elongation (Jang et al., 1997). Higher sugar 
levels stimulate leaf expansion. The timing of developmental changes is also affected by 
carbohydrates. Several reports suggest that sugar treatment induces flowering (Corbesier et al., 1998; 
Roldan et al., 1999). However, in other studies both high and low concentrations of exogenous sucrose 
inhibited the transition to flowering (Ohto et al., 2001). The intrinsic sugar content of plants also 
appears to control the regulation of onset of senescence as exogenous sugars can induce leaf 
senescence (Quirinho et al., 2000).  
Physiological studies unravelled that carbohydrates act as important signalling molecules that 
modulate gene expression in connection with sugar metabolism, developmental processes and 
hormonal pathways (for review see: Smeekens, 2000; Rolland et al., 2002). Sugar signal perception is 
primarily connected to the functions of cell wall invertases catalyzing the cleavage of sucrose into 
glucose and fructose that are exported into the cell by specific hexose transporters (see Figure 1). 
Invertases are also located in the cytoplasm and vacuolar membranes. Sucrose transporters are 
responsible for sucrose translocation into the cytoplasm. The transported sucrose is subsequently 
converted into fructose and UDP-glucose by sucrose synthases (for review see: Koch, 2004; Roitsch 
and Gonzalez, 2004). The prominent sugar signalling cascade is connected to a hexokinase (HXK2), 
which was proposed to be a major sugar sensor in plants (Jang et al., 1997). Hexokinase substrates, 
such as glucose, mannose and 2-deoxyglucose inhibit the expression of photosynthetic genes 
INTRODUCTION  2 
suggesting a feasible effect of hexokinase signalling on gene expression (Jang and Sheen, 1994). A 
disaccharide, trehalose was reported to affect plant development and biochemical pathways (for 
review see Eastmond et al., 2003). Trehalose-6-phosphate is synthesized in Arabidopsis by trehalose-
6-phosphate synthase and is thought to be an inhibitor of hexokinase transcription (Avonce et al., 
2004). The downstream signalling pathways connected to hexokinases are still largely unknown. 
Analysis of mutations causing sugar insensitivity and oversensitivity revealed that many of them are 
allelic to mutations previously isolated in ABA and ethylene signalling pathways. These results 
indicate a close cross-talk between sugar and hormone signalling (for review see: Gazzarrini and 
McCourt, 2001; Leon and Sheen, 2003). The glucose signalling pathway(s) likely involve also AMP-
activated protein kinases that mediate the sensing of the cells’ energy status, modulate the activity and 
stability of metabolic enzymes, regulate gene expression and control the activity and stability of 
transcription factors (Hardie et al., 1998). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Simplified model of glucose signalling  
Extracellular sucrose (Suc) is either directly transported into the cell by sucrose transporters (SucT) or 
hydrolyzed into fructose (Fru) and glucose (Glu) by cell wall invertases (CWIN). These monosaccharides are 
exported directly into the cell by hexose transporters (HT). Sucrose synthases (SuSy) catalyze the 
sucrose→fructose + UDP-glucose reaction. Subsequently, fructose is phosphorylated by fructokinases (FRK). 
Fructose-6-phosphate (Fru-6-P) can be turned into glucose-6-phosphate (Glu-6-Pho) by hexose phosphate 
isomerases and in this form can enter into glycolysis, and further to fatty acid and amino acid biosynthesis. 
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Hexokinase (HXK2) phosphorylates glucose and is postulated to be a sugar sensor in plant cells. Downstream 
components of the sugar signalling pathway are not well known. It is suggested that ABA and ethylene 
signalling factors are also involved. Trehalose-6-phosphate (Tre-6-P), a negative regulator of hexokinase 
transcription, is synthesized from glucose-6-phosphate by trehalose phosphate synthases (TPSs). Trehalose-6-
phosphate is subsequently converted to trehalose (Tre) by trehalose-6-phosphate phosphatases (TPP) and 
trehalose is hydrolyzed into glucose molecules by trehalase (TRE). AMP activated protein kinases (AMPKs) 
represent sensors of cellular energy status and also involved in glucose signalling. 
 
1.2. Identification and characterization of the prl1 mutant 
Classical genetic approaches provide powerful tools for identification of genes involved in 
biochemical or developmental pathways of interest (Koornneef, 1991). Moreover, mutant isolation 
allows further characterization of potential genetic interactions (e.g., suppressor screens, epistasis 
analysis etc.). In order to identify novel factors in the sugar signalling pathway, a T-DNA tagged 
population of Arabidopsis thaliana Col-0 wild type plants was germinated on MSAR plates 
supplemented with either glucose or sucrose (0.1, 0.5, 2, 4, 6, 8 and 10%). 1200 segregating M2 
mutant families were screened to identify mutants showing germination defect and/or growth 
retardation in response to high sugar content (Nemeth et al., 1998). The life cycle of a candidate 
mutant was arrested on medium containing 6% sucrose or 5% glucose, and mutant plants died 
subsequently under these conditions (Figure 2 A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Phenotype of the prl1 mutant. 
The effects of a T-DNA insertion in the PRL1 locus were analyzed in comparison to wild-type Col-0 plants 
(placed left on the pictures). The figure was adapted and modified from Nemeth et al. (1998). (A) Seedlings were 
grown on 6% sucrose. (B) Seedlings on MSAR plates containing 0.5% sucrose at light conditions. (C) Soil-
grown plants. (D) Phenotype of rosette leaves. (E) Hypocotyls. (F) Roots five days after germination. (G) Root 
hair formation. 
 
The identified T-DNA insertion event in the PLEIOTROPIC REGULATORY LOCUS 1 (PRL1) 
resulted in a recessive mutation. Soil-grown mutant plants were smaller then wild type plants, the 
A B C D
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leaves were smaller with shorter petioles and had serrated margins (Figure 2 C and D). Chlorophyll 
and anthocyanin accumulated in the mutant; hence these plants were darker than the wild type. 
Glucose, fructose, sucrose and starch content of the leaves showed two- to five-fold increase in 
comparison to the wild type. The most characteristic phenotypic trait for the prl1 mutation was that the 
root elongation was reduced two- to three-fold both in light and dark conditions (Figure 2 B). Analysis 
of the root structure revealed that prl1 mutant seedlings developed early on side roots and showed 
ectopic root hair formation (Figure 2 F and G). In addition, elongation of the epidermal cells was 
inhibited and their number was duplicated in the hypocotyls (Figure 2 E). Hormone responses of the 
prl1 mutant were tested on MSAR plates containing auxins (2,4-dichlorophenoxyacetic acid- 2,4-D or 
1-naphtaleneacetic acid-NAA), cytokinins (N6-(isopentenyl)adenosine riboside or N6-benzyladenine), 
abscisic acid, salicylic acid, methyl jasmonate, brassinosteroids, gibberellins and ethephone (i.e. 
ethylene generating agent). In response to auxin treatment roots of the prl1 plants were converted into 
proliferating callus, while wild type roots developed numerous lateral roots densely covered by root 
hairs. In response to ABA treatment the prl1 mutant displayed hypersensitive seed germination and 
bleaching of seedlings at higher ABA concentrations. Combined cytokinin and sucrose treatment of 
wild type seedlings grown in the light was observed to phenocopy developmental defects of the prl1 
mutation. Etiolated plants treated with ethylene exhibited about 20 to 30% reduction of hypocotyl 
elongation. In addition, the prl1 mutant showed growth reduction at 14°C. 
 
1.3. The Arabidopsis PRL1 gene and PRL1 orthologs 
Molecular characterization of the prl1 mutation revealed that the T-DNA insertion was located in the 
fourth chromosome disrupting sequences of the gene At4g15900 between exons 15 and 17 (Nemeth et 
al., 1998). The transcribed region of the PRL1 gene is approximately 3.5 kb, covering a 38 bp 5’ UTR, 
17 exons and a 3’ UTR of 222 bp. The PRL1 cDNA of 1461 bp encodes a protein of 54 kDa carrying 
seven WD40 repeats in its C-terminal region. The PRL gene family is small; only one homolog of 
PRL1 was identified in the Arabidopsis genome. PRL2 (At3g16650) shows 83% amino acid identity 
with PRL1. The N-terminal region of PRL2 differs considerably from PRL1 (65% identity) as 
compared to homology between the C-terminal domains of these proteins (89% identity).  
A potential ortholog of PRL1, Prp5, was identified in a mutant screen for pre-mRNA splicing 
defects in fission yeast (Schizosaccharomyces pombe, Potashkin et al., 1998). The temperature 
sensitive prp5-1 (precursor mRNA processing 5-1) mutant was shown to accumulate unspliced U6 
snRNA precursor. The phenotype of prp5-1 yeast cells was analyzed under restrictive conditions. The 
mutant displays conventional cell division cycle (cdc) phenotype: the yeast cells are elongated and the 
chromatin is condensed into thin U-shaped structures. Flow-cytometry analysis revealed that the cells 
were arrested with 2C DNA content. This result indicated that the life cycle of prp5-1 mutant proceeds 
through the S phase of cell cycle and stops in G2. Prp46p, another ortholog of PRL1 in 
Saccharomyces cerevisiae, was identified in an extensive two-hybrid screen designed for isolation of 
mutations in new splicing factors that show interaction with the Prp22p DEAH-box RNA helicase 
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(Albers et al., 2003). Subsequently, Prp46p was found to interact with Prp45p, a direct binding partner 
of Prp22p. Deletion of the PRP46 gene results in non-viable haploid spores. Construction of a 
conditional mutant strain demonstrated that PRP46 is essential in budding yeast.  
PRL1-related proteins are highly conserved also in other eukaryotes. Fission yeast Prp5p shares 
69% identity with Arabidopsis PRL1, whereas budding yeast Prp46p shares 63% amino acid identity 
with PRL1. Analogously, sequence identity is 62% with a C. elegans PRL1 homologue and 59% with 
the human homologue PLRG1 (Nemeth et al., 1998). 
 
1.4. Conserved WD-repeat proteins 
The family of WD-repeat (also known as Trp-Asp, WD40 or β-transducin motif) proteins contains 
factors with diverse cellular functions, biochemical activity and subcellular localization. A unique 
feature of these proteins is that they share short, about 40 amino acid long tandem repeats starting with 
Gly-His and terminating mainly in Trp-Asp dipeptide motives (van der Voorn and Ploegh, 1992). 
Notably, sequence identity is low among the members of the WD-repeat family. Rather, they share a 
common three dimensional structure, which was first described in the case of the Gβ subunit of a 
heterotrimeric GTPase (Lambright et al., 1996). The β propeller structure of WD-40 proteins consists 
of seven blades formed by four antiparallel β sheets of WD-repeats (Figure 3). It was reported that one 
blade is not produced by a single repeat but the C-terminus of the first repeat interlocks with the N-
terminus of the next repeat, which might stabilize the three dimensional structure of these proteins 
(Jawad and Paoli, 2002). The overall structure is a hollow truncated cone, where the small hollow is 
completely occupied by water molecules (Madrona and Wilson, 2004). This arrangement is known to 
provide a solid platform for interacting proteins to bind. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Three dimensional structure of WD40 proteins 
The structure of ScBub3p was chosen as a representative of WD-repeat proteins (Larsen and Harrison, 2004). 
WD40 repeats form four antiparallel β sheets organized into a seven-bladed β propeller structure. 
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 Comparative analysis of WD-40 proteins in the Arabidopsis genome was performed by van 
Nocker and Ludwig (2003). This investigation revealed that 269 Arabidopsis proteins contain at least 
a single WD40-motif, but the majority of the proteins (237) carry four or more tandem repeats. 
CONSTITUTIVE PHOTOMORPHOGENIC 1 (COP1) is one of the well-characterized members of 
this family. COP1 carries three distinct domains: a RING-finger motif followed by a coiled coil 
domain and the WD40 domain (for review see: Yi and Deng, 2005). COP1 was identified as negative 
regulator of light-dependent photomorphogenic development, since cop1 mutants show constitutive 
photomorphogenic phenotype in the darkness (Deng et al., 1991). COP1 functions as E3 ubiquitin 
ligase that controls the degradation of transcription factors HY5, HYH, LAF1 and HFR1 by the 26S 
proteasome complex (Saijo et al., 2003; Jang et al., 2005). 
 
1.5. PRL1 family members are subunits of conserved splicing-associated complexes 
Biochemical studies revealed that PRL1 orthologs are subunits of evolutionary conserved 
spliceosome-associated protein complexes. Mass spectrometric analyses have identified components 
of such complexes in Schizosaccharomyces pombe (McDonald et al., 1999; Ohi et al., 2002), 
Saccharomyces cerevisiae (Tsai et al., 1999; Ohi et al., 2002; Hazbun et al., 2003) and human cell 
cultures (Ajuh et al., 2000). Some of these experiments used the budding yeast SpCdc5p, fission yeast 
ScCef1p and human HsCDC5L proteins as baits and therefore the associated factors were termed as 
Cwfs or Cwcs (complexed with Cef1p/Cdc5p) or CCAPs (CDC5L complex associated proteins). 
Sequence analysis of spliceosome-associated proteins isolated by immunopurification of CDC5 
complexes exposed that the Cwf/CCAP complexes (Tarn et al., 1994, Chen et al., 2001, 2002) share 
common components with the exhaustively studied Prp19p-associated complex (Ntcstands for Prp 
nineteen complex; Tsai et al., 1999, Ohi and Gould, 2002). The Ntc complex contains at least 11 
proteins, whereas 27 distinct factors were identified in the Cwf/Cwc complexes. The common core of 
Prp and Cwf/Cwc complexes is composed of the Prp19p, Syf1p (Ntc90p), Cef1p (Ntc85p), Clf1p 
(Ntc77p), Prp46p (Ntc50p), Cwc2p (Ntc40p), Syf2p (Ntc31p), Isy1p (Ntc30p), Snt309p (Ntc25p) and 
Ntc20p protein subunits. Elements of Prp and Cwf/Cwc complexes are not yet characterized in 
Arabidopsis thaliana (Table 1). 
 
1.5.1. Prp19 
Budding yeast Prp19 was identified in a screen searching for temperature sensitive mutants with 
impaired pre-mRNA splicing (Vijayraghavan et al., 1989). Prp19 was found to carry three canonical 
domains: a U-box, a coiled coil and a WD40 domain. Members of the U-box protein family were 
recently identified to function as novel E3 ubiquitin ligases. Comparative sequence analyses and 
protein modelling studies suggest that the U-box is a derivative of the RING-domain. However, the 
zinc chelating cysteine residues are not conserved in the U-box proteins (Aravind and Koonin, 2000). 
The structure of Prp19p was defined using NMR spectroscopy (Ohi et al., 2003) and x-ray 
crystallography with multi-wavelength anomalous diffraction experiments (Vander Kooi et al., 2006). 
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The Prp19p U-box domain folds into a similar tertiary structure like RING-fingers; a central α-helix is 
surrounded by four β-strands and a hydrophobic core. Instead of Zn2+ ions, hydrogen bonds and salt 
bridges stabilize the U-box structure (Ohi et al., 2003). Prp19p forms homotetramers in vitro through 
its coiled coil domain (Figure 4). The U-box domains are located at close proximity of the central 
coiled coil bundle, whereas the WD40-repeats are flexibly attached (Ohi et al., 2005, Vander Kooi et 
al., 2006). It is suggested that the U-box is responsible for binding of an E2 ubiquitin conjugating 
enzyme and that the WD40-repeats can bind the target proteins. Point mutations in the coiled coil 
region inhibiting tetramerization of Prp19p cannot complement the lethal phenotype of budding yeast 
prp19 mutant suggesting that the tetramer formation is essential for proper function of the Ntc 
complex in vivo (Ohi et al., 2005). The Prp19 U-box protein displays ubiquitin ligase activity in vitro 
(Hatakeyama and Nakayama, 2003, Ohi et al., 2003). Surprisingly, the prp19-1 splicing mutant 
suffered a V14I substitution in the U-box domain resulting in splicing deficiency. This mutation 
disrupted the three dimensional structure of the central hydrophobic core region, which might be 
responsible for interaction with an E2 ubiquitin conjugating enzyme (Ohi et al., 2003). Point mutations 
disrupting the predicted E2 interface cannot complement the prp19-1 mutant phenotype; however, the 
protein folding is not affected (Ohi et al., 2003). Human HsPrp19 interacts directly with the β7 subunit 
of the 20S proteasome (Loscher et al., 2005). There are only two U-box genes, UFD2 and PRP19 in 
budding yeast, and six genes UFD2a, UFD2b, CHIP, UIP5, CYC4 and PRP19 in mammals. In 
Arabidopsis, 37 genes are predicted to encode U-box-like factors, two of them represent homologues 
of Prp19p (At1g04510 and At2g33340; for review see Azevedo et al., 2001).  
S. cerevisiae A.thaliana Conserved domains Reference 
AtPrp19a At1g04510 
Prp19p 
AtPrp19b At2g33340 
U-box, coiled coil, WD40 Ohi et al., 2002; Chen et al., 2002 
Syf1p (Ntc90p) AtSyf1 At5g28740 Tetratricopeptide repeats Chen et al., 2002 
Cef1p (Ntc85p) AtCDC5 At1g09770 Myb repeats McDonald et al., 1999; Ohi et al., 2002
AtCRN1a At5g45990 
AtCRN1b At3g13210 
AtCRN1c At5g41770 
Clf1p (Ntc77p) 
AtCRN2 At3g51110 
Tetratricopeptide repeats Chung et al., 1999; Chen et al., 2002 
AtPRL1 At4g15900 
Prp46p (Ntc50p) 
AtPRL2 At3g16650 
WD40 Ajuh et al., 2001; Ohi et al., 2002 
AtECM2-1a At1g07360
AtECM2-1b At2g29580Cwc2p (Ntc40p) 
AtECM2-2 At5g07060 
RNA recognotion motif Ohi et al., 2002 
Syf2p (Ntc31p) AtSyf2 At2g16680 not identified Chen et al., 2002  
Isy1p (Ntc30p) AtIsy1 At3g18790 Isy1-like splicing family Chen et al., 2001 
Snt309p (Ntc25p) not found not identified Chen et al., 1998; 1999 
Ntc20p not found not identified Chen et al., 2001 
 
Table 1. Components of the yeast Prp19-associated protein complexes and their potential orthologs in 
Arabidopsis 
The table was adapted and modified from Wang and Brendel (2004). 
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Figure 4. The Prp19-associated complex 
(A) Prp19 forms a homotetrameric complex through its coiled coil domains. The U-box domains (U) probably 
interact with E2 ubiquitin conjugating enzymes, whereas the WD40-repeats are likely involved in substrate 
binding. (B) Identified protein interactions in the Prp19- Ntc- complex. The figure was adapted from Ohi et al. 
(2005).  
 
A weak thermo-conditional mutant allele of prp19 was isolated in a mutant screen searching for 
photoactivated psoralen-sensitive yeast mutants (pso mutants, for review see: Brendel et al., 2003). 
These chemicals are successfully used in treatment of skin disorders; however, the risk of skin cancer 
among the patients increased significantly due to induced DNA lesions. Mutations in the PSO4 gene 
were found to cause pleiotropic defects, including increased sensitivity to DNA damaging agents 
(chemicals and irradiation), low frequency of spontaneous and induced recombination (i.e., gene 
conversion, crossing over and intrachromosomal recombination). The pso4 mutation, which entirely 
blocks pre-meiotic DNA synthesis and sporulation, proved to be allelic with the prp19 mutation 
indicating involvement of PRP19 in error-prone DNA repair (Grey et al., 1996). The core Ntc complex 
(Prp19, Cdc5, Prlg1 and Spf27) is associated with the WRN protein, a RecQ-type DNA helicase and 
involved in inter-strand cross-link repair (Zhang et al., 2005). In other studies, Prp19 was shown to 
interact with the terminal deoxynucleotidyl transferase and to play an important role in double-strand 
DNA repair (Mahajan and Mitchell, 2003). Prp19 was also found in a survey for differentially 
expressed genes in senescent human cells (SNEV= Senescence Evasion Factor; Grillari et al., 2000). 
SNEV transcription is repressed in senescent human cells, whereas higher SNEV mRNA level is 
detected in tumour cell lines (Voglauer et al., 2006). Overexpression of SNEV results in an extended 
life span of endothelial cell lines in vitro. This phenomenon is not connected to increased telomerase 
activity, but the cells show elevated resistance to genotoxic and oxidative stress factors causing 
double-stranded DNA breaks. The natural occurrence of DNA damage was also significantly lower in 
the SNEV overexpression lines. SNEV mRNA is upregulated in malignant breast cancer cells. 
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However, patients expressing enhanced level of SNEV had better survival rate and the formation of 
lymph node metastases was significantly decreased.  
Proteome analysis of nuclear matrix proteins with increased capability of reassembling resulted 
in the isolation of human nuclear matrix protein 200 (hNMP 200), which was later shown to be 
identical to Prp19 (Gotzmann et al., 2000). Study of subcellular localization of GFP-tagged hNMP 200 
indicated that this protein is mainly located in the nucleus, but not in the nucleolus. At the nuclear 
periphery, speckle formation was detected. In prophase, hNMP 200 is uniformly distributed and not 
associated with the chromosomes. In metaphase, an enhanced hNMP 200 signal is detected around the 
aligning chromosomes. During anaphase, hNMP 200 is localized to the mitotic spindles throughout 
chromosome segregation.  
 
1.5.2. CDC5 
Cdc5p is highly conserved both structurally and evolutionally through various model organisms (Ohi 
et al., 1998; Hirayama and Shinozaki, 1996). Initially, cdc5+ was identified as a cell division cycle 
mutant in S. pombe. The cdc5-120 mutation arrests cells in the G2 phase of cell cycle before mitosis 
(Ohi et al., 1994). The N-terminal region of Cdc5 carries three helix-turn-helix DNA-binding Myb 
domains referred to as R1, R2 and R3. However, the third repeat is imperfect as it possesses a Val-Leu 
substitution at a critical position (Carr et al., 1996; Ogata et al., 1996). In the Arabidopsis genome, 
three groups of Myb proteins are encoded: Myb1R factors with one, R2R3-type Myb factors with two, 
and Myb3R proteins with three Myb repeats (for review see Jin and Martin, 1999; Stracke et al., 
2001). Two well-characterized members of the MybR1 family are the circadian clock-related 
transcription factors CCA1 (Circadian Clock Associated 1) and LHY1 (Late elongated Hypocotyl 1). 
The majority of plant Myb-like regulators carries two repeats and is involved in diverse regulatory 
processes (e.g., Transparent testa 2-TT2, Production of anthocyanin pigment 1-PAP1, Glabrous 1-
GL1, Assymetric leaves 1-AS1, Werewolf-WER). The Myb3R factors are involved in cell cycle 
regulation.  
 Arabidopsis CDC5 binds double-stranded DNA in a sequence specific manner. CDC5 
recognizes the CTCAGCG (complementary CGCTGAG) consensus sequence (Hirayama and 
Shinozaki, 1996). Human HsCdc5 binds a consensus sequence of 12 bp (GATTTAACATAA). The 
core ANCA motif is a typical target for Myb-like helix-turn-helix transcription factors. The flanking 
symmetrical TTA/TAA sequence increases the binding affinity of Cdc5 (Lei et al., 2000). A CDC5 
ortholog in the basidiomycete mushroom Lentinula edodes specifically binds to the sequence 
GCAATGT (Miyazaki et al., 2004). However, budding yeast ScCef1p, which can complement the 
fission yeast cdc5-120 mutation, was not observed to have any DNA binding activity (Ohi et al., 
1998).  
Cdc5 is phosphorylated by a cAMP-dependent protein kinase in Lentinula (Miyazaki et al., 
2004). PCDC5RP immunopurified from COS-7 cells is also phosphorylated (Bernstein and Coughlin, 
1997), whereas rat Cdc5 is suggested to be a substrate for protein kinase CK2 (Engemann et al., 2002). 
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Human CDC5L is known as a mitotic phosphoprotein; it is phosphorylated in vitro by cyclinB-cdc2 
and cyclin E-cdc2 (Stukenberg et al., 1997; Boudrez et al., 2000). CDC5 was found to interact with a 
DAP-like serine/threonine-specific protein kinase in the yeast two-hybrid system and this result was 
verified by in vitro binding experiments (Engemann et al., 2002). Co-localization studies further 
support direct interaction between these proteins, since the DAP-kinase and CDC5 are both localized 
to nuclear speckles. However, Cdc5 is not phosphorylated by the DAP-like kinase in vitro. Cdc5 is 
also a binding partner of NIPP1, a member of PP1 serine/threonine protein phosphatase regulator 
factors that shows co-purification and co-localization with PP1C and CDC5L (Boudrez et al., 2000). 
This interaction depends on the phosphorylation state of CDC5L, only phosphorylated CDC5L is able 
to bind to NIPP1.  
In Arabidopsis a single gene encodes a CDC5 ortholog. Arabidopsis AtCDC5 (At1g09770) can 
complement the S. pombe cdc5-120 mutation suggesting functional similarity of CDC5 orthologs 
between different organisms (Hirayama and Shinozaki, 1996). Expression of the AtCDC5 gene was 
analyzed by in situ hybridization and Northern blot experiments. The AtCDC5 mRNA shows a strong 
localization to shoot and root apical meristems and leaf primordia. AtCDC5 is expressed in most 
tissues studied; the highest transcript levels are detected in roots. 
 
1.5.3. Crooked neck (CRN) proteins 
The Crooked neck (crn) locus was originally identified in a genetic screen for Drosophila embryo 
lethal mutations and mapped into the X chromosome. Crn mutant embryos display serious disorders 
during the development of nervous system, midgut and muscles (Perrimon et al., 1984). Yeast crn 
knockout mutant shows a cell cycle phenotype, the dividing cells are arrested between the G2 and M 
phase (Russell et al., 2000; Zhu et al., 2002) The CRN protein belongs to the tetratricopeptide repeat 
(TPR) family. The TPR motif is involved in mediation of protein-protein interactions (for review see 
Blatch and Lassle, 1999). Orthologs of CRN (Clf1p/Syf3p/Ntc77p) protein were characterized in 
connection with the spliceosome complex in yeast (Chung et al., 1999; Wang et al., 2003), in 
Drosophila (Raisin-Tani and Leopold, 2002) and in humans (Chung et al., 2002). In yeast, however, 
Clf1p (Crooked neck-like factor 1) is considered as one of the moonlighting proteins  with a novel role 
in DNA replication (Jeffery, 2003). Temperature sensitive clf1 mutants show cell cycle arrest between 
the G2/M transition (Zhu et al., 2002). However, when cells are blocked in G1 with α-factor, they 
display a delay in DNA accumulation and fail to enter the S phase. Physical interaction between Clf1p 
and the replication origin binding ORC complex was detected by yeast two-hybrid analysis and co-
immunoprecipitation. A possible link between Clf1 and vesicular transport proteins is also suggested 
(Vincent et al., 2003). The Arabidopsis genome encodes four Crn orthologs: AtCRN1a (At5g45990), 
AtCRN1b (At3g13210), AtCRN1c (At5g41770) and AtCRN2 (At3g51110), but these genes are yet 
not characterized. 
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1.6. Function of the Prp19-associated complex in splicing 
Transcription of eukaryotic genes that carry protein coding exons and non-coding intervening 
sequences, called introns, results in the synthesis of precursor RNA molecules. The intron sequences 
are excised from the pre-mRNAs in the nucleus and the messenger RNAs are transported to the 
cytoplasm for protein translation. Pre-mRNAs carry short consensus sequence elements at the 5’ (GU) 
and 3’ (AG) ends of intron boundaries flanking an internal branch site (UACUAAC).These sequences 
are recognized by the splicing machinery. The splicing reaction occurs by two trans-esterification 
reactions, in which covalent bonds are transferred from one location to another. This reaction does not 
require ATP hydrolysis. A free 2’-hydroxyl group of the branch site attacks the phosphate at 5’-end, 
and the reaction yields a looped lariat intermediate with the intron sequence and a cut mRNA. In the 
second step, the 3’-hydroxyl group of 5’-exon attacks the 3’ splice site resulting in a spliced and 
ligated mRNA molecule and a lariat form of intron sequence. 
 The large holoenzyme complex catalyzing the intron excision is named spliceosome that 
carries small nuclear ribonucleoprotein particles (snRNPs; U1, U2, U4, U5 and U6). The assembly of 
spliceosome and the splicing reaction are highly organized sequential process (for reviews see: Staley 
and Guthrie, 1998; Murray and Jarrell, 1999; Lorkovic et al., 2000) (Figure 5). The first step is the 
formation of the E (early presplicing) complex, in which the U1 snRNP binds to the 5’ splice junction 
in a sequence specific manner aided by complementary snRNA of this ribonucleoprotein complex. 
Subsequently, U2 binds to the branch site and the A complex of spliceosome, which is also called a 
pre-spliceosome, is assembled. The B complex is formed in two steps. First, the U5/U4/U6 tri-snRNPs 
bind to the precursor RNA-splicing complex, which undergoes a structural rearrangement by releasing 
the U1 and U4 particles. This step is followed by formation of base pair interactions between U6 and 
U2, and between U6 and the 5’ splice site. During these stages, an enzymatically active spliceosome C 
complex is assembled that can catalyze intron excision and exon ligation by two trans-esterification 
reactions.  
 With the discovery of AT-AC type introns, which represent a minor class of intron regions 
defined by evolutionally conserved but distinct consensus sequences at the 5’ and 3’ splicing 
junctions, the existence of an alternative spliceosome became evident (for reviews see Kreivi and 
Lamond, 1996; Tarn and Steitz, 1997; Lorkovic et al., 2000). This alternative splicing complex shares 
only the U5 snRNP component with the canonical spliceosomal complex and contains unconventional 
U11, U12, U4atac and U6atac particles.  
The Prp19/Cdc5 related complex is associated with the U2/U5/U6 tri-snRNP complex (Tarn et 
al. 1994; Ohi et al., 2002). The assembly of spliceosome and formation of intermediates can be 
analyzed using different ATP concentrations in vitro. At low ATP concentration inactive pre-splicing 
forms of spliceosome (Complex A and B) accumulate, while increasing the ATP concentration 
induces the assembly and rearrangement of spliceosome as these steps requires ATP hydrolysis. The 
analysis of distinct snRNP complexes revealed that the Ntc complex is associated to the spliceosome 
after the release of the U4 particle (Chan et al., 2003). After dissociation of U4 snRNP, the splicing 
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complex is reorganized and the spliceosome becomes activated. Three complementary binding sites 
were identified for the U6 snRNP at the 5’-splice junction by cross-linking experiments (Chan et al., 
2003). One was predominantly found in inactive spliceosome complexes, whereas the two others were 
identified during the splicing reaction suggesting that a switch in binding happens during spliceosome 
activation. The Ntc-depleted U6 snRNP is exclusively found in inactive binding regions (Chan and 
Cheng, 2005). Similarly, the U5 snRNP occupies only two inactive binding sites in Ntc-depleted 
splicing reactions. These data suggest that the Ntc complex is required for the stable association of 
U5/U6 snRNPs to the mRNA complementary sequences, and that the Ntc helps to lock the 
spliceosome at the active position. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Role of Ntc Prp19-complex in splicing 
Intron excision and exon ligation are highly organized sequential processes. Splicing starts with the recognition 
of 5’-splice site by the U1 snRNP (E complex). Subsequently, the U2 particle binds to the branch site of the 
intron (A complex). The B complex, carrying all five snRNPs on the precursor RNA, is still inactive. After the 
releasing of U1 and U4 snRNPs the spliceosome becomes activated by the Ntc complex (C complex). The active 
spliceosome catalyzes two trans-esterification reactions that result in the removal of intervening intron and 
ligation of adjacent exons. 
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1.7. PRL1 interacts with SNF1 related protein kinases of AMP-activated (AMPK) 
kinase family 
Since mutation of the PRL1 gene causes severe sugar and hormone-related phenotypic defects, it was 
assumed that signalling through PRL1 could be connected to overall regulation of these pathways by 
AMP-activated protein kinases (AMPKs). These kinases play a central role in the maintenance of a 
constant high ratio of ATP:ADP to store adequate energy source for normal cellular functions. Under 
stress, when ATP is limiting, the adenylate kinase catalyses the reaction of 2ADP→ATP + AMP, and 
accumulation of the AMP signal is an indicator of cell starvation (for reviews see: Hardie et al., 1998; 
Hardie, 2004). AMPKs play in role in the regulation of stress responses (e.g., oxidative stress and 
hypoxia) that lead to sudden decrease of intracellular ATP level. AMPK core complexes consist of 
three distinct subunits, the catalytic α, substrate targeting β and activating γ subunits. AMPK α 
subunits (e.g., Snf1 in yeast) carry a conserved serine/threonine protein kinase domain at their N-
termini and a C-terminal regulatory domain targeted by interactioning proteins. The substrate targeting 
β subunits (e.g., Sip1, Sip2 and Gal83 in yeast) carry a KIS (kinase interaction sequence) domain, 
which is known to bind glycogen in mammalian cells, and an interaction domain called ASC 
(association with SNF1 complex). Downstream of the highly variable N-terminal sequences, the 
AMPK γ-subunits (e.g., Snf4 in yeast) contain four tandem CBS (cystathionine β-synthase) domains, 
which are important for AMP and ATP binding. Snf1, the prototype of AMPK family in yeast, plays a 
key role in glucose repression through inhibiting the Mig1p transcriptional repressor of glucose 
regulated genes and activation of Sip4 and Cat8 positive regulators, which activate gene expression in 
response to glucose starvation (for review see: Carlson, 1999). 
Using Arabidopsis PRL1 in fusion with the Gal4 activation domain, possible PRL1 interactions with 
budding yeast Snf1p (sucrose non-fermenting 1) and Snf4p AMPK subunits were tested in two hybrid 
experiments by Bhalerao et al. (1999). The activation of HIS3 and LacZ reporter genes was observed 
in the yeast strain expressing SNF1-GBD and PRL1-GAD. Three orthologs of Snf1p were identified in 
Arabidopsis referred to as SNF-related protein kinase 1α (SnRK1α) or AKIN10, AKIN11 and 
AKIN12. Two of them, AKIN10 and AKIN11, were demonstrated to interact with PRL1 in the yeast 
two-hybrid system. The positions of the interaction domains in PRL1 and the SnRK1α kinase subunits 
AKIN10 and AKIN11 were mapped using a set of deletion constructs. These data indicated that an N-
terminal region of PRL1 residing between amino acid residues 35 and 195 is required for interaction 
with AKIN10 and AKIN11. The C-terminal WD40-repeat domain of PRL1 appeared to inhibit 
binding of these kinases as the strength of interaction observed with the full-length PRL1 protein was 
weaker as compared to the N-terminal domain. The PRL1-binding region was mapped to the C-
terminal SNF4-binding region of AKIN10 kinase subunit. The interaction between PRL1 and 
AKIN10/11 kinases was induced in yeast by low glucose (0.05%) treatment (i.e. glucose starvation). 
The interaction between PRL1 and AKIN10/11 kinases was confirmed in protein binding assay in 
vitro. PRL1 was observed to inhibit in a concentration dependent fashion the phosphorylation activity 
of both AKIN10 and AKIN11 kinases towards the specific TRX-KD substrate in vitro. 
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1.8. Arabidopsis SnRK1α kinases are found in association with the proteasome 
Recent studies highlighted the essential role of protein degradation in the control of basic cellular 
functions in plants. Surprisingly, approximately 5% of the Arabidopsis proteome represents factors 
involved in protein degradation (for review see Smalle and Vierstra, 2004; Moon et al., 2004). From 
the various proteolysis pathways, the ubiquitin/proteasome pathway is the best characterized and 
thought to be the most important in the plant system. In this pathway, proteins targeted for degradation 
are marked with ubiqutin (Ub) chain formation on lysine residues. The ubiquitination cascade is ATP 
dependent and requires three catalytic steps. An ubiquitin activating enzyme (E1) forms a thioester 
bond with the Ub and transfers Ub to the ubiquitin conjugating enzyme (E2). Ubiquitin ligases (E3s) 
play crucial roles in the recognition of substrates and in subsequent formation of Ub-chains on their 
substrate targets. The 26S proteasome degrades the ubiquitinated proteins. This multisubunit enzyme 
complex consists of a cylindrical 20S core particle and two 19S lid subunits at the ends.  
 
 
 
 
 
 
 
 
 
Figure 6. Proteasomal complexes of SnRK1α AMPK kinases 
PRL1 is a negative regulator of SnRK1α kinases (AKIN10/11) and competes for a common binding site shared 
with the SKP1/ASK1 SCF E3 ubiquitin ligase subunit. The model proposes that SnRK1α kinase and the SCF E3 
ligase subunits CULLIN 1 and SKP1/ASK1 are assembled in a common SCF-proteasome complex when PRL1 
is depleted (e.g., degraded). This figure is adapted from Farras et al. (2001). 
 
The SnRK1α subunits, AKIN10 and AKIN11 were used as baits in yeast-two-hybrid assay, in order to 
find specific interacting partners. Some well-known elements of the proteasomal degradation system 
were uncovered by this screen. SKP1/ASK1 (S phase kinase-associated protein 1/Arabidopsis Skp1-
like 1) and the α4/PAD1 subunit of the 20S proteasome were found to bind specifically to the C-
terminal domains of AKIN10 and AKIN11 kinases (Farras et al., 2001). These data were also 
confirmed by in vitro binding assay. The ASK1-binding domain of SnRK1α kinases were identified 
using a series of deletion constructs and mapped to the region of C-terminal regulatory domain of 
AKIN11, which interacts with the β and γ SnRK1 subunit and PRL1. Competitive binding 
experiments showed that PRL1 inhibits interaction of SKP1/ASK1 with the SnRK1α kinase subunits. 
The SnRK1α subunits co-purified with the 26S proteasome isolated from Arabidopsis cell suspension. 
Co-immunoprecipitation experiments with total protein extract and purified proteasome from 
CaMV35S::ASK1-HA expressing cell suspension revealed that an SnRK1α kinase subunit, either 
AKIN10 or AKIN11 occurs in common proteasomal complexes with the SKP1/ASK1 and CULLIN 1 
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subunits of SCF E3 ubiqutin ligase complexes. These data suggested that when PRL1 binds to the 
SnRK1α kinases the SKP1/ASK1 subunit of SCF E3 ubiquitin ligases is competed out (Figure 6). 
Hence, PRL1 and SKP1/ASK1 are predicted to occur in distinct proteasomal complexes. 
Consequently; when the SnRK1α kinase is no longer inhibited by PRL1, interaction of the kinase with 
SKP1/ASK1 can target SCF E3 ubiquitin ligase complexes and their specific substrates to the 
proteasome. 
 
1.9. Aims of the present work 
Carbohydrates play a central role in plant metabolic and developmental processes. Nonetheless, the 
mechanisms governing sugar signalling are still not understood in detail. With the isolation of the prl1 
insertion mutant, a potential novel regulator in the sugar signalling cascade was identified (Nemeth et 
al., 1998). The prl1 mutant displayed hypersensitivity to sucrose, glucose and plant hormones, such as 
ethylene, ABA, auxin and cytokinin. Moreover, several sugar, ethylene and ABA regulated gene was 
found to be upregulated by the prl1 mutation. Several PRL1 interacting partners, including the 
SnRK1α subunits of Arabidopsis AMP-activated kinase orthologs, were identified in yeast-two-hybrid 
screens and confirmed by in vitro pull-down assays (Bhalerao et al., 1999). Further studies suggested 
that PRL1 inhibits the activities of SnRK1α kinases and competes with binding of the SKP1/ASK1 
subunits of SCF E3 ubiquitin ligase subunit to proteasome-associated SnRK1α proteins (Farras et al., 
2001). This data connected PRL1 function to SCF and proteasome-dependent protein degradation 
pathways. 
 
The major goal of the Ph.D. project was to characterize some of the regulatory roles played by PRL1 
in sugar, hormone and developmental pathways. The studies described in this thesis were designed  
Ö To characterize temporal and spatial regulation of PRL1 promoter activity using β-Glucuronidase 
reporter gene fusions with PRL1 transcription regulatory sequences, 
Ö  To characterize regulatory elements of the PRL1 promoter using a set of promoter deletions,  
Ö To search for transcription factors that bind to regulatory elements of the PRL1 promoter in yeast 
one-hybrid assays, 
Ö The study cellular and subcellular localization of the PRL1 protein using HA-epitope labelled and 
GFP-tagged PRL1 constructs in combination with indirect immunofluorescence confocal laser 
scanning microscopy,  
Ö To analyse the effects of PRL1 misexpression using genomic and cDNA constructs expressed by 
cell type and tissue specific promoters in a prl1 genetic complementation system, 
Ö  To study the stability of PRL1 protein in planta using a chemically-inducible gene expression 
system,  
Ö To test possible involvement of proteasome-dependent degradation in the regulation of PRL1 
protein stability in cell suspensions and in planta using proteasome inhibitors, 
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Ö To identify possible destruction signals (degrons) and analyse their effects on the stability of 
PRL1 protein by site-specific mutagenesis and expression studies in cell suspension and in planta. 
Ö To perform basic biochemical characterization of the PRL1 protein complex using epitope 
labelling and immunoprecipitation approaches, 
Ö To test potential interaction of PRL1 with the evolutionary conserved spliceosome-associated 
AtCDC5 protein in yeast two-hybrid and immunoprecipitation assays, 
Ö To investigate potential proteasomal interaction of PRL1 and AtCDC5 proteins using 
immunoprecipitation and western blotting with specific antibodies. 
Ö To identify new prl1 mutant alleles and search for mutations in the PRL2 gene that codes for a 
PRL1 homologue,  
Ö To initiate the construction of prl1 double mutants with mutations in genes coding for PRL1 
interacting proteins, and  
Ö To perform site-directed alanine scanning mutagenesis of PRL1 for further mapping of regulatory 
and protein interaction domains. 
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2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Chemicals, enzymes and laboratory supplies  
Company      Product 
Affiniti Research Products Ltd., Mamhead, UK: Antibodies 
 
Amersham Biosciences GmbH, Freiburg, Germany:  ECLTM Enhanced Chemiluminescence Kit 
Gradient mixer 
       HybondTM-N nylon membrane 
HyperfilmTM  
       Peristaltic pump 
 
Beckman Instruments Inc., Palo Alto, USA:  Centrifuge tubes 
 
Bethyl Laboratories Inc., Montgomery, USA:  Anti-Ubiquitin antibody 
 
BIOMOL GmbH, Hamburg, Germany:  X-Gal(5-Bromo-4-Chloro-3-Indolyl-1-ß-D-
galactopyranoside) 
  X-Gluc(5-Bromo-4-Chloro-3-Indolyl-1-ß-D-
glucuronide CHA-salt) 
 MG132 
 
Bio-Rad, München, Germany:    Bradford Reagent 
       Pre-stained Protein Standard 
       Goat anti-Rabbit-HRP IgG (H+L) 
 
Boehringer Mannheim, Germany:   RNase A 
        
Calbiochem Corp., Darmstadt, Germany:  Ethidium bromide 
       Miracloth 
 
Clontech, Palo Alto; USA:    Salmon sperm carrier-DNA 
TransfromerTM site-directed mutagenesis kit 
 
Corning Inc., Corning, USA:    Costar® Disposable Serological Pipettes 
 
Difco Laboratories, Detroit, USA:   Bacto-agar 
       Bacto-peptone 
       Bacto-tryptone 
       Yeast Extract 
       Yeast Nitrogen Base without amino acids 
 
Duchefa, Haarlem, the Netherlands:   ATP 
Carbenicillin Disodium Salt 
       Cefotaxime sodium  
       Phytoagar 
       Ticarcillin/Clavulanic Acid 
 
Eppendorf AG, Hamburg, Germany:   Safe-lock tubes (0.5, 1.5 and 2.0 ml) 
Single use pipette tips 
 
Eastman Kodak Co., Rochester, USA:   Kodak X-Omat AR-5 Film 
 
Cambrex Bio Science Inc., Rockland, USA:   Seakem® LE Agarose 
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Invitrogen GmbH, Karlsruhe, Germany:  1kb molecular mass marker 
       Gateway® LR ClonaseTM enzyme mix 
       Platinum® Pfx DNA polymerase 
       Restriction endonucleases 
       Taq DNA Polymerase, recombinant 
 
Greiner bio-one GmbH, Kermsmünster, Austria: Petri dishes 
       Falcon tubes (15 and 50 ml) 
       Cellstar® Suspension culture plates 
 
Heirler Cenovis GmbH, Radolfcell, Germany:  Milk Powder  
 
Merck, Darmstadt, Germany:    2-propanol 
       Chloroform 
       Ethanol 
       D-Glucose 
Glycine 
       Nystatine 
       N,N-dimethylformamide 
       General chemicals 
 
Metabion International AG, Martinsried, Germany Oligonucleotides 
 
Millipore, Bedford, USA:    Filter 0.025μm white VSWP 
       ImmobilonTM-P (PVDF membrane) 
       SterivexTM 0.22µM filter units 
 
New England Biolabs, Frankfurt am Main, Germany: Antarctic Phosphatase 
Restriction Endonucleases 
T4 DNA ligase    
 T4 Polymerase 
 
Qiagen GmbH, Hilden, Germany:   QIAprep® Spin Miniprep kit 
       QIAquick® Gel extraction kit 
QIAquick® PCR purification kit 
 
Peqlab Biotechnologie GmbH, Erlangen, Germany: E.Z.N.A.® Plasmid miniprep kit I. 
 
Pierce Biotechnology Inc., Rockford, USA:  Goat anti-Chicken IgG, (H+L), HRP 
       Goat anti-Rabbit IgG, (H+L), HRP 
       Rabbit anti-Chicken IgG, (H+L), HRP 
       RestoreTM Western Blot Stripping Buffer 
 
Riedel de Haen, Seelze, Germany:   Ca-hypochlorite  
 
Roche Diagnostics GmbH, Mannheim, Germany: Alkaline phosphatase from calf intestine 
anti-GFP 
       anti-HA 
       anti-c-Myc 
       Hygromycin 
 
Carl Roth GmbH, Karlsruhe, Germany:   dNTP solutions 
Filter units 0.22μm 
       Phenol 
       Rotiphorese® 40 (29:1) 
 
Santa Cruz Biotechnology Inc., Santa Cruz, USA: Protein A/G PLUS-Agarose 
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       HA probe (F-7) 
 
Sartorius AG, Göttingen, Germany:   Minisart 0.22µm and 0.45µm filter units 
 
Serva Electrophoresis GmbH, Heidelberg, Germany: Bromphenol Blue-Na-salt 
Ponceau S solution 
       Sarcosyl 
SDS 
 
Sigma-Aldrich Co., St. Louis, USA:   Amino acids 
Ammoniumpersulfate 
Antibiotics 
       BSA 
c-Myc peptide 
Cyclohexymide 
CTAB (Cetyl-trimethylammonium bromide) 
       DTT (Dithiothreitol) 
       Goat anti-Rat IgG, (H+L), HRP 
HA-peptide 
Igepal 
       Lithium acetate 
Lyticase 
       MS-Basal salt mixture 
       MS-Basal salt with minimal organics/ MSMO  
 PEG (Polyethylene glycol) MW 3350 
       PMSF (Phenylmethylsulphonyl fluoride) 
       PVP-40 (Polyvinyl pyrrolydone-40) 
       β-mercaptoethanol 
       Sodium deoxycholate 
Sucrose 
TEMED 
       TritonX-100 
       Tween-20 
       General chemicals 
 
Upstate Co., Lake Placid, USA:    Anti-Histone 2A antibody 
 
Takara Bio Inc., Otsu, Shiga, Japan:   TaKaRa LA TaqTM DNA Polymerase 
 
Whatman, Maidstone, USA:    3MM paper 
       Whatman circles 
 
 
2.1.2. Bacterial Strains 
2.1.2.1. E. coli strains 
BMH 71-18 mutS  thi supEΔ(lac-proAB) [mutS::Tn10][F' proAB, lacIq ZΔM15] 
 
DB3.1 F- gyrA462 endA1 (sr1-rec A) mcr B mrr hsd S20(rB- ,mB-) sup E44 
ara14 galK2 lacY1 proA2 rpsL20(SmR ) xyl 5 .leu mtl1 
 
HB101 (DH10B)  Δ(mrr-hsd RMS-mcrBC) mcrA recA1 
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2.1.2.2. Agrobacterium tumefaciens strains 
GV3101 (pMP90)  C58C1, rif, pMP90 (pTiC58∆T-DNA), Gmr (Koncz and Schell, 1986) 
 
GV3101 (pMP90RK) C58C1, rif, pMP90RK (pTiC58∆T-DNA), Gmr, Kmr (Koncz and 
Schell, 1986) 
 
2.1.2.3. Yeast strains 
Y190  MATa, ura3-52, his3-Δ200, lys2-801, ade2-101, trp1-901, leu2-3, 112, gal4Δ, gal80Δ, 
URA3::GAL1UAS-GAL1TATA-lacZ, cyhr2, LYS::GAL1UAS-HIS3TATA-HIS3 (Flick and 
Johnson, 1990; Harper et al., 1993) 
  
Y187  MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, met, gal4Δ, gal80Δ, 
URA3::GAL1UAS-GAL1TATA-lacZ (Harper et al., 1993) 
 
YM4271 MATa, ura3-52, his3-200, ade2-101, lys2-801, leu2-3, 112, trp1-901, tyr1-501, gal4-
Δ512, gal80-Δ538, ade5::hisG (Liu et al., 1993; Wilson et al., 1991). 
 
2.1.3. Plant material 
2.1.3.1.1. Arabidopsis thaliana 
Genotype Ecotype   Obtained from 
Wild type Col-0    Rédei, 1992 
prl1 Col-0    Nemeth et al., 1998 
prl1 SALK_008466 Col-8    Alonso et al., 2003 
prl1 SALK_039427 Col-8    Alonso et al., 2003 
prl1 SALK_096289 Col-8    Alonso et al., 2003 
prl1 SAIL_1276G04 Col    Sessions et al., 2002 
prl2 GABI_228D02 Col-0    Rosso et al., 2003 
prl2  KONCZ16136 Col-0    Rios et al., 2002 
pip-a GABI_197C07 Col-0    Rosso et al., 2003 
pip-c SALK_010773 Col-8    Alonso et al., 2003 
pip-c SALK_039094 Col-8    Alonso et al., 2003 
pip-d SAIL 586 H06 Col    Sessions et al., 2002 
pip-d KONCZ38225  Col-0    Rios et al., 2002 
cpb20 KONCZ372 Col-0    Papp et al., 2004 
pip-e SAIL_613D12 Col    Sessions et al., 2002 
pip-f SALK_014647  Col-8    Alonso et al., 2003 
pip-h KONCZ65425 Col-0    Rios et al., 2002 
pip-i SALK_000718 Col-8    Alonso et al., 2003 
pip-i SALK_011213 Col-8    Alonso et al., 2003 
pip-i GABI_160C01  Col-0    Rosso et al., 2003 
pip-i Wisc446659 Col-0    Sussman et al., 2000 
pip-k SAIL_1284G09 Col    Sessions et al., 2002 
pip-k KONCZ77621 Col-0    Rios et al., 2002 
pip-l SALK_037227  Col-8    Alonso et al., 2003 
CS85391    Col er 105   NASC  
CS86061    Col er 105   NASC 
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CS86130    Col er 105   NASC  
CS87948    Col er 105   NASC  
CS91910    Col er 105   NASC  
CS92359    Col er 105   NASC  
CS93156    Col er 105   NASC  
CycB1.1::GUS   C24   Ferreira et al., 1994, Himanen et al., 2002 
 
2.1.3.1.2. Arabidopsis cell suspensions 
Experiments were performed using Arabidopsis thaliana (Col-0) photosynthetic light-grown and root-
derived dark-grown cell suspensions. 
 
2.1.4. Plasmids vectors and constructs 
2.1.4.1. Plasmid vectors 
pACT2    Clontech, Durfee et al., 1993 
pAS2    Clontech, Durfee et al., 1993 
pBluescript II SK -    Stratagene, La Jolla, USA 
pDONR207    Invitrogen 
pER8-XVE(Hygr)    Zuo et al., 2000 
pER8-XVE(Km)    Ph.D. thesis M. Lafos, 2006 
pGreen-MSC    gift of I. Searle 
pHISi-1    Clontech 
pLacZi    Clontech 
pODB8    Loevet et al., 1997 
pPAMnptII    gift of B. Ülker 
pPAMpat    gift of B. Ülker 
pPCV002    Koncz et al., 1994 
pPCV812      Koncz et al., 1994 
pPily    Ferrando et al., 2000 
 
2.1.4.2. Plasmid constructs 
pACT2-PRL1      Nemeth et al.,. 1998 
pAS2-PRL1      Nemeth et al.,1998 
pAS2-PRL2      Ph.D. thesis F.Breuer, 2000 
pAS2-PRL1-Cterm     Bhalerao et al., 1999 
pAS2-PRL1-Nterm     Bhalerao et al., 1999 
pBS-PRL1      K. Nemeth, unpublished 
pBS-PRL1-cDNA     K. Nemeth, unpublished 
pBS-PRL1-Sma     gift of I. Kovács 
pER8(Hygr)-AKIN11-HA    Ph.D. thesis K. Berendzen, 2005 
pER8(Hygr)-PAM1     A. Obershall, unpublished 
pPCV002-35S::PRL1-HiA    J. Jásik unpublished 
pDONR207-AS1prom     H. An, unpublished 
pDONR207-4CL1prom     H. An, unpublished 
pDONR207-KNAT1prom    An et al., 2004 
pDONR207-STMprom     An et al., 2004 
pDONR207-SUC2prom    An et al., 2004 
pDONR207-TobRB7prom    An et al., 2004 
pDONR207-UFOprom     An et al., 2004 
pER8-iGUS      gift of I. Kovács 
pPCV812-UFD1-HiA     I. Kovács, unpublished 
pACT-CDC5      This work 
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pBS-PRL1-cDNA-GFP     This work 
pBS-PRL1-cDNA-HA     This work 
pBS-PRL1-2introns-cDNA-GFP   This work 
pBS-PRL1-2introns-cDNA-HA    This work 
pBS-PRL1-2introns-cDNA-SMA1   This work 
pBS-PRL1gen-HA-ATG    This work 
pBS-PRL1-HA      This work 
pBS-PRL1-HA-G77E    This work 
pBS-PRL1-PROM-UTR    This work 
pBS-PRL1-STAB-2introns-GFP   This work 
pBS-STAB-PRL1 -cDNA-GFP    This work 
pER8(Km)-PRL1cDNA-HA    This work 
pER8(Km)-PRL1gen-HA    This work 
pGreen-AS1::PRL1cDNA-HA    This work 
pGreen-AS1::PRL1gen-HA    This work 
pGreen-4CL1::PRL1cDNA-HA   This work 
pGreen-4CL1::PRL1gen-HA    This work 
pGreen-KNAT1::PRL1cDNA-HA   This work 
pGreen-KNAT1::PRL1gen-HA    This work 
pGreen-PRL1-cDNA-HA    This work 
pGreen-PRL1gen-HA-ATG    This work 
pGreen-STM::PRL1cDNA-HA    This work 
pGreen-STM::PRL1gen-HA    This work 
pGreen-SUC2::PRL1cDNA-HA   This work 
pGreen-SUC2::PRL1gen-HA    This work 
pGreen-TobRB7::PRL1cDNA-HA   This work 
pGreen-TobRB7::PRL1gen-HA   This work 
pGreen-UFO::PRL1cDNA-HA    This work 
pGreen-UFO::PRL1gen-HA    This work 
pHISi-1-PRL1-PROM     This work 
pLacZi-PRL1-PROM     This work 
pPAMnptII-PRL1-cDNA-GFP    This work 
pPAMnptII-STAB-PRL1-cDNA-GFP   This work 
pPAMpat-CDC5-HA     This work 
pPCV002-ODB     This work 
pPCV002-PRL1-GFP     This work 
pPCV002-PRL1-HA     This work 
pPCV002-PRL1-HA-G77E    This work 
pPCV002-PRL1-HA-XhoI    This work 
pPCV002-PRL1-cDNA-HA    This work 
pPCV002-PRL1-2introns-cDNA-HA   This work 
pPCV002-PRL1-PROM-UTR    This work 
pPCV002-PRL1-STAB-GFP    This work 
pPCV812-PRL1-PROM    This work 
pPCV812-PRL1-PROM-ATG    This work 
pPCV812-PRL1-PROM-POLIT   This work 
pPCV812-PRL1-PROM-TTTShort   This work 
pPCV812-PRL1-PROM-UTR    This work 
pPCV812-PRL1-PROM-XhoI-BmgBI   This work 
pBS-PRL1-HA-MUT1    This work 
pBS-PRL1-HA-MUT2    This work 
pBS-PRL1-HA-MUT3    This work 
pBS-PRL1-HA-MUT4    This work 
pBS-PRL1-HA-MUT5    This work 
pBS-PRL1-HA-MUT6    This work 
pBS-PRL1-HA-MUT7    This work 
pBS-PRL1-HA-MUT8    This work 
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pBS-PRL1-HA-MUT9    This work 
pBS-PRL1-HA-MUT10    This work 
pBS-PRL1-HA-MUT11    This work 
pBS-PRL1-HA-MUT12    This work 
pBS-PRL1-HA-MUT13    This work 
pBS-PRL1-HA-MUT14    This work 
pBS-PRL1-HA-MUT15    This work 
pBS-PRL1-HA-MUT16    This work 
pBS-PRL1-HA-MUT17    This work 
pBS-PRL1-HA-MUT18    This work 
pBS-PRL1-HA-MUT19    This work 
pBS-PRL1-HA-MUT20    This work 
pBS-PRL1-HA-MUT21    This work 
pBS-PRL1-HA-MUT22    This work 
pBS-PRL1-HA-MUT23    This work 
pBS-PRL1-HA-MUT24    This work 
pBS-PRL1-HA-MUT25    This work 
pBS-PRL1-HA-MUT27    This work 
pBS-PRL1-HA-MUT28    This work 
pBS-PRL1-HA-MUT30    This work 
pPCV002-PRL1-HA-MUT1    This work 
pPCV002-PRL1-HA-MUT2    This work 
pPCV002-PRL1-HA-MUT3    This work 
pPCV002-PRL1-HA-MUT4    This work 
pPCV002-PRL1-HA-MUT5    This work 
pPCV002-PRL1-HA-MUT6    This work 
pPCV002-PRL1-HA-MUT7    This work 
pPCV002-PRL1-HA-MUT8    This work 
pPCV002-PRL1-HA-MUT9    This work 
pPCV002-PRL1-HA-MUT10    This work 
pPCV002-PRL1-HA-MUT11    This work 
pPCV002-PRL1-HA-MUT12    This work 
pPCV002-PRL1-HA-MUT13    This work 
pPCV002-PRL1-HA-MUT14    This work 
pPCV002-PRL1-HA-MUT15    This work 
pPCV002-PRL1-HA-MUT16    This work 
pPCV002-PRL1-HA-MUT17    This work 
pPCV002-PRL1-HA-MUT18    This work 
pPCV002-PRL1-HA-MUT19    This work 
pPCV002-PRL1-HA-MUT20    This work 
pPCV002-PRL1-HA-MUT21    This work 
pPCV002-PRL1-HA-MUT22    This work 
pPCV002-PRL1-HA-MUT23    This work 
pPCV002-PRL1-HA-MUT24    This work 
pPCV002-PRL1-HA-MUT25    This work 
pPCV002-PRL1-HA-MUT27    This work 
pPCV002-PRL1-HA-MUT28    This work 
pPCV002-PRL1-HA-MUT30    This work 
 
2.1.5. Arabidopsis yeast two hybrid cDNA library 
A cDNA library was prepared from A. thaliana (Col-0) cell suspension (K. Salchert, 1997; Nemeth et 
al., 1998). The cDNA products were cloned in fusion with the Gal4-DNA activation domain (GAD), 
using EcoRI-(5’) and XhoI-(3’) adaptors in plasmid pACT2.  
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2.1.6. Oligonucleotides 
2.1.6.1. Oligonucleotides for DNA sequencing 
3GAD   5’-GTTTTTCAGTATCTACGATTC-3’ 
5GAD   5’-CAAACCCAAAAAAAGAGATC-3’ 
CDC5-seq  5’-GCTCAGAGACAGGATGCTCCAG-3’ 
END-SEQ  5’-CTATGATTGAGCTCTAGGGAAACC-3’ 
Frev   5’-AGCGGATAACAATTTCACACAGGA-3’ 
GR-seq   5’-CTCCTTACCTACTGCTTCCAGAC-3’ 
GUS-UP  5’-ACAGGCCGTCGAGTTTTTTGATTTCAC 5’- 
HA-seq   5’-AGCATAATCTGGAACCTGCACATC-3’ 
Junction down  5’-CATGCGAGGCTGATAAGACGA-3’ 
Junction up  5’-CCATGGACGGGAGAGAGAAGAG-3’ 
P1   5’-CTATACAGGTTCCTCAGGGAAG-3’ 
P2   5’-GGTCATTGCTCGGACAGATTTC-3’ 
SeqG77E  5’-CTCTGTTGTGTATGTTACTG -3’ 
T3 primer  5’-ATTAACCCTCACTAAAG-3’ 
T7 primer  5’-AATACGACTCACTATAG-3’ 
 
2.1.6.2. Oligonucleotides for cloning 
CDC5-F  5’-GGAATTCGCATGAGGATTATGATTAAGGGAGG-3’ 
CDC5-R  5’-CCCTCGAGTTATGCAGAAGCTTCCATGGCTATG-3’ 
GFP-F   5’-GCTCTAGAATGGGTAAAGGAGAAGAAC-3’ 
GFP-R   5’-TCCCCGCGGTTATTTGTATAGTTCATCC-3’ 
GR-HA 5’-GCTCTAGATATCCATACGATGTTCCAGATTATGCTGAAG 
CTCGAAAAACAAAGAAAA-3’ 
GR-R   5’-TCCCCGCGGTCATTTTTGATGAAACAGAAGC-3’ 
GUS-F   5’-GCTCTAGAATGTTACGTCCTGTAGAAACCCCAACC-3’ 
GUS-R   5’-TCCCCGCGGTCATTGTTTGCCTCCCTGC-3’ 
HASpe 5’-CACTAGTTTAAGCATAATCTGGAACATCGTATGGATAGA 
AGCGCCTAATCTCCT-3’ 
MycSpe 5’-CACTAGTTTAAAGATCCTCCTCAGAAATCAACTTTTGCTC 
GAAGCGCCTAATCTCCTT-3’ 
POLI   5’-TCCCCCCGGGGGCTGAGACGAATCTGCTTGC-3’ 
PR-F   5’-GGAATTCGCCATAAGGTAAAACATTGAGTCTC-3’ 
PR-R   5’-GCTCATTGATGCGGTCAGGTTGA-3’ 
Prl1ndef  5’-GGAATTCCATATGCCGGCTCCGACGACG-3’ 
SexAI   5’-GCATAAGACACTAAAACCTGG-3’ 
UTR   5’-TCCCCCGGGCGTTCTTCTTTTAGGGTTTAGAGAG -3’ 
XhoIF   5’-CCGCTCGAGATGCCGGCTCCGACGACGG-3’ 
 
2.1.6.3. Oligonucleotides for site-directed mutagenesis 
G77E   5’-GTTGCGTTTGAAGGTGTAGAACCTG-3’ 
Mut1 5’-CCGGCTCCGACGACGGCTATCGCACCCATCGCAGCACAGT 
CACTG-3’ 
Mut2 5’-AAAGAACGATGGCTGCTGCTACGACGGAGATCGAAGCTAT 
CGAAGCACAG-3’ 
Mut3   5’-GAAGCACAGTCACTGGCAGCTCTCAGTCTCAAATCC-3’ 
Mut4   5’-AAGCTCAGTCTCGCATCCCTCGCACGATCACTTGAA-3’ 
Mut5   5’-CTGAAAAAGCTCGCTCTCAAAGCTCTCAAACGATCA-3’ 
Mut6   5’-AAATCCCTCAAAGCAGCACTTGAACTCTTC-3’ 
Mut7   5’-CGATCACTTGCACTCTTCGCTCCCGTCCATGTC-3’ 
Mut8   5’-GAACTCTTCTCTGCTGTCCATGGCCAA-3’ 
Mut9   5’-TTCTCTCCCGTCGCTGGCGCATTCCCTCCTCCT-3’ 
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Mut10   5’-TTCCCTCCTCCTGCTCCGGCAGCGTTAGTCTTC-3’ 
Mut11   5’-GCAGCAAGCAGATTGCTCTCGCTCATAAGGTAAAA-3’ 
Mut12   5’-CAGATTCGTCTCAGCGCTGCTGTAAAACATTGAGTC-3’ 
Mut13   5’-TTTGTACAGATGGCAGTTGCGGCTGGAGGTGTAGAA-3’ 
Mut14   5’-TTTGGAGGTGTAGCACCTGTTGTGGCTCAACCTCCACGT-3’ 
Mut15   5’-AGTCAACCTCCAGCTGCACCTGACCGCATC-3’ 
Mut16   5’-CCTCCACGTCAACCTGCTGCTATCAATGAGCAGCCA-3’ 
Mut17   5’-CCTGACCGCATCAATGCTGCTCCAGGACCTTCA-3’ 
Mut18   5’-CAGCCAGGACCTGCAAATGCTCTTGCTCTCGCAGGTGTT-3’ 
Mut19   5’-GCAGCTCCTGCAGGGGCTAAGAGTACGCAA-3’ 
Mut20   5’-CTCCTGAAGGGTCTGCTGCTACGCAAAAGGGTGCG-3’ 
Mut21   5’-GGGTCTAAGAGTACGGCAGCTGGTGCGACAGAGAGT-3’ 
Mut22   5’-AGGGTGCGACAGCTGCTGCTATTGTTGTTGG-3’ 
Mut23   5’-AACTATACAGGTGCTGCAGGGAAGAGCACC-3’ 
Mut24   5’-ACAGGTTCCTCAGGGGCTGCTACCACCATTATACCTGCA-3’ 
Mut25   5’-CCTGCAAATGTAGCTGCATATCAAAGGTTT-3’ 
Mut26   5’-AAGATGTGGAAAGCAGCTGCTAATGCAACTCCA-3’ 
Mut27   5’-AATGCAACTCCAGCAACTGCTCCTATCAATTTC-3’ 
Mut28   5’-CCTATCAATTTCGCTCCACCAAAGGAGATT-3’ 
Mut29   5’-TTCTTCAAACCACCAGCTGCTATTAGGCGCTTCTAT-3’ 
Mut30   5’-CCAAAGGAGATTGCTGCCTTCTATCCATACGAT-3’ 
NotI   5’-ACCGCGGTGACTGCCGCTCTAGAA-3’ 
Nsi   5’-GTTCTACAAAAACGCATCCCGAGAGC-3’ 
Sca   5’-CTGTGACTGGTGACCACTCAACCAAGTC-3’ 
STABmut 5’-GTTGGTCCAACTTTACTGGGTCCAATAGTGCCTAAAGGCT 
TGAACTATAC-3’ 
TTT 5’-GTAAAGATGGTTGATTTACTTAGATTTTTTTTTTTTTTTTGT 
TGTGTATGTTACTGATTTTAGAAG -3’ 
 
2.1.6.4. Oligonucleotides to screen for T-DNA insertion mutants in Arabidopsis  
FISH1   5’-CTGGGAATGGCGAAATCAAGGCATC-3’ 
FISH2   5’-CAGTCATAGCCGAATAGCCTCTCCA-3’ 
LB1-sail  5’-GCCTTTTCAGAAATGGATAAATAGCCTTGCTTCC-3’ 
LB3-sail  5’-TAGCATCTGAATTTCATAACCAATCTCGATACAC-3’ 
PRL1 3'  5’-AACCTGTATTATCATAACACGCTGC-3’ 
PRL1 5'  5’-ACTTGAACTCTTCTCTCCCGTCCAT-3' 
PRL1 ups  5’-GATGCGTTTCAGATCTTGGCGTG-3’  
PRL1-5'rev  5’-ATGGACGGGAGAGAAGAGTTCAAGT-3’ 
PRL2 5'  5’-GAACAGGGAGGTCGAAACTCAGTCAC-3’ 
PRL2 3'  5’-TTCACTCTCCAGCGAACCTAACCAT-3’ 
SAIL DAP RB2 5’-GTATGTTGTGTGGAATTGTGAGCGGATAAC-3’ 
SALK LB  5’-TTTGGGTGATGGTTCACGTAGTGGG-3’ 
 
 
2.2. General buffers, stock solutions and growth media 
2.2.1.1. Solutions 
Phenol/Chloroform/Iso-amylalcohol:  mix to a ratio of 25:24:1 
TE:      10 mM Tris.HCl, 1 mM EDTA, pH 8.0 
X-gal     20 mg/ml in N,N-dimethyl formamide 
X-gluc     20 mg/ml in N,N-dimethyl formamide 
Cycloheximide    100 mM in ethanol 
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β-estradiol     10 mM in DMSO 
MG132     50mM in DMSO 
 
2.2.2. Antibiotics 
Antibiotics   Stock solution   Working concentration 
Ampicillin   50 mg/ml in water  50 mg/l 
Basta    200 mg/ml   250 mg/l 
Carbenicillin   50 mg/ml in water  50 mg/l 
Cefotaxime/Claforan  200 mg/ml in water  200-400 mg/l 
DL-Phosphinotricine  10 mg/ml in water  10 mg/l 
Hygromycin   15 mg/ml in water  15 mg/l 
Kanamycin   50 mg/ml in water  50mg/l for bacteria;  
        100mg/l for plants 
Nystatine   50 mg/ml in DMSO  25-50 mg/l 
Rifampicin   25 mg/ml in methanol  100 mg/l 
Spectinomycin   50 mg/ml in water  100 mg/l  
Sulfadiazine   7.5 mg/ml in water  15 mg/l 
Tetracyclin   10 mg/ml in water  12.5 mg/l 
Ticarcillin/Clavulanic acid  150 mg/ml in water  150 mg/l 
 
All antibiotics were filter sterilized and stored at -20°C. 
 
2.2.3. Plant hormones 
Abscisic acid (ABA)    1 mg/ml in methanol 
6-Benzylaminopurine (BAP)   1 mg/ml 1N NaOH 
2,4-dichlorophenoxyacetic acid (2,4-D)  1 mg/ml ethanol 
Gibberellin (GA3)    1 mg/ml in ethanol 
Indole 3-acetic acid (IAA)   1 mg/ml in 1N KOH 
Kinetin      1 mg/ml 1N NaOH 
Methyl jasmonate    10 mg/ml in ethanol 
1-naphtylacetic acid (NAA)   1 mg/ml 1N KOH 
Salicylic acid (SA)    0.5 M in ethanol 
 
All hormone solutions were filter sterilized and stored at -20°C. 
 
2.2.4. Culture media 
2.2.4.1. Bacterial media 
2.2.4.1.1. LB medium: 
  Bacto-Tryptone  10g/l 
  Bacto-Yeast Extract 5g/l 
  NaCl   10g/l 
 
Adjust pH to 7.5 with NaOH. For solid media add 20g/l Bacto-Agar. Autoclave for 20 min at 120°C. 
 
2.2.4.1.2. YEB medium: 
  Beef Extrect  5g/l 
  Bacto yeast extract 1g/l 
  Bactopeptone  1g/l 
MATERIALS and METHODS   27 
  Sucrose  5g/l 
 
Adjust pH to 7.4 with NaOH. For solid medium add 15g/l Bacto-agar. Autoclave for 20min at 120°C 
and after sterilization 20ml/l of 0.1M MgCl2 was added. 
 
2.2.4.2. Yeast media 
2.2.4.2.1. YPD yeast medium 
  Difco-peptone  20g/l 
  Yeast extract  10g/l 
  Glucose  20g/l 
 
For solid media add 20g/l Bacto-agar. Autoclave for 15 min at 120°C. 
 
2.2.4.2.2. Synthetic Minimal medium 
  Yeast Nitrogen Base w/o amino acids  6.7g/l 
  Glucose     20g/l 
 
Dissolve in 900 ml of water. Adjust pH to 5.8 with NaOH. For solid media add 20g/l Bacto-agar. 
Autoclave 15 min at 120°C. 
 
10X Drop-out solution: 
L-Isoleucine   300mg/l 
L-Valine   1500mg/l 
L-Adenine hemisulfate salt 200mg/l 
L-Arginine-HCl  200mg/l 
L-Histidine-HCl  200mg/l 
L-Leucine monohydrate 1000mg/l 
L-Lysine-HCl   300mg/l 
L-Methionine   200mg/l 
L-Phenylalanine  500mg/l 
L-Threonine   2000mg/l 
L-Tryptophan   200mg/l 
L-Tyrosine   300mg/l 
L-Uracil   200mg/l 
 
2.2.4.3. Plant media 
2.2.4.3.1. Arabidopsis cell suspension culture medium  
 
Root derived cell suspension:  MS Basal Mix    4.3 g/l 
     B5 vitamin (100X)  10 ml 
     Sucrose   3% 
Adjust pH to 5.8 with KOH, autoclave at 120°C for 15 min and before use add 2,4-D to final 
concentration of 1mg/l. 
 
B5 Vitamin (100X)   Nicotinic Acid  1mg/ml 
     Pyridoxin-HCl  1g/ml 
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     myo-Inositol  100mg/ml 
     Thiamine-HCl  10mg/ml 
 
Photosynthetic cell suspension:  MSMO Salts   4.4 g/l 
     Sucrose   3%  
Adjust pH to 5.8 with KOH, autoclave at 120°C for 15 min and before use add 0.5mg/l NAA and 
0.1mg/l kinetin pH adjusted to 5.8 with KOH 
 
2.2.4.3.2. Plant culture medium 
MSAR medium (Koncz et al., 1994) 
     Macroelements  25.0 ml/l 
     Microelements  1.0 ml/l 
     Fe-EDTA  5.0 ml/l 
     CaCl2·2H2O  5.8 ml/l 
     KI   2.2 ml/l 
     B5 vitamin  2.0 ml/l 
     Sucrose  5g/l 
 
pH was adjusted to 5.8 with KOH and 0.6 g/l phytoagar was added. 
 
Macroelements:  20 g/l NH4NO3, 40 g/l KNO3, 7.4 g/l MgSO4·7 H2O, 3.4 g/l KH2PO4,  
2 g/l Ca(H2PO4)2· H2O 
 
Microelements:   6.2 g/l H3BO3, 16.9 g/l MnSO4·4H2O, 8.6 g/l ZnSO4·7H2O, 0.25 g/l 
    Na2MoO4·2 H2O, 0.025 mg/l CuSO4·5H2O, 0.025 mg/l CoCl2.6H2O 
 
Fe-Na2-EDTA:   5.56 g/l FeSO4·7H2O, 7.46 g/l Na2-EDTA·2 H2O 
 
KI:    375 g/l KI 
 
CaCl2:    75g/l CaCl2·2H2O 
 
 
2.2.5. Antibodies 
2.2.5.1. Primary antibodies 
  
Anti-Amidase: Rabbit polyclonal antibody raised against Arabidopsis amidase (ATAM1 At5g07360) 
peptide. Dilution: 1:2,000. 
Anti-c-Myc: Mouse monoclonal antibody raised against a peptide from human c-Myc protein. 
Dilution: 1:1,000. 
Anti-CULLIN 1: Rabbit polyclonal antibody raised against Arabidopsis CULLIN 1 protein (Gray et 
al., 1999) Dilution: 1:6,000. 
Anti-HA:  Rat monoclonal antibody (clone 3F10) to a peptide derived from the hemagglutinin 
protein of the human influenza virus (Roche) Dilution: 1:1,000. 
Anti-Histone H2A: Rabbit antiserum recognizing a synthetic peptide corresponding to amino acids 88-
97 of human Histone 2A (Upstate Co) Dilution: 1:1,000 
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Anti-PRL1: Rabbit polyclonal antibody raised against a PRL1 specific peptide (Nemeth et al., 
1998) Dilution: 1:1,000. 
Anti-19S Proteasome:  Rabbit polyclonal antibody to 19S regulator non-ATPase subunit Rpn6 (S9) 
(Affiniti Research). Dilution: 1:2,000. 
Anti-20S Proteasome:  Mouse monoclonal antibody raised against the human 20S proteasome particle 
subunits α1, 2, 3, 5, 6 and 7 (Affiniti Research). Dilution: 1: 1,000. 
Anti-SKP1: Rabbit polyclonal antibody recognizing the C-terminal peptide of SKP1 protein. 
Anti-SnRK1α: Rabbit polyclonal antibody raised against the tobacco NPK5 protein (Muranaka et al., 
1994). Dilution: 1: 5,000 or 1:10,000. 
Anti-tubulin: Mouse monoclonal antibody to α-tubulin (clone DM 1A), purified chick brain tubulin 
was used as immunogen (Sigma). Dilution: 1:1,000 or 1:2,000. 
Anti-ubiquitin: Rabbit antibody recognizing a peptide corresponding to amino acids 1-50 of soybean 
ubiquitin (Bethyl Laboratories Inc). Dilution: 1:1,000. 
 
2.2.5.2. Secondary antibodies 
Goat anti-Rabbit IgG, (H+L), HRP   Dilution: 1:10,000 
Goat anti-Rat IgG, (H+L), HRP   Dilution: 1:10,000 
Rabbit anti-Chicken IgG, (H+L), HRP   Dilution: 1:10,000 
 
 
2.2.6. Bioinformatic Resources 
2.2.6.1. Softwares 
• Adobe Acrobat 6.0 Professional 
• Adobe Photoshop CS and Adobe Photoshop Elements 2.0 
• Bioedit Sequence Alignement Editor version 4.8.10 
• Clone Manager 7 version 7.01 
• CLUSTAL W Multiple Sequence Alignment Program version 1.83 (Feb 2003)  
• Diskus version 4.30.102 
• DNASTAR (GeneQuest, Editseq, MapDraw, Megalign, Primer Select, Protean, SeqMan) 
• Kodak 1D Image Analysis Software version 3.6.5 K2 
• Leica Confocal Software LCS Lite version 2.61 
• Microsoft Office 2003 
 
2.2.6.2. Databases 
• Arabidopsis Information Resource (TAIR) http://www.arabidopsis.org/ 
• The Institute for Genomic Research (TIGR) http://www.tigr.org/ 
• The European Bioinformatics Institute (EBI) http://www.ebi.ac.uk/ 
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• National Center for Biotechnology Information (NCBI) http://www.ncbi.nih.nlm.gov/ 
• European Molecular Biology Laboratory (EMBL) http://www.embl-heidelberg.de/  
• Salk Institute Genomic Analysis Laboratory Arabidopsis sequence indexed T-DNA  insertion 
http://signal.salk.edu/ 
• Arabidopsis thaliana microarray database and analysis toolbox 
(http://www.genevestigator.ethz.ch; Zimmermann et al., 2004) 
• Database of plant cis-acting regulatory DNA elements (http://www.dna.affrc.go.jp/PLACE; Higo 
et al., 1999) 
 
 
2.3. METHODS 
 
2.3.1. General molecular biology methods 
2.3.1.1. Preparation of plasmid DNA by alkaline lysis (modified from Birnboim and Doly, 1979) 
A single E. coli colony was inoculated in 2-5ml of LB medium supplemented with appropriate 
antibiotics. Bacterial cultures were grown overnight at 37°C with vigorous shaking (250 rpm). 
Cultures were transferred into 2ml eppendorf tubes and pelleted at maximum speed for 1 min in a 
tabletop centrifuge. Then, the supernatant was removed and the cell pellets were dried for 1 min in 
inverted position. (Alternatively the pellet was frozen and kept on -20°C for later use.) Cells were 
resuspended by vortexing in 280 µl of ice-cold solution I. Bacterial cells were lysed by adding 360 µl 
of freshly prepared solution II, and the tubes were gently inverted few times in order to mix solutions. 
After 5 min incubation, 540 µl of ice-cold solution III was added to neutralize the lysate and the 
mixture was kept at 4°C for 10 min. The cell debris was removed by centrifugation at 13,000 rpm for 
10 min. 1ml of the supernatant was transformed into new eppendorf tube and nucleic acids were 
precipitated with 0.5 ml of isopropanol at -20°C for at least 10 min. Nucleic acids were pelleted by 
centrifugation at 13,000 rpm for 10 min and the supernatant was removed. Dried nucleic acids were 
resuspended in 0.5 ml of 25 µg/µl RNase A solution and incubated at 37°C for 1 h. Subsequently, 
DNA was precipitated with 0.6 ml of solution IV and dissolved in 50 µl of water or TE buffer. 
 
Solution I:  50 mM Tris.HCl (pH 8.0), 50 mM glucose, 10mM EDTA 
Solution II:  200 mM NaOH, 1% SDS (freshly prepared) 
Solution III:  3 M NaOAc (pH 4.8) or 3 M KAc (pH 6.0) 
Solution IV: 88% isopropanol, 0.2 M KAc 
 
For sequencing, DNA was prepared using QIAprep® plasmid isolation kit (Qiagen) or E.Z.N.A.® 
Plasmid miniprep kit I. (Peqlab) to obtain high quality and purity. 
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2.3.1.2. DNA sequencing 
Plasmids and DNA fragments were sequenced in collaboration with the Automatic DNA Isolation and 
Sequencing (ADIS) service of MPIZ. For sequencing, an Applied Biosystems 3730XL Genetic 
Analyser was used. 
 
2.3.1.3. Phenol/Chloroform extraction  
To remove contaminating proteins, DNA samples were supplemented with 1/10 volume of 3 M 
sodium acetate solution (pH 5.2) and then mixed by vortexing with equal volume of 
phenol/chloroform solution (1:1, v/v) and centrifuged at 13,000 rpm for 5 min. The aqueous upper 
phase was collected in a new eppendorf tube and the extraction step with phenol/chloroform was 
repeated until there was no more precipitated protein ring between the water and organic solvent 
phases. Then, to remove phenol traces from the solution, equal amount of chloroform:iso-amylalcohol 
(24:1) mixture was added and vortexed. Phases were separated by centrifugation and DNA was 
precipitated by 2 volumes of ethanol. 
 
2.3.1.4. DNA precipitation 
DNA was precipitated using ethanol or isopropanol. In the case of ethanol precipitation, 1/10 volume 
of 3 M sodium acetate (pH 5.2) and 2 volumes of absolute ethanol were added to DNA samples, 
mixed and incubated at -20°C for at least 10 min. DNA was pelleted by centrifugation at top speed for 
10 min. The DNA pellet was washed with 70% ethanol and centrifuged again. For isopropanol 
precipitation 0.7 volumes of isopropanol was added to the samples and incubated on ice for at least 20 
min. Then, DNA was pelleted by high speed centrifugation (13,000 rpm for 10 min). DNA pellets 
were dissolved in water or TE buffer. 
 
2.3.1.5. Agarose gel electrophoresis 
Plasmids, DNA fragments and PCR products were separated by agarose gel electrophoresis. The 
agarose concentration of the gel depends on the size of the DNA fragments being analyzed. Generally, 
0.8-1% (w/v) agarose concentration was used. For large fragments (>5kb) 0.5% (w/v), whereas for 
small fragments (<0.5 kb) 3% (w/v) agarose gels were prepared. Agarose was dissolved in 1 X TAE 
buffer supplemented with 25 µl/l ethidium bromide and heated in a microwave oven until boiling. The 
solution was allowed to cool down to approximately 65°C and then poured into a plastic tray sealed at 
the edges with tape and casted with appropriate combs and allowed the gel to set completely. Then, 
the gel was transferred into a gel tank. DNA samples were mixed with loading dye and loaded into the 
gel slots. For size estimation, 1kb DNA ladder (Invitrogen) or PstI or HindIII digested λ phage DNA 
marker was used. Electrophoresis was performed in 1X TAE buffer at between 50 to 150 V. DNA was 
visualized using an UV light transilluminator. Gel images were captured by a Kodak DC-120 ZOOM 
digital camera and processed with the Kodak Digital Science 1D V.3.0.2 software. 
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TAE buffer:  1X     50X 
40 mM Tris    242 g Tris 
40 mM Acetic acid   57.1 ml glacial acetic acid 
1 mM EDTA    100 ml 0.5 M EDTA (pH 8.0) 
 
6 X Loading dye: 40% sucrose, 0.25% bromphenol blue 
 
2.3.1.6. Purification of DNA fragments from agarose gels 
After gel electrophoresis, DNA fragments were excised from the agarose gel placed on an UV light 
transilluminator. DNA was extracted and purified using QIAquick® Gel Extraction Kit (Qiagen) 
following the manufacturer’s instructions. 
 
2.3.1.7. Measurement of nucleic acid concentration 
DNA concentration was determined by spectrophotometry. OD260 value of 1 corresponds to 50 µg/ml 
of double stranded DNA concentration and 40 µg/ml RNA concentration. In pure preparations 
OD260/OD280 ratio should be between 1.8/2.0 (Sambrook et al., 1989). 
 
2.3.1.8. Digestion with restriction endonucleases 
Digestions of DNA samples were performed with restriction endonucleases according to the 
manufacturers’ instructions. Typically, reactions were carried out in 1.5 ml Eppendorf tubes in a final 
volume of 20 or 50 µl using 1-5 U enzyme/µg DNA. The duration of the digestion varied from 2  h to 
overnight. 
 
2.3.1.9. Generating blunt ends of digested DNA fragments 
Overhanging DNA ends were blunted with T4 DNA polymerase (NEB). This enzyme catalyzes DNA 
synthesis in 5’-3’ direction and has 3’-5’ exonuclease activity (Ausubel et al., 1999). Hence, T4 
polymerase can used for 3’ overhang removal and 3’ recessed end fill-in. Digested vector DNA was 
dissolved in 1X restriction enzyme reaction NEBuffer supplemented with 100 µM dNTPs. 1 unit 
enzyme/µg DNA was added to the reaction and incubated 15 min at 12°C. T4 DNA polymerase was 
inactivated by adding EDTA to the mixture (10 mM final concentration) followed by heating to 75°C 
for 20 min. 
 
2.3.1.10. Dephosphorylation of DNA ends 
In order to prevent self-ligation of linearized vectors, digested plasmids were treated with 
phosphatases. These enzymes catalyze the removal of 5’ phosphate groups from DNA and RNA 
molecules that are essential for ligation (Chaconas and van de Sande, 1980). 
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2.3.1.10.1. Calf-intestine alkaline phosphatase (CIAP) treatment 
2 units of CIAP was added to 1 µg linearised DNA and incubated at 37oC for 30 min. The enzyme was 
removed by gel electrophoresis or phenol/chloroform extraction. 
 
2.3.1.10.2. Antarctic phosphatase treatment 
Preferably antartic phosphatase (NEB) was used for dephosphorylation of DNA. This enzyme can be 
heat inactivated and therefore no further purification is necessary. Linearized vectors were purified 
after gel electrophoresis and 1/10 volume of antartic phosphatase reaction buffer was added to the 
sample. Reaction mixture was supplemented with 5 U of antartic phosphatase and incubated for 1 h at 
37°C. Enzyme was inactivated at 65°C for 5-10 min. 
 
2.3.1.11. DNA ligation 
Ligation of linearized vectors and DNA fragments was performed using T4 DNA ligase (NEB). 20 µl 
of reaction mixture contained T4 DNA Ligase Reaction buffer, vector and insert fragment in a molar 
ratio of 1:3, 1 µl of T4 DNA ligase and supplementing amount of water. Recirculization of cloning 
vectors was controlled by ligation containing exclusively the vector. Generally, ligations were 
performed overnight at 12°C.  
 
2.3.1.12. Gateway® LR cloning reaction 
Gateway® technology is based on the site-specific recombination of λ phage. LR Clonase™ enzyme 
mix promotes recombination between entry clone and destination vector. Following components were 
mixed in 1.5 ml eppendorf tube: 
   Entry clone (100-300 ng)  1-10 µl 
   Destination vector (~300 ng)  2 µl 
   5X LR Clonase™ Reaction Buffer 4 µl 
   LR Clonase™ enzyme mix  1 µl 
   TE buffer, pH 8.0   up to 20 µl 
Reactions were incubated at 25°C 1-2 h then enzyme mix was inactivated by adding 2 µl of Proteinase 
K solution and the samples were incubated at 37°C for 10 min.  
 
2.3.1.13. PCR amplification 
2.3.1.13.1. Recombinant Taq DNA polymerase 
For amplification of DNA fragments, recombinant Taq DNA polymerase (Invitrogen) was used. A 
master mix was prepared for multiple reactions from the following components on ice: 
   10X PCR buffer (-MgCl2)  10 µl 
   10 mM dNTP mixture   2 µl 
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   50 mM MgCl2    3 µl 
   Primer mix (10 µM each)  5 µl 
   Template DNA    1 µl 
   Taq DNA polymerase (5 U/ µl)  1 µl 
   Autoclaved distilled water to  100 µl 
For PCR amplification a Byozym Multicycler PTC 240 TetradTM 2 machine was used. The reactions 
were performed in 20 µl final volume using the following program: 
   1. Denaturation:   95°C for 5 min 
   2. Denaturation:   95°C for 30 sec 
   3. Annealing:   58°C for 30 sec 
4. Extension: 72°C for 30 sec-3 min depending on fragment 
length 
   5. Terminal step:  72°C for 5 min. 
Normally 25-30 cycles were performed. Samples can be stored at 4°C before further analysis. 
 
2.3.1.13.2. Platinum® Pfx DNA polymerase 
For cloning purposes Pfx DNA polymerase were used. This enzyme possesses proofreading 3’-5’ 
exonuclease activity and provides high fidelity. Following components were mixed in 200 µl PCR 
tubes: 
   10X Pfx Amplification buffer  5 µl 
   10 mM dNTP mixture   1.5 µl 
   50 mM MgSO4    1 µl 
   Primer mix (10 µM each)  1.5 µl 
   Template DNA    1 µl 
   Platinum Pfx DNA Polymerase  1 µl 
   Autoclaved distilled water  to 50 µl. 
After denaturation step (94°C for 2 min) three-step cycling program was used: 
   Denaturation:  94°C for 15 sec 
   Annealing:  55°C for 30 sec 
   Extension:  68°C for 1 min/kb. 
25-30 cycles were performed followed by a longer extension step (68°C for 5 min). Reaction 
temperature was maintained at 4°C. 
 
2.3.1.14. Site-directed mutagenesis of plasmids 
Site-directed mutagenesis was performed using the TransformerTM Site-Directed Mutagenesis Kit 
(Clontech). The mutagenesis strategy is based on that two mutations are introduced at the same time 
using simultaneous annealing of specific primers to single-stranded circular DNA. In addition to the 
desired nucleotide changes, another primer is used containing mutations in a unique restriction site. 
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This facilitates the elimination of non-mutated plasmid DNA by selective restriction digestion. For site 
specific mutagenesis 5’ end phosphorylated primers were used. The annealing reaction was prepared 
as follows: 
   10X Annealing Buffer  2 µl 
   Plasmid DNA   2 µl 
   Selection primer  2 µl 
   Mutagenic primer  2 µl 
   Water    12 µl 
The template plasmid DNA was denatured in a boiling water bath (100 °C) for 3 min, and then the 
samples were chilled on ice for 5 min. For DNA synthesis, the annealing reaction mix was 
supplemented with 
   10X Synthesis buffer  3 µl 
   T4 DNA polymerase  1 µl 
   T4 DNA ligase   1 µl 
   Water    5 µl. 
The reaction mixes were incubated for 30 min at 37°C. The enzymes were inactivated by heating at 
70°C for 5 min. 3 µl of synthesis reaction was digested with a preselected restriction enzyme in order 
to linearize the parental plasmid DNA. After restriction digestion, 0.5 µl of reaction mix was 
transformed into electro-competent E. coli mutS (repair deficient) cells in order to amplify the 
mutagenized strand. After 1 h recovery, transformed bacteria were inoculated into 4 ml of liquid LB 
containing antibiotics for selection and incubated overnight with vigorous shaking. Next day, from the 
E. coli culture the plasmid DNA was purified, and 2 µl DNA (~50 ng) was digested with the selective 
endonuclease to eliminate once again the non-mutated plasmid molecules. 0.5 µl of digested plasmid 
DNA was transformed into E. coli HB101 cells, which were then plated on selective LB medium. 12-
24 independent colonies were tested for their restriction digestion pattern and 3-6 positive clones were 
sequenced in order to verify the presence of desired point mutations. 
 
2.3.1.15. Isolation of plasmid DNA from Agrobacterium tumefaciens 
Agrobacterium culture (5 ml) was grown for 2 days with constant shaking at 28°C. Bacterial cells 
were pelleted and then resuspended in 150 µl of solution I. Subsequently 300 µl of solution II was 
added to the cells and lysis was performed at 55°C for 10 min. Then, 225 µl of solution III was added 
and mixture was incubated on ice for 10 min. Cell debris was removed by centrifugation at 13,000 
rpm for 10 min. Subsequently, DNA was precipitated with 2 volumes of 100% ethanol and centrifuged 
at 13,000 rpm for 10 min. Pellet was washed with 70% ethanol, centrifuged and dried. DNA was 
dissolved in 50 µl of water or TE buffer. Plasmids were either analyzed by PCR amplification or they 
were transformed to E. coli for further analysis after preparation of plasmid DNA. Solutions I, II and 
III are described under 2.2.1.1. 
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2.3.1.16. Transformation of bacterial cells 
2.3.1.16.1. Preparation of electrocompetent E. coli cells (Dower et al., 1998) 
A single colony from 1-5 day-old plate was inoculated in 10 ml of liquid LB and the bacterial culture 
was grown overnight at 37°C with constant shaking (200 rpm). The next evening, 1 ml of this culture 
was inoculated into 300 ml of liquid LB and incubated overnight at 37°C with shaking. In the 
morning, the bacterial culture was diluted to OD600 0.1-0.2 and cells were incubated at 16-20°C with 
shaking until the OD600 reached 0.5-0.6. From this step on the bacteria were kept on ice. All 
centrifugation steps were performed at 4°C in plastic tubes pre-chilled at -20°C. For washing, ice cold 
distilled water was used. Bacteria were pelleted by centrifugation in GSA tubes at 5,000 rpm for 20 
min and resuspended in 200 ml of cold water. This washing step was repeated 3 times to remove salts, 
and then cells were resuspended in 50 ml of water and transferred into a 50 ml falcon tube. Competent 
bacteria were spun down for 10 min at 5,000 rpm. Supernatant was removed completely and the cells 
were resuspended in 800 µl of 7% DMSO solution and divided into 50 µl aliquots in eppendorf tubes. 
Competent cells were frozen immediately in liquid nitrogen and kept at -70°C. 
 
2.3.1.16.2. Preparation of electrocompetent A. tumefaciens cells 
Competent Agrobacterium tumefaciens was prepared using a similar protocol as in case of E. coli 
cells. Agrobacteria were incubated in liquid YEB medium at 28°C. After final washing step, cells were 
resuspended in sterile 10% glycerol solution. 
 
2.3.1.17. Transformation of E.coli cells by the heat-shock method 
1-5 µl of plasmid DNA was added to 50 µl competent bacterial cells. Cells were incubated on ice for 
30 min and then heat-shocked at 42°C for 0.5-1.5 min. Recovery was done at 37°C for 1 h upon 
adding 1 ml of LB medium. The transformation mixture was plated onto selective LB plates. 
 
2.3.1.18. Electroporation of bacterial cells 
An aliquot of competent E. coli or A. tumefaciens cells was thawed on ice. Cells were mixed with 0.5-
3 µl of either plasmid DNA or pre-dialysed ligation mixture and transferred into prechilled 0.2 cm 
electroporation cuvettes. Transformation was performed in a Bio-Rad Gene Pulser set to 2.5 kV 
voltage, 25 µF capacitance and 200 Ω resistance. After electroporation, bacteria were suspended in 1 
ml of liqiud LB medium, transferred into a centrifuge tube and incubated for 1 h at 37°C. After 
recovery phase, cells were spread on solid LB media supplemented with antibiotics. In the case of A. 
tumefaciens, cells were incubated at 28°C and plated on selective YEB medium. 
 
2.3.2. Protein biochemical methods 
2.3.2.1. Preparation of protein extracts from plant material 
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Frozen plant material was ground in liquid nitrogen in a mortar with pestle. Fine tissue powder was 
transferred into a centrifuge tube and extraction buffer supplemented with 25 µl/ml plant protease 
inhibitor cocktail was added. The extract was thawed on ice for 30 min and the protein sample was 
vortexed several times. Cellular debris was removed by centrifugation at 13,000 rpm in a benchtop 
centrifuge for 10-20 min at 4°C. The supernatant was transferred into new tube and 5X SDS protein 
loading buffer was added to the crude extract. Proteins were denatured for 5 min at 95°C. 
 
Extraction buffer: 50 mM Tris.HCl (pH 7.5), 10% glycerol, 1 mM EDTA, 150 
mM NaCl, 0.2% Igepal 
 
Protease inhibitor cocktail: 1 mM benzamide, 2µg/ml pepstatin, 5µg/ml of aprotinin, 
leupeptine 
 
5X SDS protein loading buffer: 2% SDS, 10% glycerol, 50 mM Tris-HCl (pH 6.8), 5% β-
mercaptoethanol, 0.1% Bromphenol blue 
 
2.3.2.2. Determination of protein concentration 
To determine the protein concentration of samples, the Bradford assay was used (Bradford, 1976). 
After extraction, 1 or 2 µl of protein sample was mixed with 1 ml BioRad Protein Assay Concentrated 
Dye Reagent, which was previously diluted 5 times in water. After 5 min incubation at RT, OD595 
value was measured with a spectrophotometer. The protein amount was determined by the help of a 
standard curve obtained previously using a series of dilutions of bovine serum albumin (BSA). 
 
2.3.2.3. Electrophoretic separation of proteins 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE, Laemmli, 1970) was used to separate proteins 
according to their size. Protein gels were poured between 10 cm x 8 cm glass plates (Protean mini gel 
system) using 1 mm spacers. Generally, 4.5 ml of 12% separating gel was poured first and overlayed 
with butanol. After polymerization, the butanol was removed and the surface of gel was rinsed with 
water. On the top of the separating gel, a stacking gel layer was poured and casted with a 10 or 15-well 
comb. The gel was placed into an electrophoresis buffer tank and protein samples were loaded using a 
Hamilton syringe and run in SDS-PAGE running buffer at 30 mA. The size of separated proteins was 
estimated using prestained protein markers (Bio-Rad). 
 
Components for two 12% gels 
 
Separation gel (12%):   5.4 ml ddH2O 
  3.0 ml 29:1 acrylamide to bisacrylamide (40%) 
2.5 ml 1.5 M Tris.HCl [pH 8.8] 
0.1 ml 10% SDS 
50 µl 10% APS 
5 µl TEMED 
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Stacking gel (4 %):   2.4 ml ddH2O 
1 ml 1 M Tris.HCl [pH 6.8] 
0.5 ml 29:1 acrylamide to bisacrylamide (40%) 
40 µl 10% SDS 
30 µl 10% APS 
5 µl TEMED 
 
SDS-running buffer:   25 mM Tris 
192 mM glycine 
0.1% SDS 
 
2.3.2.4. Western blotting 
2.3.2.4.1. Transfer of proteins from SDS-PAGE gels onto membranes 
In order to detect proteins with specific antibodies, proteins separated by SDS-PAGE were transferred 
and immobilized onto PVDF membranes (Towbin et al., 1979). The membrane was rinsed in 100% 
methanol for 30 sec and then incubated in Transfer buffer. The stacking gel was removed from the 
separating SDS-PAGE gel and the gel was equilibrated in 1X transfer buffer for 5 min. Then, a 
transfer “sandwich” was assembled from the following components: sponge layer, 3x 3MM Whatman 
paper, SDS-PAGE gel, PVDF membrane, 3x 3MM Whatman and sponge layer. This sandwich was 
placed in a wet blotter transfer apparatus such that the membrane faced the anode and the gel 
sandwich was fully submerged in Transfer buffer. Protein transfer was performed either for 2-3 h at 25 
V or overnight at 10 V. 
 
Transfer buffer   50mM Tris, 50mM Boric acid [pH 8.0] 
 
2.3.2.4.2. Staining of PVDF membranes 
To monitor successful protein transfer and/or determine equal protein loading, membranes were 
stained in Ponceau staining solution for 1 min and the unspecific stain was washed out with water or 
1X TBS solution (Hughes et al., 1988). 
 
Ponceau staining solution:  0.2% Ponceau S in 3% trichloroacetic acid 
 
2.3.2.4.3. Antibody Probing 
After protein transfer, the PVDF membranes were blocked in blocking solution for 1 h at room 
temperature or at 4°C overnight. Then, the primary antibody diluted in blocking solution was poured 
on the membrane and incubated for 2 h followed by washing the membrane 3 times for 10 min with 
washing buffer. Subsequently, the filters were incubated for 1.5 h with a horseradish peroxidase 
conjugated secondary antibody diluted in blocking solution. The membranes were then washed 3 times 
for 10 min with washing buffer.  
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TBS:      137 mM NaCl, 2.7 mM KCl, 20 mM Tris.HCl [pH7.4]  
Blocking solution:   5% milk powder in 1X TBS with 0.05% Tween-20 
Washing buffer:   1X TBS with 0.2% Tween-20 
 
2.3.2.4.4. Detection of chemiluminescent signal 
To visualize the position of proteins using horseradish peroxidase conjugated second antibodies, an 
enhanced chemiluminescence (ECL) detection kit was used. Freshly prepared 1:1 mixture of the two 
ECL reagents was applied onto the PVDF membranes. Light emission was captured on HyperfilmTM 
by autoradiography and the films were developed in Optimax X-ray Film Processor. 
 
2.3.2.4.5. Stripping of PVDF membranes 
The same membrane could be probed with another antibody after removing the IgGs of the first 
reaction. Stripping was performed either using Ponceau solution since it contains TCA that can 
denature proteins, or using RestoreTM Western blot stripping buffer. In the latter case, the membrane 
was incubated in the buffer for 5-15 min at room temperature on a shaker. Subsequently, the 
membrane was washed 2-3 times with 1X TBS. 
 
2.3.2.5. Size separation of protein complexes on linear glycerol gradient 
Plant protein complexes were separated according to their sizes on glycerol density gradient. 10 ml of 
10-40% gradient was prepared by using a gradient mixer and 1 ml nuclear or total cell protein extract 
was loaded on the top. Separation was done in an ultracentrifuge by centrifugation at 25,000 g for min. 
16 h at 4°C. 300 µl fractions were collected and were analyzed by western blotting. 
 
Glycerol gradients: 10% or 40% glycerol, 50 mM HEPES [pH 7.5], 50 mM KCl, 5 mM MgCl2, 
10 µM ZnS04, 1 mM PMSF, 2 mM ATP, 10µl/ml plant protease inhibitor mix 
 
2.3.2.6. Immunoprecipitation of protein complexes 
To prepare crude protein extracts, plant material was ground to fine powder, proteins were extracted in 
extraction buffer (as in 2.3.2.1) and total protein amount was measured using Bradford assay. To 1 mg 
input protein 10 µl (2 µg) of mouse monoclonal α-HA antibody was added. The reaction mixture was 
incubated overnight in the cold room on a rolling platform. Next morning, 20 µl of protein A/G 
agarose resin was added to each 1 mg of total input protein. The protein sample was incubated for 1-4 
h in the cold room on a rolling platform. The protein A/G resin carrying the immunoprecipitated 
proteins was collected by centrifugation at 1,000 g for 5 min at 4°C and the supernatant was removed. 
The beads were washed 3 times with extraction buffer in eppendorf tubes. A final washing step was 
then performed using extraction buffer lacking any detergent. After centrifugation, the supernatant was 
removed and proteins were eluted from the protein A/G resin with 1 mg/ml HA peptide, using the 
same volume as protein A/G for the elution volume. The elution was performed at room temperature 
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for 15 min with gentle shaking. After peptide elution, the beads were boiled with 1X SDS loading 
buffer in order to remove all proteins from protein A/G agarose. The immunoprecipitated proteins 
were analyzed by western blotting. 
 
2.3.3. Yeast molecular biology methods 
2.3.3.1. Small scale transformation of yeast cells using the lithium acetate method 
S. cerevisiae cells were inoculated from a 3-5-day-old plate in 20 ml of YPD medium and were grown 
overnight with vigorous shaking at 28°C. From the overnight culture an aliquot was transferred into 
fresh YPD to prepare a starter culture of OD600~0.2, which was incubated at 28°C with shaking for ~3-
4 h. Cells were collected by centrifugation for 5 min at 3500 rpm and resuspended in 50 ml of water. 
This washing step was repeated 3 times. After centrifugation, cells were resuspented in 10 ml of 100 
mM LiAc solution and incubated for 5 min at 28°C. Then, the cell suspension was divided into 1.5 ml 
centrifuge tubes according to the number of transformations. Cells were centrifuged and the 
supernatant was removed. Following components were added on top of the pellet in this order: 
    240 µl 50 % PEG 
    36 µl 1 M LiAc 
    25 µl 2 mg/ml SS-DNA 
    5 µl plasmid DNA 
    45 µl ddH2O 
The transformation mixture was resuspended and incubated for 30 min at 28°C and then 30 µl of 
DMSO was added. Subsequently, heat shock was done at 42°C for 20 min with occasional shaking by 
vortexing. Then, the cells were chilled on ice for 2 min and pelleted. After removal of the supernatant, 
cells were resuspended in water or 1X TE buffer and plated on selective SD medium. 
 
2.3.3.2. Plasmid isolation from yeast 
A yeast colony was inoculated from a fresh plate in 10 ml of appropriate SD liquid medium and 
incubated O/N at 28°C with shaking (200-220 rpm). Cells were centrifuged at 13,000 rpm for 5 min. 
The supernatant was carefully removed and cells were resuspended in the residual liquid. 10 µl of 
lyticase solution was added and then cells were vortexed and incubated for 30-60 min at 37°C with 
shaking at 200-250 rpm. Then, 10 µl of 20% SDS was added, the samples were mixed and subjected 
to a freeze/thaw cycle at -20°C. The sample volume was adjusted to 200 µl with 1X TE buffer (pH 7) 
and then 200 µl of phenol:chloroform:isoamyl alcohol (25:24:1) was added. The samples were 
vortexed and centrifuged at 13,000 rpm for 10 min. The upper aqueous phase was transferred into a 
new centrifuge tube and mixed with 8 µl of 10 M ammonium acetate and 500 µl of 100% ethanol. The 
tubes were incubated at -70°C for 1 h and then the precipitated DNA was collected by centrifugation 
at 14,000rpm for 10 min. The DNA pellet was dried and resuspended in 20 µl of water. 
Lyticase solution: 5 units/µl in TE buffer 
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2.3.3.3. β-galactosidase filter lift assay 
Yeast colonies were grown for 2-3 days at 30°C on ImmobilonTM-Nylon membranes. A Whatman 
paper was presoaked in Z-Buffer/X-Gal solution in a 100-mm Petri dish. The membrane with the 
colonies was placed in liquid nitrogen until it was completely frozen (about 4 sec), and then thawed at 
room temperature, and this procedure was repeated 3 times. Then, the filter was placed with its colony 
side up on the presoaked Whatman paper. The filters were incubated at 30°C and checked periodically 
for appearance of blue color.  
Z-Buffer:   16.1 g/l Na2HPO4·7H2O, 5.50 g/l NaH2PO4·H2O, 
0.75 g/l KCl, 0.246 g/l MgSO4·7H2O, [pH 7.0]  
 
Z-Buffer/X-gal solution: 100 ml Z-Buffer, 0.27 ml β-mercaptoethanol, 
1.67 ml X-gal (20mg/ml) 
 
2.3.3.4. Yeast one-hybrid assay 
To screen for cDNA clones of transcription factors that can bind to cis-regulatory promoter elements 
of interest, a yeast one-hybrid assay was used. At first, the target promoter constructs were integrated 
into the genome of the YM4271 strain. Lines carrying the target-pHISi-1 construct were tested on 
SD/-His plates with different 3-AT concentrations (0, 15, 30, 45 and 60 mM 3-AT) in order to 
determine a suitable 3-AT concentration to suppress background activity of the HIS3 reporter gene 
prior initiating the library screening. Colonies with target-pLacZi constructs were tested for 
background lacZ expression using a colony lift assay. Library scale transformation was done using an 
AD-cDNA library obtained from A. thaliana green cell suspension and the resultant transformation 
mixture was plated on SD/-His/-Leu/+25 mM 3-AT. Colonies resulting from HIS3 activation were 
isolated. DNA-binding activity was confirmed by transforming target-pLacZi reporter strain with the 
candidate pACT clones and colony lift assay was performed to monitor lacZ activity. 
 
 
2.3.4. Plant tissue culture and transformation 
2.3.4.1. Plant growth conditions in the greenhouse 
Arabidopsis thaliana plants were grown in 7 x 7 cm plastic pots at 22oC day and 18°C night 
temperature, 70% humidity in trays under either short day (8h light/16h dark) or long day conditions 
(16 h light/8 h dark) under 200 to 400 µEinstein m−2s−1 irradiance. 
 
2.3.4.2. In vitro cultivation of A. thaliana seedlings 
Sterilized Arabidopsis seeds were germinated and grown in MSAR seed medium containing 0.5% 
sucrose, half concentration of macro-elements and no vitamins, under short day conditions at 20°C 
using 200 to 400 μEinstein m-2 s-1 irradiance.  
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2.3.4.3. Maintenance of Arabidopsis cell suspensions 
Each week, 10-15 ml from 50 ml one-week-old Arabidopsis thaliana (ecotype Col-0) cell suspension 
was subcultured in 35-40 ml cell suspension medium for culture maintenance (Mathur and Koncz, 
1998). The cells were grown under constant agitation of 120–150 rpm at 18-22°C. Photosynthetic cells 
suspensions were maintained using 200 to 400 μEinstein m-2 s-1 white light. 
 
2.3.4.4. Sterilization of A. thaliana seeds 
Seeds were placed in an Eppendorf tube and immersed in 70% Ethanol for 1-2 min followed by 
treatment with Ca-hypochlorite solution for 15 min on a rolling platform. Seeds were then rinsed 3 
times with sterile water and either plated directly on appropriate growth medium or allowed to dry in a 
sterile hood overnight. 
 
Ca-hypochlorite solution: 5% CaOCl2 containing 0.1% Trition X-100 in water  
 
2.3.4.5. Agrobacterium-mediated transformation of A. thaliana plants by the floral dip method 
For transformation (Clough and Bent, 1998), bolting plants cultivated in 10 cm pots (10-12 plants/pot) 
were used. 300-500 ml overnight culture of Agrobacterium cells was pelleted at 5000 rpm for 10 min. 
Agrobacteria were resuspended in 300 ml of transformation medium and plant inflorescences were 
submerged in this solution for 5 min. Plants were then covered with a plastic bag, which was removed 
2 days later. Seeds were collected in paper bags and selected on MSAR plates containing antibiotics. 
 
Transformation medium:  ½ MS salts 
     1X B5 vitamins 
     5% sucrose  
     pH 5.7 
     0.044 μM BAP 
     0.005% Silwet L-77 
 
2.3.4.6. Agrobacterium-mediated transformation of A. thaliana cell suspensions 
Two- to-three-day-old cell suspension was transformed with Agrobacterium. Bacterial overnight 
culture was centrifuged at 5,000 rpm for 10 min and the cells were resuspended in cell suspension 
medium at OD600 1.0. From this bacterium inoculum, 2-4 ml was added to the Arabidopsis cell culture. 
After 1-2 h of standing, the cell suspension was cultivated as usual. After 2-3 days, antibacterial 
antibiotics (ticarcillin, cefotaxime) were added to the culture. The cell suspension was subcultured 
following the original weekly cycle with addition of antibiotics to select for the T-DNA encoded 
resistance marker. (Ferrando et al., 2000). 
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2.3.4.7. Selecting for transformed plants 
2.3.4.7.1. Selection under sterile conditions  
Seeds were sterilized in 15 ml tubes and sawn on MSAR medium containing appropriate antibiotic 
supplemented with cefotaxime to kill Agrobacterium. Antibiotic resistant transformants were 
transferred first onto non-selective media, then later into soil. Plants were cultivated in the greenhouse 
and seeds were collected for further analysis. 
 
2.3.4.7.2. Selection in the greenhouse 
T1 seeds were sawn on soil in 14 cm x 20 cm containers and after germination 4-5-day-old plantlets 
were sprayed with 250 mg/ml BASTA solution supplemented with 0.1% Tween-20. Spraying was 
repeated every second day until sensitive plants died. Transformed plants carrying the BASTA 
resistance selectable marker were transferred to single pots, cultivated in the greenhouse and seeds 
were collected. 
 
2.3.4.8. Crosses of Arabidopsis plants 
To perform crosses of Arabidopsis plants following bolting, mature flowers and siliques were removed 
from stems. Two to three flowers were emasculated with a pair of forceps by removing petals, sepals 
and immature anthers. Pollen from a mature male plant was used to dust the stigma. Seed maturation 
was monitored regularly and fully grown siliques were collected. 
 
2.3.4.9. Measurement of flowering time 
To assess flowering time phenotype of Arabidopsis mutants, the number of rosette leaves was counted 
when flower buds appeared at the apical meristem. Flowering time was determined at short day (8 h 
light/16 h dark) and long day (16 h light/8 h dark) conditions. 
 
2.3.4.10. DNA extraction from plant material 
For isolation of DNA from plants, the cetyl-methyl-ammonium bromide (CTAB) method adapted 
from Rogers and Bendich (1985) was used. Plant material was collected into centrifuge tubes and 
frozen in liquid nitrogen. Tissue was ground using a plastic rod fitted into a drilling machine. 0.5 ml of 
preheated (65°C) CTAB 2X was added to the grind the tissue. The crude extract was vortexed and 
incubated at 65°C for 5-30 min, and then placed on ice. 0.4 ml of chloroform was added and the 
extract was vortexed and centrifuged for 5 min at 13,000 rpm. 700 µl from the upper water phase was 
withdrawn and added to 1/10 volume (70 µl) of preheated (65°C) CTAB 10X. Subsequently, 400 µl of 
chloroform was added, the sample was mixed well and centrifuged for 5 min at 13,000 rpm. Then, 0.6 
ml of DNA extract from the upper phase was added to 0.6 ml of CTAB Precipitation Buffer, and then 
mixed and centrifuged for 10 min at 13,000 rpm. The supernatant was completely removed and the 
pellet was air-dried for few minutes. The pellet was dissolved in 0.3 ml of High Salt TE buffer, and 
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thereafter 0.6 ml of 100% ethanol was added. DNA was precipitated at -20°C for 15 min, and then 
collected by centrifugation for 15 min. Finally the DNA sample was washed with 70% ethanol and 
after brief drying dissolved in 50 µl of 0.1 x TE. 
 
CTAB 2X:   2% (w/v) CTAB, 100 mM Tris.HCl [8.0], 20 mM EDTA [8.0] 
 1.4 M NaCl, 1% (w/v) polyvinylpyrrolidone  
CTAB 10X:   10% (w/v) CTAB, 0.7 M NaCl 
CTAB Precipitation Buffer: 1% (w/v) CTAB, 50 mM Tris-HCl [8.0], 10 mM EDTA [8.0] 
High Salt TE:   10 mM Tris-HCl [8.0], 1 mM EDTA [8.0], 1 M NaCl 
 
2.3.4.11. Histochemical assay of β-glucuronidase (uidA) reporter enzyme activity in planta 
Freshly harvested seedlings or cell suspension cultures were immersed in X-Gluc solution and vacuum 
treated for 3 min in an exicator, and then incubated overnight at 37°C. The plant material was stored in 
70% ethanol at room temperature after several washing/destaining steps using 70% ethanol (Jefferson 
et al., 1987). 
 
X-Gluc solution (1L):   1 g X-Gluc dissolved in 2 ml DMSO 
0.1 % Triton X-100 
0.1 M Na phosphate buffer [pH 7.0]  
0.5 mM K3Fe(CN)6 and 0.5 mM K4Fe(CN)6 
 
2.3.4.12. Isolation of plant cell nuclei  
20 g of frozen plant material was ground in liquid nitrogen. The powder was mixed with 40 ml of 
nuclear grinding buffer and the sample was incubated in the cold room on ice until extraction buffer 
was melted. The extract was filtered through two layers of Miracloth and one layer of 50 µm nylon 
mesh and centrifuged at 3,500 rpm for 10 min at 4°C. After removal of supernatant, the crude nuclear 
pellet was washed three times with nuclear wash buffer followed each time by centrifugation at 3,500 
rpm for 5 min at 4°C. The nuclear pellet was dried for few minutes. Extraction of nuclear proteins was 
performed in nuclear lysis buffer using a dounce homogenisator. 
  
Nuclear grinding buffer:  1 M hexylene glycol 
     50 mM Tris-HCl pH 7.5 
     10 mM MgCl2 
     2 mM ATP 
     0.2% Triton X-100 
     1 mM DTT 
     0.8 mM PMSF 
     10 µl/ml PIC 
Nuclear wash buffer:   0.5 M hexylene glycol 
     50 mM Tris-HCl pH 7.5 
     10 mM MgCl2 
     2 mM ATP 
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     0.2% Triton X-100 
     1 mM DTT 
     0.8 mM PMSF 
     10 µl/ml PIC 
Nuclear lysis buffer:   50 mM HEPES pH 7.5 
     50 mM KCl 
     5 mM MgCl2 
     10 µM ZnSO4 
     1% Triton X-100 
     0.5% Sarcosyl 
     0.1% Na-deoxycholate 
     0.1% Igepal 
     1 mM PMSF 
     10 µl/ml PIC 
 
 
2.3.5. Cell biological methods 
2.3.5.1. Light microscopy 
Light microscopy was performed with Leica MZFLIII microscope and images were captured and 
processed with Diskus version 4.30.102 program. 
 
2.3.5.2. Indirect immunofluorescence microscopy 
The indirect immunofluorescence microscopy studies were performed in collaboration with Dr. Jan 
Jásik. Seedlings collected 7 days after germination were fixed, embedded, sectioned and probed with 
epitope specific antibodies as described previously by Ferrando et al. (2000). Fluorescence images 
were examined using Leica Aristoplan and DMRB microscopes using fluorescein-5-isothiocyanate 
(FITC) and rhodamine (CyTM3) filters, and recorded with a Hitachi HV-20 camera controlled by a 
Diskus computer program. 
 
2.3.5.3. Confocal laser scanning microscopy 
The localization of GFP-tagged proteins in fresh tissue samples was with the Leica SP2 AOBS (Leica, 
Bensheim, Germany) system. GFP was excited with the Argon laser at 488 nm and the emitted 
fluorescence was detected between 505 and 535 nm, the autofluorescence of chlorophyll was detected 
at 620-720. Simultaneous brightfield images were recorded by a transmission detector. Merging of 
images and calculations of 3D projections were performed with the Leica LCS software. Selected 
images were processed with Adobe Photoshop. 
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3. RESULTS 
3.1. Analysis of PRL1 gene expression pattern and identification of essential 
transcription regulatory regions 
3.1.1. Overexpression of PRL1 cDNA 
To facilitate the isolation and biochemical analysis of PRL1-associated protein complexes, various 
cDNA contructs were previously generated to overexpress the PRL1 protein in fusion with short 
hemagglutinin (HA) or c-Myc peptide epitopes in transgenic plants and cell suspensions. The PRL1 
cDNA was thus fused to an intron-containing HiA epitope coding sequence and cloned into a gene 
expression cassette downstream of the CaMV35S promoter by J. Jásik (Ferrando et al., 2000). At the 
start of this thesis work, this construct was introduced into wild type Col-0 and prl1 mutant plants and 
thereafter lines carrying the CaMV35S::PRL1-HiA in homozygous form were isolated. Subsequently, 
a genetic complementation assay was performed to test whether the overexpression construct could 
restore the complex pleiotropic prl1 mutant phenotype to wild type and thereby prove that this 
construct was functional. The majority of prl1 plants (over 70%) carrying the CaMV35S:PRL1-HiA 
construct showed wild type leaf and rosette phenotype when grown in soil in the greenhouse (data not 
shown). To determine whether the root elongation defect of the prl1 mutant was also complemented 
by this construct, the root length of an isolated homozygous line was investigated (Figure 7 A).  
 
 
 
 
 
 
 
 
 
 
Figure 7. Genetic complementation assay with the CaMV35S:PRL1-HiA construct  
(A) Root length of a prl1 mutant carrying the CaMV35S:PRL1-HiA construct was compared to that of prl1 
mutant plants on vertical plates. (B) Root length of prl1 and wild type plants homozygous for the 
CaMV35S:PRL1-HiA construct were measured 15 days after germination. (C) Immunodetection of HA-tagged 
PRL1-HiA protein using an anti-HA antibody. Wild type and prl1 plants homozygous for CaMV35S:PRL1-HiA 
were grown on MSAR medium containing 0.5 % sucrose. Total protein samples were extracted from 2-week-old 
seedlings and resolved on 12% SDS-PAGE gel. 
 
Seedlings were grown on vertically oriented MSAR plates for 15 days then the root length of ten 
individuals from each line was measured. As control, wild type and prl1 plants grown on the same 
plate were scored. Surprisingly, the data indicated that the CaMV35S:PRL1-HiA construct did not 
complement the prl1 short root phenotype. The root length of plants homozygous for both CaMV35S-
PRL1-HiA and prl1 mutation was comparable to that of the prl1 mutant, which has approximately 3-
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fold shorter roots than wild type seedlings (Figure 7 B). Overexpression of the PRL1-HiA cDNA did 
not result in any phenotypical change in the wild type background. The synthesis of PRL1-HiA protein 
in these lines was verified by immunodetection using an anti-HA antibody (Figure 7 C). Total protein 
extracts were prepared from two-week-old seedlings carrying the CaMV35S:PRL1-HiA construct in 
homozygous state in either prl1 or wild type background. Significantly high levels of PRL1-HiA 
signals were detected in both cases corresponding to the full length protein but several smaller bands 
were also observed suggesting possible degradation of PRL1. 
 
3.1.2. Genetic complementation assay using an estradiol-inducible PRL1 genomic construct  
The failure to obtain genetic complementation of prl1 root elongation defect by overexpression of 
PRL1 cDNA supported the observations of Nemeth et al. (1998), who could obtain genetic 
complementation only with the wild type PRL1 genomic clone. Therefore, to perform a conditional 
genetic complementation assay, we have labelled the PRL1 gene with HA epitope coding sequences 
and cloned it in the estradiol-inducible pER8 (XVE) binary plant expression vector (Zou et al., 2000). 
First, the PRL1 genomic fragment was fused to HA-tag in a pBS vector. The last 200 bp of PRL1 
coding region was amplified using HASpe and Prl1ndef primers (2.1.6.2) and the C-terminal coding 
region was exchanged in the pBS-PRL1 genomic clone with this PCR amplified fragment using NdeI-
SpeI digestion. The pER8 binary vector, which was modified by exchanging its hygromycin resistance 
plant selectable marker gene for a kanamycin resistance gene (Ph.D. thesis Lafos, 2006), carries only 
two unique cloning sites downstream of its estradiol-inducible promoter: a 5’ XhoI and a 3’ SpeI site. 
Upon investigation of the pBS-PRL1-HA genomic construct, both sites appeared to be suitable for 
subcloning. As a unique XhoI site was present just upstream of the start codon of the PRL1 gene, this 
site and an SpeI site downstream of the PRL1 stop codon were used to construct the expression vector 
pER8(Km)-PRL1genomic-HA. This construct was transformed into prl1 mutant plants and T1 
transgenic seedlings were selected in the presence of kanamycin. All kanamycin resistant T1 plants 
showed wild type leaf and rosette phenotype. T2 progeny of ten T1 plants was further investigated in 
order to check their root elongation phenotype by growing of seedlings on MSAR plates placed 
vertically. All kanamycin resistant T2 progeny segregated at 3:1 or higher ratio the wild type and prl1 
root phenotype, indicating that even in the absence of estradiol induction the pER8(Km)-
PRL1genomic-HA construct also complemented the root elongation defect caused by the prl1 
mutation (Figure 8 A).  
 To further investigate this unexpected behaviour of pER8(Km)-PRL1genomic-HA construct, 
an estradiol induction experiment was performed with eight T2 lines. Seeds were sterilized and plated 
on MSAR plates containing kanamycin. Resistant seedlings were transformed into liquid MS medium 
containing 0.5% sucrose and 1/2 MS salts two weeks after germination. Half of the plant material was 
treated with 2 μM estradiol dissolved in DMSO, while the other half was incubated with equivalent 
amount of DMSO. The samples were induced for 24 h and then frozen in liquid nitrogen. Crude 
protein extract was prepared and PRL1-HA expression was monitored by western blotting using an 
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anti-HA antibody. High levels of PRL1-HA protein were detected even if the seedlings had not been 
induced with estradiol and only a slight induction was observed as a consequence of estradiol 
treatment (Figure 8 B).  
 
 
 
 
 
 
 
 
 
Figure 8. Analysis of estradiol inducible PRL1-HA synthesis in transgenic plants carrying the 
pER8(Km)-PRL1genomic-HA construct 
(A) Root length of T2 progeny of plants carrying the estradiol-inducible pER8(Km)-PRL1genomic-HA construct 
was measured on vertical MSAR plates containing 0.5% sucrose. T2 families of all examined T1 lines 
segregated wild type-like and prl1 mutant (marked with red arrow) at 3:1 or higher ratios. (B) Estradiol 
induction was performed with seedlings selected on kanamycin plates. Plants were transformed into liquid MS 
medium and incubated for 24h with either DMSO (-) or 2 μM estradiol dissolved in DMSO (+). Protein extracts 
prepared from these seedlings were separated by 12% SDS-PAGE gel and the PRL1-HA protein was detected by 
western blotting with anti-HA antibody. 
 
3.1.3. Testing the stringency of estradiol induction of pER8 vector using a GUS reporter gene 
The pER8 vector constructed by Zuo et al. (2000) carries a gene driven by a constitutive active G10-
90 promoter that encodes a chimera protein composed of the LexA DNA-binding domain (residues 1-
87), the acidic transcription activation domain of VP16 (residues 403-479) and the regulatory region 
of the human estrogen receptor hER (residues 282-595). As second component, pER8 carries an 
inducible gene expression cassette providing a multiple cloning site downstream of eight copies of 
LexA operator sequence and an upstream CaMV35S minimal promoter. The chimeric LexA-VP16-
hER protein is constitutively expressed but can only activate transcription of the target gene by 
CaMV35S-LexA promoter upon estradiol treatment. The presence of estradiol induces changes in the 
protein conformation, allowing the LexA DNA-binding domain to recognize the LexA operator of 
CaMV35S-LexA promoter. In addition, pER8 carries a hygromycin resistance gene as plant selectable 
marker. 
 To determine whether genetic complementation of the prl1 mutation by the pER8(Km)-
PRL1genomic-HA construct in the absence of estradiol induction resulted from high basic level 
activity of the LexA-CaMV35S minimal promoter of pER8, we performed a control experiment. To 
monitor the stringency of estradiol-dependent gene expression from pER8, an intron containing GUS 
(uidA) reporter gene was inserted downstream of the inducible CaMV35A-LexA promoter in the 
pER8-iGUS control plasmid by I. Kovács. This plasmid was transformed into A. tumefaciens GV3101 
(pMP90) and wild type plants were subsequently transformed. T1 seeds were germinated on 
hygromycin selection plates and transgenic plants were isolated. Seeds from ten T2 families were 
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germinated on selection plates and after two weeks plantlets were transferred into liquid MS media 
containing either 2 μM estradiol dissolved in DMSO or only equivalent amount of DMSO. GUS 
reporter enzyme activity was monitored by histochemical staining after 24 h induction. Plants that 
were treated only with DMSO did not show GUS staining, whereas as a result of estradiol induction 
high GUS activity was observed in all tissues of seedlings, although some differences in expression 
levels were observed between different T2 lines (Figure 9). This control experiment demonstrated that 
the pER8 expression system is tightly regulated by estradiol. Therefore, the results also suggested that 
the genomic XhoI-SpeI PRL1 fragment contains important transcription regulatory elements, which 
are likely sufficient to drive specific PRL1 expression conferring genetic complementation of the prl1 
mutation. 
 
 
 
 
 
 
 
Figure 9. Histochemical assay of GUS reporter enzyme activity of pER8-iGUS seedlings in the 
absence and presence of estradiol 
Seedlings were grown on selective MSAR plates for two weeks and then resistant plants were transferred into 
liquid MS medium supplemented with either DMSO or 2 μM estradiol dissolved in DMSO for 24 h. After 
induction, the seedlings were stained with X-Gluc solution overnight at 37°C. 
 
3.1.4. Characterization of an estradiol-inducible PRL1 cDNA construct 
To strengthen the hypothesis that transcription regulatory elements within the PRL1 gene were 
responsible for estradiol-independent expression and genetic complementation conferred by the 
pER8(Km)-PRL1genomic-HA construct, we had to perform an additional control experiment. This 
experiment addressed the question whether the PRL1 cDNA expressed by the pER8 vector would 
complement the prl1 mutation. The PRL1 cDNA was PCR amplified using the XhoIF and HASpe 
primers (2.1.6.2) and the obtained DNA fragment was digested with XhoI-SpeI and inserted into XhoI-
SpeI cleaved pER8. The accuracy of PCR was controlled by DNA sequencing. This pER8(Km)-PRL1-
cDNA-HA construct was transformed into Agrobacterium and then into prl1 mutant plants to select 
T1 transformants on MSAR plates supplemented with kanamycin. The plants carrying the resistance 
marker showed prl1 mutant phenotype both in MS medium and upon later transfer into soil. The 
phenotype of these transgenic plants was further characterized in the T2 generation by measuring the 
root lengths of seedlings germinated on vertically oriented MS plates (Figure 10 A). This control 
experiment clearly demonstrated that the pER8(Km)-PRL1-cDNA-HA construct failed to complement 
the root elongation defect of the prl1 mutant when plantlets were growing without estradiol. Our 
prediction that the XhoI-SpeI PRL1 genomic fragment that carried only 62 bp upstream of the ATG 
DMSO Estradiol
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codon carried transcription regulatory sequences required for wild type PRL1 expression and 
complementation of the prl1 mutation thus appeared to be correct.  
 
 
 
 
 
 
 
 
Figure 10. Analysis of plants carrying the estradiol-inducible pER8(Km)-PRL1-cDNA-HA construct 
(A) T2 progeny of pER8(Km)-PRL1-cDNA-HA transformed plants were germinated on vertical MSAR plates 
and the root length was monitored after 2 weeks. (B) Immunodetection of HA epitope tagged PRL1-HA protein 
by western blotting using anti-HA antibody. Seedlings were selected on kanamycin containing MSAR plates for 
two weeks and then transferred into liquid MS medium supplemented with either DMSO (-) or 2 μM estradiol in 
DMSO (+). Samples containing 20 μg of total protein were resolved by 12% SDS-PAGE gel. Ponceau staining 
of the corresponding membrane used for western blotting is shown as a control for equal loading. 
 
To test estradiol-inducibility of the pER8(Km)-PRL1-cDNA-HA construct in the prl1 mutant, 
seedlings from eight T2 independent families were grown on kanamycin containing plates for two 
weeks and then transferred into liquid MS medium containing 2 μM estradiol or equivalent amount of 
DMSO. The plant material was snap-frozen in liquid nitrogen after 24 h incubation. Total protein 
samples were extracted and separated on a 12% SDS-PAGE gel and subjected to western blotting with 
anti-HA antibody to detect the HA-epitope-tagged PRL1-HA protein. (Figure 10 B). Despite 
considerable variation between the transformed lines, PRL1-HA protein was only detected in the 
estradiol-induced seedlings. This confirmed that the pER8 expression system was tightly regulated. 
 To investigate genetic complementation ability of the pER8(Km)-PRL1-cDNA-HA construct, 
ten lines from the T2 progeny of transformed plants were germinated on kanamycin-free vertical 
MSAR plates supplemented with 4 μM estradiol. Root length of seedlings was measured at the age of 
7 days and 17 days (Figure 11). Five lines showed prl1 root phenotype after 7 days and five lines (#1, 
#2, #5, #7 and #9) had long roots similar to wild type plants. The segregating prl1 mutant seedlings 
were removed from the T2 populations and the root phenotype was assessed again at day 17 after 
germination for two lines (#2, #5) which showed wild type phenotype. The other lines (#1, #7 and #9), 
which showed complementation of the prl1 root elongation defect after 7 days, discontinued normal 
root development and their root length was between those of prl1 and wild type at day 17. 
 In seedlings collected from the different T2 families at day 17 after germination, the 
expression levels of PRL1-HA protein were compared by western blotting with anti-HA antibody 
(Figure 12). Crude protein samples were also extracted from lines that showed wild type root length 
only after 7 days. In each case, 20 μg of protein sample was resolved by 12% SDS-PAGE and equal 
loading was controlled by Ponceau staining and western blotting of the same membrane with an anti-
tubulin antibody. Lines #2 and #5, showing wild type root elongation phenotype at both days 7 and 17  
WT
pER8-
PRL1-cDNA
A B
- +  - +     - +
PRL1-HA
#5 #6 #7
RESULTS   51 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Genetic complementation analysis with the estradiol-inducible pER8(Km)-PRL1-cDNA-
HA construct.  
Root length of ten T2 lines was monitored on kanamycin-free vertical MSAR plates containing 4 μM estradiol at 
days 7 and 17 after germination. Three phenotypic classes could be distinguished: i) lines that showed prl1 
phenotype at both of the time points of root measurement (#3, #4, #6, #8 and #10), ii) lines that displayed wild 
type root length at day 7 but had shorter than wild type roots at day 17 (#1,#7 and #9) and iii) lines that showed 
wild type root phenotype both at days 7 and 17 after germination (#2 and #5). Segregating prl1 mutant plants are 
marked with red arrows. Wild type (WT) and prl1 mutant plants were germinated on each plate as controls for 
direct comparison (not shown for each plate).  
 
 
 
 
 
 
 
 
Figure 12. Immunodetection of PRL1-HA protein in seedlings displaying full or partial 
complememtation of prl1 root elongation defect by the eastradiol-inducible pER8(Km)-
PRL1-cDNA-HA construct in the presence of estradiol. 
Protein extracts were prepared from lines 1, 2, 5, 7 and 9 at day 17 after germination. Each sample, containing 20 
μg of protein, was resolved by 12% SDS-PAGE gel and analyzed by western blotting. The membrane was 
stained with Ponceau-S and subjected to immunodetection first with anti-HA IgG and then after stripping with 
anti-tubulin antibody. 
 
after germination, expressed the highest level of PRL-HA protein, whereas in all other lines lower 
levels of PRL1-HA protein was detected. These results indicated that complementation of the prl1 root 
elongation defect correlated with high level overexpression of PRL1 cDNA. Thus, the failure of 
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SAIL 1276 G04
aaattaattgtgttcatttcccttttaaaagaatttttcggcgcaacaaaatcgtgaaat  
                                   <-LB SAIL 1276 LB  -> 
tgatataaataaaCTCGAGattattaatataaccctttttcacttcacttctctttctct  
       XhoI 
ctaaaccctaaaagaagaacgATGCCGGCTCCGACGACGGAGATCGAACCCATCGAAGCA  
 
 
C
genetic complementation with the first tested 35S::PRL1cDNA-HiA construct probably reflected the 
fact that a certain threshold of wild type PRL1 protein synthesis is necessary for full genetic 
complementation of the prl1 root elongation defect.  
 
3.1.5. Characterization of the prl1-5 (SAIL_1276G04) mutant allele 
We have screened the publicly available insertion mutant collections for new prl1 alleles. In the SAIL 
collection, we identified a T-DNA insertion in the PRL1 promoter region. PCR amplification of DNA 
fragments carrying the boundaries of the T-DNA insertion was performed using combinations of 
PRL1 gene specific PRL1 ups and PRL1 5’rev primers with the right border (RB) specific DAP RB2 
and left border (LB) specific SAIL LB3 T-DNA primers (2.1.6.4). PCR analysis of 19 plants from the 
segregating M3 population has identified homozygous lines, which did not carry the wild type DNA 
fragment of 1.8 kb amplified by the gene specific primers (Figure 13 A and B, lines 1, 4, 7, 10 and 
15). Combinations of the T-DNA left border primer with both PRL1 ups and PRL1 5’rev gene specific 
primers yielded PCR products indicating that the SAIL_1276G04 mutant line carried an inverted 
tandem (LB-RB/RB-LB) T-DNA repeat in the PRL1 promoter region.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Localization of the T-DNA insertion in the prl1-5 (SAIL_1276 G04) mutant  
(A) PCR analysis M3 seedlings using the PRL1 ups and PRL1 5’rev gene specific primers. (B) PCR 
amplification of the T-DNA left border junction using the SAIL LB3 and PRL1 ups primers. (C) Schematic 
illustration of the insertion site and sequence of the T-DNA LB junction facing the 5’-end of the PRL1 gene in 
the SAIL_1276G04 mutant. The 5’ UTR is marked with blue colour.  
 
Sequencing of the PCR amplified T-DNA left border junctions revealed that the inverted T-DNA 
repeat was integrated 85 bp upstream of the ATG codon of the PRL1 gene. The position of the 
SAIL_1276G04 T-DNA insertion (designated later as the prl1-5 allele) was located 17 bp upstream of 
the XhoI site that represented the 5’-end of the PRL1 gene fragment, which we used in the pER8(Km)-
PRL1genomic-HA construct characterized in section 3.2.1. Sequences downstream of the T-DNA 
insertion and the XhoI site carried only the TATA-box and 5’ non-translated UTR sequences of the 
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PRL1 gene (Figure 13 C). To characterize the segregation and phenotype caused by the 
SAIL_1276G04 T-DNA insertion, seeds from the M2 and derived M3 families were germinated on 
selective MSAR plates containing DL-phosphinothricin (PPT) and on non-selective MSAR plates. 
Plants homozygous for prl1-5 (SAIL_1276 G04) mutation showed wild type phenotype (data not 
shown). This observation suggested that either the mannopine synthase 2’ promoter (MAS 2’) located 
upstream of the left border of the SAIL-1276 G04 T-DNA insert resulted in the transcription of the 
PRL1 or – as suggested by our previous results – PRL1 sequences located downstream of the XhoI site 
(at position -62 upstream of ATG) carried all regulatory elements necessary for proper transcription of 
the PRL1 gene.  
 
3.1.6. Search for putative regulatory elements in the PRL1 promoter sequence 
Our results obtained with the prl1-5 (SAIL_1276G04) T-DNA insertion mutant and genetic 
complementation studies with the pER8(Km)-PRL1genomic-HA construct strongly suggested that 
transcription of the PRL1 gene is controlled by an unusual promoter region, which overlaps with 5’-
sequences of the coding region. The XhoI site used for construction of the pER8(Km)-PRL1genomic-
HA vector was located only 62 bp upstream of the ATG codon in the vicinity of a putative TATA-box 
(TATAAAT) at position -78 bp (Figure 14).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Putative transcription regulatory sequences in the PRL1 promoter sequence 
The PRL1 promoter sequence was analyzed to predict the localization of putative transcription regulatory 
regions. TC-rich elements were present in the 5’ UTR and the second intron. A polyT stretch was found in the 
first intron. These regions are underlined and marked with bold letters. Exons are marked with lilac letters and 
underlined. The 5’-UTR sequence is blue coloured. Intron and 5’-upstream promoter sequences are indicated 
with black letters. Putative TATA-box sequences are labelled with orange colour and underlined. Restriction 
enzyme recognition sites are denoted with red letters and underlined. 
UTR
-87   TGAAATTGATATAAATAAACTCGAGATTATTAATATAACCCTTTTTCACTT
XhoI
-36   CACTTCTCTTTCTCTCTAAACCCTAAAAGAAGAACGATGCCGGCTCCGA
14   CGACGGAGATCGAACCCATCGAAGCACAGTCACTGAAAAAGCTCAGTC
62   TCAAATCCCTCAAACGATCACTTGAACTCTTCTCTCCCGTCCATGGCCA
111  ATTCCCTCCTCCTGACCCGGAAGCGTTAGTCTTCTTCGATCCCCAATTT
160   TCGATTCGAATCTTCATTTTCTTCACTAAGTTTTTATGATTTCTTCGTTTT
211  TTTTTTTTTTTTTTGCAGCAAGCAGATTCGTCTCAGCCATAAGGTAAAAC
261  ATTGAGTCTCTCTTACCAGTCTTTAGAAATTTATTTCAGTTATTCGCTTTT
312  AATGTCTATTGATTGGATTTTGGTTTAAAGCTTCGAACTTTAGGTTTATTC
363  AGGTTTTTCCATAATTGTTCTAAATCTTCAGGTTTTGTTACCAATAATAGT
414   AAAGATGGTTGATTTACTTAGACTCTCTCTCTCTCTCTGTTGTGTATGTT
464   ACTGATTTTAGAAGTTTTCTTTGTACAGATGAAAGTTGCGTTTGGAGGTG
514  TAGAACCTGTTGTGAGTCAACCTCCACGTCAACCTGACCGCATCAATGA
BmgBI
563  GCAGCCAGGACCTTCAAATGCTCTTTCCCTCGCAGGTGTTTTTCATATCA
613  CTATGTCTTGGTGAAAGATAAAAACTTGTTTCTTGTTTGCTATTTGCATTC
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We have also identified an alternative TATA-box (TATTAAT) at position -60 bp, just upstream of the 
putative transcription initiation site CACTTCACTT sequence. This site is embedded into a TC-rich 
region of the 5’ UTR (TCACTTCACTTCTCTTTCTCTCT) that resembles to postulated binding sites 
of plant GAGA-binding factors that may function as transcriptional activators (Santi et al., 2003). 
Within the coding region, the first intron contains an 18-nucleotide long polypyrimidine tract followed 
by an unusually short second exon of 24 bp. This sequence arrangement was reported to be crucial in 
proper splicing (Simpson et al., 2004). In the second intron, we have identified another TC-repeat 
(CTCTCTCTCTCTCTCT) with possible relevance in regulation of transcription.  
 
3.1.7. Construction of a PRL1 promoter-driven GUS reporter gene 
To characterize the temporal and spatial regulation of the unusual promoter region of the PRL1 gene, a 
PRL1::GUS reporter gene construct was generated. As source construct, we used a plasmid generated 
by Nemeth et al. (1998) for genetic complementation of the prl1 mutation using the wild type PRL1 
gene. A 7.9 kb XbaI-SpeI fragment was isolated from the pgcPRL16 genomic clone of Nemeth et al., 
(1998) and inserted into the binary vector pPCV002 for transformation of prl1 plants. This genomic 
DNA fragment carried a 5’ promoter region of 3.5 kb upstream of the coding region. In control 
experiments performed by J. Jásik in our laboratory this 3.5 kb promoter region, extending to the XhoI 
site upstream of the ATG, proved to be transcriptionally inactive. This, together with our previous 
results, also suggested that intragenic sequences might be important for proper transcription of the 
PRL1 gene. Therefore, in construction of the PRL1::GUS reporter gene we combined the 3.5 kb 
upstream promoter region with sequences of the 5’-UTR and coding region extending to the start of 
the third exon of the PRL1 gene. From the pBS-PRL1 plasmid, carrying the genomic region of PRL1, 
an XbaI-BmgBI DNA fragment was cloned into the promoter testing vector pPCV812 digested with 
XbaI-SmaI restriction enzymes. Thus, the GUS reporter gene was fused in frame with the third exon of 
the PRL1 gene. This binary vector pPCV812-PRL1-PROM was transferred into Agrobacterium 
GV3101 (pMP90RK) and then used for transformation of dark- and light-grown cell suspensions and 
wild type plants. The expression of the GUS reporter enzyme was confirmed in the transformed cell 
suspensions by histochemical assays. To study the expression of PRL1-GUS reporter gene in plants, 
transformed T1 seedlings were selected on hygromycin plates. From 65 T1 lines isolated, T2 progeny 
of ten independent lines were used in subsequent study of expression pattern of the PRL1-GUS 
reporter construct. 
 
3.1.8. Characterization of PRL1 promoter activity in planta 
Spatial expression pattern of the PRL1-GUS reporter gene was characterized by monitoring the GUS 
enzyme activity with histochemical staining. Plant material after a short vacuum treatment was 
incubated in X-Gluc solution overnight at 37°C. On the following day, plants were fixed and destained 
in 75% ethanol. The T2 lines were tested at the age of one and two weeks in order to monitor possible 
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developmental changes in PRL1 promoter activity. Comparative evaluation of the data showed that 
PRL1 promoter is active in most tissues (Figure 15).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Histochemical analysis of PRL1::GUS expression pattern 
(A), (B) One week-old seedlings. (C) Two weeks-old seedling. (D), (H) Root apical meristems. (E-G), (I-K) 
Lateral root formation. (L) Rosette leaf. (M) Stem with flowers (N), (O) Etiolated seedlings at the age of 5 and 
12 days. 
 
GUS staining was detected in roots, cotyledons, hypocotyls, leaves and petioles. Apparently, the GUS 
activity was the highest in apical meristems. In roots, the PRL1::GUS construct showed expression in 
the root apices, the central cylinder and meristems of emerging lateral roots. In shoots, the PRL1 
promoter showed high activity in the apical meristem and leaf primordia. During later development, 
GUS activity was notably restricted to vascular tissues of mature leaves. In various organs collected 
from fully developed plants growing in the greenhouse, GUS activity was also detected in flowers and 
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siliques. In shoots, the lateral meristems displayed high GUS activity. The PRL1 promoter was also 
active in dark-grown seedlings showing strong expression in their apical meristems. 
 
3.1.9. Construction of GUS reporter lines with PRL1 promoter deletions  
To identify sequence elements that play a role in regulation of PRL1 transcription, a set of promoter 
deletion constructs was made. To clone a short 0.6 kb version of the PRL1 promoter into pPCV812, 
the genomic clone pBS-PRL1 was digested with XhoI-BmgBI, the overhanging ends of the isolated 
DNA fragment were filled with T4 DNA polymerase and this fragment was inserted into SmaI 
digested and dephoshorylated pPCV812 vector. The orientation of the promoter segment and its 
junction sequence in the resulting pPCV812-PRL1-PROM-XhoI-BmgBI construct was checked by 
DNA sequencing. Downstream of the XhoI site (position -62 upstream of ATG), this construct 
contained a putative TATA-box, a transcription initiation site in the 5’ UTR, and the first two exons 
and introns. The GUS reporter gene was placed in frame with the third exon of PRL1.  
 The second construct was designed to carry an extended promoter region 5’-upstream of the 
start codon. The pBS-PRL1 genomic clone was digested with BstBI and XmaI enzymes. The 3’end of 
the promoter region ending precisely upstream of the ATG codon was PCR amplified using SexAI and 
UTR primers (2.1.6.2). The accuracy of the PCR amplification was verified by DNA sequencing. This 
PCR amplified DNA fragment was digested with BstBI-XmaI and was inserted into the pBS-PRL1 
genomic clone, which was digested with BstBI and XmaI enzymes to yield the construct pBS-PRL1-
PROM-UTR construct. From this plasmid, a 3.5 kb promoter region extending to the position of the 
ATG was excised and inserted into XbaI-SmaI sites of the pPCV812 promoter testing vector as XbaI-
XmaI fragment. Subsequently, the junctions of the PRL1 promoter segment in the obtained pPCV812-
PRL1-PROM-UTR plasmid were confirmed by sequencing.  
 The third promoter construct, pPCV812-PRL1-PROM-POLIT was designed to use the short 
(0.3 kb) version of the PRL1 promoter in combination with a deletion of the second intron. The short 
promoter region, starting from the XhoI site and extending downstream to the end of second exon, was 
amplified by PCR using SexAI and POLI primers (2.1.6.2). The sequence of PCR amplified DNA 
fragment was verified by sequencing. This 0.3 kb fragment was digested with XhoI, its ends were 
filled-in with T4 DNA polymerase, cut with XmaI and then ligated into XhoI-SmaI sites of pPCV812. 
In pPCV812-PRL1-PROM-POLIT, the GUS gene was thus cloned in frame with the second exon of 
the PRL1 gene. The plasmids carrying the described PRL1 promoter constructs were transferred into 
Agrobacterium GV3101(pMP90RK) and transformed into wild type plants, as well as into light- and 
dark-grown cell suspensions for monitoring GUS reporter enzyme activities. 
 
3.1.10. Comparison of activity of PRL1 promoter-GUS constructs 
The activity of different PRL1 promoter constructs was first compared in stably transformed cell 
suspensions using GUS histochemical assay. One week-old cells were transferred into centrifuge tubes 
and pelleted at 1,000 rpm for 2 min. The supernatant cell suspension medium was removed and cells 
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were mixed with X-Gluc staining solution and incubated at 37°C overnight. Next day, the X-Gluc 
solution was removed, the cells were washed and kept in 75% ethanol. GUS reporter activities of the 
PRL1 promoter deletion constructs were compared to that of previously characterized (3.1.7) full 
length PRL1 promoter construct pPCV812-PRL1-PROM. The line carrying the pPCV812-PRL1-
PROM-BmgBI-XhoI construct with a short promoter region extending from position -62 to the start of 
the third exon 3’-downstream, showed high GUS activity, which was only slightly lower than the 
activity of pPCV812-PRL1-PROM full-length promoter construct. By contrast, construct pPCV812-
PRL1-PROM-UTR (i.e. carrying a deletion of exon-intron sequences downstream of the ATG) and 
pPCV812-PRL1-PROM-POLIT lines (i.e., containing the short promoter in combination with deletion 
of intron 2) showed barely detectable GUS reporter enzyme activities in both dark-grown and light-
grown photosynthetic cell suspension lines (Figure 16).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. GUS histochemical assay of activities of PRL1 promoter deletion constructs in cell 
suspensions 
PRL1 promoter constructs were introduced into light-grown photosynthetic and dark-grown root-derived 
Arabidopsis cell suspension. Cells from stably transformed suspensions one week after medium change were 
incubated with X-Gluc solution overnight, destained and washed with 75% ethanol. 
 
 
These data suggested that promoter sequences located 5’-upstream of the XhoI site (position -62 
upstream of ATG) play only a minor role in the regulation of PRL1 expression. This data is also 
supported by our observation that construct pER8(Km)-PRL1genomic-HA, which carried PRL1 gene 
driven by the same short promoter, could fully complement the root elongation defect of the prl1 
mutant (see: section 3.1.2). On the other hand, deletion of the second intron resulted in nearly full 
inactivation of the short PRL1 promoter indicating that this region of the PRL1 gene contains essential 
Root derivedPhotosynthetic
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transcription regulatory sequences. This result indicated that the active core of the PRL1 promoter 
region extends as far as the third exon into the coding region.  
Spatial expression patterns of the PRL1 promoter deletion constructs were compared by 
histochemical assay of GUS activities in wild type Arabidospsis Col-0 background. Transformed 
seedlings carrying the different constructs were selected on hygromycin containing MSAR plates. 
Seedlings representing T2 progeny of five independent T1 lines were stained with X-gluc solution 
overnight at 37°C two weeks after germination. As in cell suspensions, GUS activity was detected 
only with the pPCV812-PRL1-PROM and pPCV812-PRL1-PROM-XhoI-BmgBI constructs that both 
carry PRL1 gene sequences between position -62 and start of the third exon. Deletion of sequences 
downstream of the ATG and deletion of the second intron resulted in inactivation of the PRL1 
promoter in all tissues (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Histochemical staining of GUS reporter enzyme activity controlled by the short PRL1 
promoter construct pPCV812-PRL1-PROM-XhoI-BmgBI 
Dark and light grown seedlings and various plant organs were stained with X-gluc solution as in Figure 15. (A) 
One week-old seedling. (B) Two weeks-old seedling. (C), (D) Developing leaves. (E-J) Root apical meristem 
and lateral root formation. (K) Rosette leaf. (L) Stem with flowers. (M), (N) Etiolated seedlings at the age of 5 
and 12 days. 
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Comparison of spatial and temporal expression patterns of the short promoter pPCV812-PRL1-
PROM-XhoI-BmgBI (Figure 17) and full-length promoter pPCV812-PRL1-PROM (Figure 15) lines 
however indicated significant quantitative differences. The activity of the short promoter appeared to 
be restricted to meristematic tissues (e.g., vascular cylinder, apical and root meristems, developing 
side-roots and cotyledons of etiolated seedlings) it showed a similar pattern as the full-length PRL1 
promoter. This data suggested that sequences located upstream of position -62 do play a role in 
quantitative regulation of the PRL1 promoter. However, inactivation of the promoter by deletion of 
intron 2 indicated that the second intron carries essential regulatory sequences that also specify organ 
and tissue specificity of PRL1 gene expression. 
 
3.1.11. Elimination of candidate regulatory regions from the second intron 
Bioinformatic analysis of potential regulatory sequences within the short PRL1 promoter (section 
3.1.6) indicated that the 5’ UTR and second intron contain similar TC-rich elements. To determine 
whether any of these TC-rich elements play a role in the regulation of activity of the PRL1 promoter, 
two additional promoter deletions were generated. To delete the TC-rich sequence, TATA-box and 5’-
UTR sequences located between the XhoI site (position -62) and the ATG codon, the plasmid pBS-
PRL1genomic-HA-ATG was first digested with XhoI, then filled in with T4 DNA polymerase, and cut 
with BmgBI. The obtained fragment was inserted into a dephosphorylated SmaI site of pPCV812 to 
produce pPCV812-PRL1-PROM-ATG. To remove the TC-repeat from second intron, the repeat was 
mutagenized into a polyT stretch using a TransformerTM site-directed mutagenesis kit. Plasmid pBS-
PRL1-HA was used for site specific mutagenesis using the TTT and NotI primers (2.1.6.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Histochemical assay of promoter-GUS constructs carrying deletions of TC-rich repeat 
sequences.  
Two constructs were created in order to remove TC-repeats from the 5’-UTR region and second intron of the 
PRL1 promoter. Histochemical GUS staining was performed with transformed light-grown cell suspension and 
two weeks old transgenic Col-0 plants.  
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The presence of the mutation was confirmed by sequencing and a positive clone was used for 
subsequent DNA manipulation. The mutated genomic fragment was digested with XhoI-BmgBI, the 
overhanging end was filled in with T4 DNA polymerase, and this fragment was ligated into pPCV812 
cut with the SmaI restriction enzyme. This obtained pPCV812-PRL1-PROM-TTT construct was also 
sequenced. These vectors were transformed into wild type Arabidopsis plants, as well as to dark- and 
light-grown cell suspensions. 
 Histochemical GUS assays were performed with cells of stably transformed light- and dark-
grown cell suspensions and the results were compared to those obtained by the control pPCV812-
PRL1-PROM-BmgBI-XhoI construct that carried the wild type short PRL1 promoter (Figure 16). 
Deletion of the TC-repeat from either the 5’-UTR region or the second intron did not reduce the 
activity of the short PRL1 promoter in transformed cells. Similar results were obtained also by 
inspecting the intensity and pattern of GUS activities monitored by histochemical staining in seedlings 
transformed with the pPCV812-PRL1-PROM-ATG and pPCV812-PRL1-PROM-TTT constructs 
(Figure 18). This data indicated that the TC-rich repeat regions do not play a major role in the 
regulation of PRL1 promoter activity. 
 
3.1.12. Confirmation of importance of intragenic PRL1 regulatory sequences by genetic 
complementation assays  
To confirm that intragenic sequences are indeed essential for proper control of the PRL1 gene 
expression, genetic complementation assays were performed with the prl1 mutant. For these 
experiments a binary vector was constructed, which did not contain any promoter region upstream of 
the multiple cloning site. First, a variant of pPCV002 vector was created by introduction of an XmaI 
/SmaI cleavage site. Vectors pPCV002 and pODB8 (Louvet et al., 1997) were digested with XbaI and 
BamHI and a 2.5 kb fragment of pODB8 was inserted into pPCV002. This pPCV002-ODB vector was 
used for further DNA manipulations. A construct was designed based on the results of Nemeth et al. 
(1998), except there was an HA-epitope introduced to the C-terminal end of PRL1. Plasmids pBS-
PRL1-HA and pPCV002-ODB were digested with XbaI-XmaI and ligated. The obtained clone 
pPCV002-PRL1-HA contained the 3.5 kb full length promoter and the full-length 3.7 kb PRL1 coding 
region. The PRL1-HA gene in pPCV002-PRL1-HA is identical with the gene construct present in the 
complementation construct pER8(Km)-PRL1genomic-HA described in 3.1.2, but does not contain a 
short segment of the CaMV35S promoter upstream of the PRL1 gene, which could have influenced the 
gene expression in case of pER8(Km)-PRL1genomic-HA.  
 To clone a full-length PRL1 gene with short promoter (i.e., starting with the XhoI site at 
position -62), pPCV002-ODB was digested with XbaI, blunted with T4 polymerase and cleaved with 
XmaI. The PRL1 gene segment was isolated from pBS-PRL1-HA by XhoI digestion, T4 DNA 
polymerase fill-in the end and subsequent XmaI cleavage. This fragment was ligated into filled-in 
XhoI-XmaI sites of pPCV002-OBD to yield the constructs pPCV002-PRL1-HA-XhoI.  
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 To create a third construct, in which the full-length 3.5 kb PRL1 promoter drives the 
expression of the PRL1 cDNA, first, the PRL1 promoter was cloned into the pPCV002 vector. 
Plasmids pPCV002-ODB and pBSK-PRL1-PROM-UTR were both digested with XbaI-XmaI and 
ligated. The obtained pPCV002-PRL1-PROM-UTR plasmid was digested with SmaI to insert the 
PRL1-HA cDNA, which was isolated from pBS-PRL1-cDNA-HA as XhoI-SpeI fragment and treated 
with T4 DNA polymerase. The obtained clone was named pPCV002-PRL1-cDNA-HA.  
 In order to link a functional PRL1 short promoter extending from position -62 to the third exon 
to the PRL1-HA cDNA, the promoter fragment was isolated by MscI-BmgBI the plasmid pBS-PRL1 
and cloned upstream of PRL1-HA cDNA by MscI-BmgBI in pBS-PRL1-cDNA-HA to yield the pBS-
PRL1-2introns-cDNA-HA. To reconstruct the full-length promoter upstream of the PRL1-HA cDNA 
coding region, the short promoter-PRL1-HA cDNA fragment was isolated as XhoI-SpeI fragment from 
pBS-PRL1-2introns-cDNA-HA, treated with T4 DNA polymerase and inserted into a 
dephyosphorylated SmaI site of pPCV002-PRL1-PROM-UTR to produce pPCV002-PRL1-2introns-
cDNA-HA. All constructs were checked by restriction digestion analyses and sequencing, and then 
were transferred to Agrobacterium and transformed into prl1 mutant plants. 
 Transgenic plants carrying the pPCV002-PRL1-HA, pPCV002-PRL1-HA-XhoI, pPCV002-
PRL1-cDNA-HA and pPCV002-PRL1-2introns-cDNA-HA constructs were analyzed for 
complementation of leaf, rosette and root elongation phenotype of the prl1 mutant. Seeds were 
germinated on selective MSAR plates containing kanamycin for all constructs. 63 pPCV002-PRL1-
HA, 53 pPCV002-PRL1-HA-XhoI and 56 pPCV002-PRL1-2introns-cDNA-HA independent T1 lines, 
which were assayed for genetic complementation and all showed wild type leaf and rosette phenotype 
(Figure 19 A). By contrast, the progeny of all 32 kanamycin resistant T1 seedlings carrying the 
pPCV002-PRL1-cDNA-HA displayed prl1 mutant phenotype. 
 Root length as a quantitative marker of prl1 mutation was measured to confirm alternatively 
the complementation activity of different constructs. Root length of a homozygous pPCV002-PRL1-
HA transformed T3 line was compared to those of five segregating T2 families of pPCV002-PRL1-
HA-XhoI and pPCV002-PRL-2introns-cDNA-HA transformants. The non-complementing pPCV002-
PRL1-cDNA-HA lines were excluded from this assay, since the transformants could not be 
distinguished from the prl1 mutant as their root elongation was similarly blocked. Seeds were 
germinated on MSAR plates in vertical position and root length was measured two weeks later. As a 
control wild type and prl1 mutant seeds were placed on each plate and quantified thereby also 
allowing comparison between plates, if desired. All transformed lines carrying the pPCV002-PRL1-
HA, pPCV002-PRL1-HA-XhoI and pPCV002-PRL-2introns-cDNA-HA constructs showed wild type 
root length (Figure 19 B). This result demonstrated that all constructs which carried PRL1 sequences 
between position -62 and the third intron (i.e., promoter XhoI-SpeI fragment) in combination with 3’-
downstream sequences of the PRL1 gene or cDNA were fully functional and complemeted the prl1 
mutation. These data also showed that the upstream promoter region is not sufficient for proper gene 
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expression, but the full-length promoter together with the first two introns provides adequate 
information for mRNA transcription. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Phenotypic analysis of PRL1 complementation constructs 
(A) Phenotype of soil-grown pPCV002-PRL1-HA, pPCV002-PRL1-HA-XhoI, pPCV002-PRL1-cDNA-HA and 
pPCV002-PRL1-2introns-cDNA-HA transformed T1 plants. (B) Root length of a homozygous pPCV002-PRL1-
HA line and five of each T2 lines carrying either pPCV002 PRL1-2introns-cDNA-HA or pPCV002-PRL1-HA-
XhoI was measured two weeks after germination. Wild type and prl1 mutant plants were used as controls. 
 
 
3.1.13. Western blot analysis of PRL1 complementation constructs 
To correlate the genetic complementation data with PRL1 protein expression levels, western blot 
analysis of HA epitope labelled PRL1 protein was performed in five independent T2 families of 
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pPCV002-PRL1-HA-XhoI, pPCV002-PRL1-cDNA-HA and pPCV002-PRL1-2introns-cDNA-HA 
transformed prl1 mutant plants and compared to those detected in a homozygous pPCV002-PRL1-HA 
prl1 transformant as control. Seeds were germinated on selective kanamycin plates, three-week-old 
plants were frozen in liquid nitrogen, and total protein samples were extracted. Equal amounts (25 µg) 
of protein samples were size separated by 8% SDS-PAGE gels and analyzed by western blotting using 
an anti-HA antibody. There were minor differences observed between lines, but all prl1 
complementing lines carrying the pPCV002-PRL1-HA, pPCV002-PRL1-HA-XhoI and pPCV002-
PRL1-2introns-cDNA-HA constructs expressed comparable high amount of PRL1-HA protein. By 
contrast, the PRL1-HA protein was only detected in few pPCV002-PRL1-cDNA-HA transformed 
lines after a long exposure time (1 h or O/N). In conclusion, the protein expression data excellently 
correlated with the observed complementation phenotype. The minimal PRL1 promoter and the full 
length upstream region together with the first two exons and introns were as active as the full-length 
PRL1 gene. Genetic complementation of the prl1 mutation was thus unequivocally demonstrated to 
critically depend on the expression level of wild type PRL1 protein.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. Immunodetection of PRL1-HA protein in prl1 lines complemented with different PRL1 
gene constructs 
Seeds from T2 families of complemented lines were germinated on selective plates and plant material was 
harvested after three weeks. Total protein was extracted and 25 μg of protein samples were separated by 8% 
SDS-PAGE gels. Western blotting was performed with anti-HA antibody. Chemiluminescence was captured for 
5 min for all short exposures. pPCV002-PRL1-cDNA-HA western blots were also exposed overnight. Equal 
loading of protein extract was verified by Ponceau staining. 
 
3.1.14. PRL1-HA expression in different tissues of complemented lines 
Initial experiments demonstrated that mature leaf material from soil-grown T1 lines tested in western 
blotting analysis contained less PRL1 protein in the pPCV002-PRL1-HA-XhoI transgenic lines than in 
pPCV002-PRL1-2introns-cDNA-HA transformed plants (data not shown). T2 plants were investigated 
to confirm this data. Three weeks-old seedlings were collected from selective plates and rosette leaves, 
stems, cauline leaves, flowers and siliques were harvested from five weeks-old soil-grown plants. 
Plant material was ground in liquid nitrogen and total protein samples were extracted. Proteins were 
resolved by 8% SDS-PAGE, on which 25 μg protein samples were loaded in each slots. PRL1-HA 
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expression was monitored by western blotting using anti-HA antibody. This experiment showed that 
there was no significant difference in PRL1-HA protein levels between the two constructs. Plants 
carrying the pPCV002-PRL1-HA-XhoI and pPCV002-PRL1-2introns-cDNA-HA constructs showed 
comparable levels of PRL1-HA protein in various tissues. The strongest PRL1-HA expression was 
observed in seedlings and flowers, but considerable amount of protein was also present in stems. The 
lowest PRL1-HA-signal was detected in rosette and cauline leaves.  
 
 
 
 
 
 
 
 
 
 
Figure 21. Immunodetection of PRL1-HA protein in various organs of complemented lines 
Plant material was collected from selective plates and five-week-old soil-grown plants. From each sample, 25μg 
of protein was resolved by 8% SDS-PAGE gel for western blotting with anti-HA antibody. 
 
3.1.15. Complementation studies using heterologous promoters 
Analysis of the PRL1 expression pattern revealed that PRL1 was expressed in a wide variety of 
tissues, including meristems, leaves, cotyledons and roots. To identify precisely in which tissue PRL1 
plays a critical role for proper plant development, a misexpression approach was developed. Since 
PRL1 is predominantly expressed in apical and lateral meristems, the aim was to determine, in which 
domain of the shoot apical meristem (SAM), if any, PRL1 expression is critical for normal 
development. To undertake this study, seven heterologous promoters were chosen, from which four 
are shoot apical meristem specific and three promoters are active in other plant organs. The latter 
promoters served as internal controls. The promoters of AtKNAT1 (KNOTTED-LIKE 1, At4g08150) 
and AtSTM (SHOOT MERISTEMLESS, At1g62360) genes are active in the entire meristem, but are 
not activated in leaf primordia (Lincoln et al., 1994; Long et al., 1996). The AtUFO (UNUSUAL 
FLORAL ORGANS, At1g30950) gene is expressed in a subset of STM expressing shoot apical 
meristem (SAM) cells (Ingram et al., 1995), whereas AtAS1 (ASYMMETRIC LEAVES 1, At2g37630) 
is exclusively active in developing leaf primordia (Byrne et al., 2000). The promoter of AtSUC2 
(SUCROSE TRANSPORTER 2, At1g22710) is active in companion cells of the phloem (Stadler and 
Sauer 1996), whereas At4CL1 (4-COUMARATE:COA LIGASE 1, At1g51680) promoter is xylem 
specific (Hauffe et al., 1993). Finally, a root-specific promoter TobRB7 is active in the central cylinder 
of roots (Yamamoto et al., 1991). In the misexpression experiments, the cDNA and a PRL1 genomic 
fragment starting from the ATG codon (see below) were linked to these heterologous promoters. All 
constructs carried coding sequences of an HA epitope immediately upstream of their stop codons. In 
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the cloning procedure, the pBS-PRL1-cDNA-HA and pBS-PRL1genomic-HA-ATG constructs were 
digested with XhoI-SpeI and the PRL1 gene and cDNA fragments were cloned into XhoI-SpeI sites of 
the pGreen-MCS-GW vector (An et al., 2004). Promoters were introduced 5’-upstream from the PRL1 
coding regions using the Gateway technology. The completed constructs were sequenced and 
subsequently transformed into prl1 mutant plants. Transformants were selected in the greenhouse 
applying BASTA selection and resistant plants were transferred into single pots and analyzed for 
complementation. 
 
3.1.16. Phenotypic analysis of PRL1 misexpressing plants 
The phenotype of four weeks old T1 plants was investigated in the greenhouse. All plants transformed 
with the PRL1 genomic fragment fused to different heterologous promoters showed wild type 
phenotype (data not shown). In combination with different upstream promoter elements, the PRL1 
regulatory sequences defined between the ATG codon and third intron in our previous experiments 
appeared to be sufficient to confer suitable high level of PRL1 expression for genetic 
complementation.  
 Phenotypic analysis of lines expressing the PRL1 cDNA from different promoters revealed 
that constructs with the AtSUC2 and the AtAS1 promoter were able to complement the serrated prl1 
leaf phenotype (Figure 22 A). The lines expressing PRL1-cDNA-HA sequences under the control of 
At4CL1, AtUFO, AtKNAT1, AtSTM, and TobRB7 promoters maintained the prl1 leaf and rosette 
phenotype. T2 generations of the cDNA constructs were investigated further. The root phenotype of 
lines transformed with the various cDNA expression constructs was inspected in five independent T2 
families in each case by growing seedlings on vertical MSAR plates. All examined lines showed short, 
prl1-type root structure, including the AtSUC2, AtAS1, and root specific TobRB7 promoter driven 
cDNA constructs (Figure 22 B). These data suggested that the developmental alteration leading to 
serrated leaf phenotype in the prl1 mutant can be corrected in PRL1 is specifically expressed in the 
differentiating vascular meristem or in the entire area of leaf primordia, but not by expression of PRL1 
in different layers of SAM. The analysis of the root and other cell type specific PRL1 misexpression 
lines also showed that the PRL1 signal is not transmittable. 
 To compare expression levels of the PRL1-HA protein in the PRL1 misexpressing lines, 
western blot analyses were performed with protein extracts prepared from three weeks old seedlings 
grown on selective MSAR plates (Figure 22 C). Equal amounts of protein samples (25 μg) were 
separated by SDS-PAGE and the PRL1-HA signal was detected with anti-HA antibody. Plants 
transformed with AtKNAT1, AtAS1 and AtTobRb7 promoter driven PRL1-cDNA-HA constructs 
expressed high levels of PRL1-HA, whereas lines carrying the AtSUC2 and At4CL1 cDNA constructs 
showed lower PRL1-HA levels. However, in lines transformed with the STM::PRL1-cDNA-HA and 
AtUFO::PRL1-cDNA-HA genes no signal was detected when 25 μg of total protein was analyzed. The 
experiments were repeated with these lines by using 40 μg of protein samples, which provided faint 
HA-signals after overnight exposure on the western blots. Unlike in our experiments with PRL1 
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promoter deletions, the overall level of PRL1-HA expression detected in the transformed lines showed 
no correlation with the results of genetic complementation assays. Evidently, confined expression of 
PRL1 to specific cell types and developmental phases is only sufficient for rescuing some aspects of 
the complex developmental defect causued by the prl1 mutation, as seen in case of leaf phenotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. Genetic complementation assays using misexpression of the PRL1 cDNA from different 
heterologous promoters 
The PRL1 cDNA was expressed by different heterologous promoters (described in the text) in the prl1 mutant. 
(A) Phenotype of soil-grown plants. (B) Root phenotype of AtAS1::PRL1-cDNA-HA and ATSUC2::PRL1-
cDNA-HA plants (all others are not shown). (C) Immunodetection of PRL1-HA with anti-HA antibody in protein 
samples prepared from 3 weeks old T2 seedlings. 25 μg of protein samples were resolved by 8% SDS-PAGE. 
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3.2. Yeast-one-hybrid screening for transcription factors binding to intragenic PRL1 
promoter sequences 
3.2.1. Construction of promoter testing vectors and selection of test strains for yeast-one-
hybrid assay 
Analysis of the PRL1 promoter-GUS fusion constructs showed that sequences in the second intron of 
the PRL1 gene play an important role a role in regulation of PRL1 gene expression. To search for 
transcription factors that recognize sequences within the second intron of PRL1 gene, a yeast-one-
hybrid experiment was performed. Two test constructs were generated. One was placed into the 
pHISi-1 vector for the library screen and the same promoter fragment was inserted into pLacZi for an 
independent control of the candidate clones. Sequences of the second intron were PCR amplified using 
PR-F and PR-R primers (2.1.6.2). This DNA fragment was digested with XbaI-BmgBI and ligated into 
EcoRI-SmaI sites of the yeast one-hybrid vectors pHISi-1 and pLacZi (2.3.3.4). Subsequently, the 
pHISi-1 clone was used for the library screen, whereas the same promoter fragment inserted in pLacZi 
served as an independent control to identify the candidate clones. 
 The first step of one-hybrid assay requires that the target constructs are integrated into the 
genome of the yeast YM4271 strain. To achieve this, the pHISi-1-PRL1-PROM construct was 
linearized by XhoI digestion and the pLacZi-PRL1-PROM plasmid was digested with NcoI restriction 
enzyme. Subsequently, the vector DNAs were transformed separately into yeast cells by the lithium 
acetate method (2.3.3.1). Transformants were selected on SD/-His plates incubated for 3-5 days at 
28°C and large positive colonies were investigated further. The pHISi-1 vector was reported to be 
leaky therefore, unspecific HIS expression must be suppressed by adding a competitive inhibitor 3-AT 
(3-aminotriazol) to the medium. Six pHISi-1-PRL1-PROM yeast transformants were plated on SD/-
His plates containing various (0, 15, 30, 45 and 60 mM) concentrations of 3-AT in order to identify a 
transformant displaying low background of HIS expression and to determine simultaneously the 
correct 3-AT concentration for eliminating the residual HIS activity during the screen. One out of six 
transformants failed to grow in the presence of 15 mM 3-AT and was therefore selected as host for the 
one-hybrid screen (Figure 23). In the library screen the 3-AT selection level was set to 25 mM. 
Background lacZ activity was checked by colony-lift assay and none of the 16 transformed yeast 
colonies tested showed lacZ expression (data not shown).  
 
 
 
 
 
 
 
Figure 23. Selection of pHISi-1 reporter strain 
Intron 2 sequences of the PRL1 promoter inserted pHISi-1 constructs were integrated into the genome of yeast 
strain YM4271. Six independent transformants were analyzed on SD/-His medium supplemented with 0, 15, 30, 
45 and 60 mM 3-AT. Line #2 showed the lowest HIS background expression since colonies failed to grow in the 
presence of 15 mM 3-AT. 
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3.2.2. Isolation of a cDNA encoding a PRL1 intron 2 binding factor  
To search for transcription factors recognizing intron 2 sequences of intragenic PRL1 promoter region, 
the yeast host strain carrying chromosomally integrated pHISi-1-PRL1-PROM was transformed with a 
pACT2 cDNA library constructed from mRNA isolated from an Arabidopsis thaliana cell suspension. 
Large-scale Li-acetate transformation was performed and cells were plated on SD/-His/25mM 3-AT 
plates. The screen yielded approximately 6x107 transformants. Seven candidates were isolated that 
were able to grow on medium lacking histidine in the presence of 25 mM 3-AT (Figure 24). The 
activation of HIS gene was confirmed on 25 and 50 mM 3-AT containing plates, while an empty 
pACT2 vector transformed line was used as negative control. DNA was isolated from the HIS+ 
colonies and used for transformation of the indicator pLacZi-PRL1-PROM containing test strain. 
Colony LacZ filter lift assays indicated the activation of PRL1 intron 2 containing pLacZi-PRL1-
PROM reporter gene. Sequencing these candidate pACT2 constructs revealed that the cDNA inserts of 
all seven clones encoded a plant specific transcription factor AtNAM (No apical meristem, 
At1g52880). The AtNAM coding sequence was in frame with the GAL4 activation domain in all 
plasmids. 
 
 
 
 
 
 
 
 
 
 
Figure 24. Yeast one-hybrid assay 
The library screen resulted in seven transformants, which grew on SD/-His medium supplemented with 25 mM 
3-AT. These transformants were tested on selective medium containing 0, 25 and 50 mM 3-AT. The host strain 
carrying the pHISi-1-PRL1-PROM target construct was also transformed with empty pACT2 vector and this 
transformant was used as control. Plasmid DNAs isolated from the HIS+ clones growing in the presence of 50 3-
AT were introduced by transformation into the pLacZi-PRL1-PROM test strain to confirm the activation 
capability of pACT-cDNA clones. 
 
AtNAM belongs to the plant specific NAC (NAM, ATAF1/2, CUC2) family of transcription factors 
that contains over hundred genes in Arabidopsis. The longest cDNA in the pACT clones carried a full-
length coding region for the AtNAM protein of approximately 30kDa. AtNAM carries a highly 
conserved DNA-binding NAC domain and histidine repeats in its N-terminal domain, whereas the C-
terminal domain is responsible for trans-activation (Figure 25 A). A putative NAC binding site was 
previously identified in the CaMV35S promoter by DNaseI foot-printing by Duval et al. (2002). 
Although PRL1 intron 2 sequences lack putative NAC-binding sites, the target sequences inserted in 
the yeast reporter constructs pHISi-1-PRL1-PROM and pLacZi-PRL1-PROM also carried a short 
segment of exon 3, which contained two potential NAC recognition sites (Figure 25 B). It is likely that 
these NAC binding sites were responsible for activation of the expression of HIS and LacZ reporter 
genes in the one-hybrid assay.  
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 Analysis of publicly available Genevestigator expression database indicated that AtNAM is 
transcribed in siliques, senescent leaves and sepals but its expression is barely detectable in radicles, 
ovary, pollen and shoot apex (Figure 25 C). In comparison, PRL1 mRNA is detected also by 
microarray analysis in most tissues in a relatively constant distribution, showing the highest levels in 
callus and shoot apex, and the lowest expression in pollen. During different developmental stages 
PRL1 was expressed evenly and strongly, whereas AtNAM appears to be silent during germination and 
bolting. Therefore, if at all, AtNAM may only represent a potential regulator of PRL1 in specific 
tissues and developmental phases, the confirmation of which requires further studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. Domain structure, binding site and regulation of expression of AtNAM 
(A) Domain structure of AtNAM. A conserved DNA-binding NAC-domain is located in the N-terminus and the 
activation domain is present at the C-terminal region. A histidine repeat is found downstream of the NAC 
domain. (B) Putative recognition sequence of AtNAM (sense and antisense sequence) and analysis of potential 
NAC-binding sites in the PRL1 promoter sequence used in the one-hybrid bate. The sequence of PRL1 intron 2 
is printed in black, whereas sequences derived from exon 3 are marked with blue colour. Potential NAC-binding 
sites in exon 3 sequences are highlighted with red and underlined. (C) Transcription of AtNAM and PRL1 genes 
in different organs and developmental stages as displayed in the Genevestigator database. 
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3.3. Analysis of expression pattern and cellular localization of PRL1 protein 
 
3.3.1. Construction of a vector for expression of a PRL1-GFP fusion protein 
To characterize the expression pattern of PRL1 protein in diverse plant tissues, the green fluorescent 
protein (GFP) was fused to the C-terminus of the PRL1 protein. In the construction of PRL1-GFP 
expression vector, we relied on our previous observation showing that that the 3.5 kb PRL1 promoter 
and the first two introns are sufficient for the proper regulation of PRL1 gene expression. To eliminate 
the stop codon of the PRL1 gene, the pBS-PRL1-2introns-cDNA-HA plasmid was digested with SpeI, 
the ends were filled in with T4 DNA polymerase, and after BglII digestion the DNA was ligated with a 
SmaI-BglII fragment isolated from pBS-PRL1-SMA to reconstruct the 3’-end of the PRL1 gene in 
pBS-PRL1-2introns-cDNA-Sma. This plasmid was digested with XbaI and SacII to clone the GFP 
coding region, which was PCR amplified using the primers GFP-F and GFP-R (2.1.6.2), and then 
digested with XbaI-SacII. The obtained plasmid pBS-PRL1-2introns-cDNA-GFP was digested with 
XhoI-SacII, the ends were filled in with T4 DNA polymerase and the isolated PRL1-GFP expression 
cassette was inserted into SmaI digested pPCV002-PRL1-PROM-UTR. This pPCV002-PRL1-GFP 
construct was introduced into light-grown cell suspension, as well as wild type and prl1 mutant plants.  
 
3.3.2. Localization of PRL1-GFP fusion protein in planta  
Subcellular localization of the PRL1-GFP fusion protein was first assayed in photosynthetic cell 
suspension one week after subculturing, then the analysis was extended to seven days old seedlings 
expressing the PRL1 promoter driven PRL1-GFP reporter protein in the prl1 mutant. The confocal 
laser scanning microscopy was performed in collaboration with Dr. E. Schmeltzer. The PRL1-GFP 
fusion protein was detected in all investigated plant organs and cell types (Figure 26). The PRL1 
protein was predominantly present in the nucleus, although in cell suspension low level of GFP signal 
was also observed in the cytoplasm. The highest level of PRL1-GFP was detected in meristematic 
cells of the root apex and in the early leaf primordia. However, GFP signal was also captured in 
considerably lower intensity in fully developed cells of leaves and roots. 
 
3.3.3. Subcellular immunolocalization of PRL1-HA protein  
To examine the subcellular localization of the PRL1 protein in more detail, prl1 mutant plants were 
transformed with the pPCV002-PRL1-HA construct (3.1.12). Seven days old T2 seedlings, showing 
genetic complementation of the prl1 mutation, were fixed, embedded, sectioned and probed with HA 
epitope specific antibodies as described previously by Ferrando et al. (2000) and Farras et al. (2001). 
Indirect immunoflourescence localization studies performed in collaboration with Dr. Ján Jásik 
confirmed that the PRL1-HA protein was localized nearly exclusively in nuclei of all cells in shoots 
and roots showing particularly high levels in the apical meristems (Figure 27).  
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Figure 26. Analysis of PRL1-GFP expression pattern in planta by confocal laser scanning microscopy 
Cellular localization of PRL1-GFP fusion protein in (A) cell suspension, (B) leaf primordia, (C) hypocotyl with 
leaf primordia, (D) leaf trichome, (E) root apical meristem and (F) lateral roots. The first row represents the GFP 
fluorescence, the second is the chloroplast autofluorescence and the third row is the merge of the two 
independent images (in the case of B, C and E the light microscopic picture is also merged). 
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Figure 27. Cellular localization of PRL1-HA in a complemented prl1 mutant  
Transgenic prl1 mutant plants carrying the pPCV002-PRL1-HA were used for immunolocalization. 
Sections were stained with the fluorescent DNA dye DAPI and with mouse monoclonal anti-HA 
antibody. (A) Subcellular localization of PRL1-HA protein in root cells. (B) Longitudinal root section. 
(C) Shoot apical meristem. 
 
3.3.4. Effects of plant hormone treatments on PRL1 protein level 
To investigate potential effects of various hormones on PRL1 protein expression levels, homozygous 
transgenic prl1 mutant plants transformed with the PRL1 promoter driven PRL1 genomic construct 
pPCV002-PRL1-HA were subjected to various hormone treatments. Four homozygous lines were 
analyzed simultaneously. Seeds were germinated on MSAR medium containing 0.5% sucrose on 
nylon mesh. Seedlings were transferred into liquid MS media supplemented with plant hormones after 
two weeks and each hormone treatment was performed for 24 h. The control seedlings were incubated 
in liquid MS medium containing 0.5% sucrose. Crude protein samples were extracted and resolved by 
8% SDS-PAGE. Western blotting was performed with anti-HA antibody to detect PRL1-HA protein 
and equal loading was confirmed with an anti-tubulin antibody. The results showed that hormone 
treatments caused no dramatic changes in PRL1-HA protein levels. The highest level of PRL1-HA 
protein was detected in plants treated with 6% sucrose, whereas PRL1-HA level was slightly 
decreased in response to ABA treatment (Figure 28). 
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Figure 28. Effects of hormone treatments on PRL1 protein levels 
Two weeks old prl1 plants carrying the complementing pPCV002-PRL1-HA construct were incubated with 
various plant hormones for 24 h. 25 μg of protein samples were resolved by 8% SDS-PAGE, and western 
blotting was performed with anti-HA antibody to detect HA-tagged PRL1 protein. The same membrane was 
probed with an anti-tubulin antibody to verify equal loading. CTRL: control, plants were kept for 24 h in liquid 
MS medium containing 0.5% sucrose. In other cases, the liquid MS medium was supplemented with: 6% 
sucrose, 0.2 mg/l kinetin (KIN), 0.2 mg/l 6-Benzylaminopurine (BAP), 0.5 mg/l 2,4-dichlorophenoxyacetic acid 
(2,4-D), 0.05 μM salicylic acid (SA), 10 μM methyl-jasmonate (MJ), 0.1 mg/l abscisic acid (ABA), 0.1 mg/l 
gibberellin GA3  (GA3) and 10 μM 1-aminocyclopropane-1-carboxylic acid (ACC, ethylene precursor). 
 
In a second experiment, homozygous PRL1::PRL1-HA plants in prl1 mutant background were 
grown for 3 weeks on MSAR plates on nylon mesh. Subsequently, the seedlings were transferred to 
liquid MS medium supplemented with various hormone solutions and treated for 5 h and 24 h before 
isolation of protein samples that were analyzed by immunoblotting with anti-HA antibody. As a result 
of 50 mM salicylic acid treatment, the seedlings died after 24 h, which was not noted with any other 
hormone. Samples collected after 5 h SA-treatment showed a significant reduction of PRL1-HA level 
whereas PRL1-HA remained constant in case of other hormone treatments. This result suggested 
induction of cell death by SA overdose possibly stimulates destruction of the PRL1 protein.  
 
 
 
 
 
 
Figure 29. Immunodetection of PRL1 protein in seedlings treated with 50mM salicylic acid 
Seedlings were treated for 5 h in MS medium in the absence (CTRL) or presence of 50mM salicylic acid (SA). 
Protein extracts were immunoblotted with anti-HA antibody. As loading control, the membrane was stained with 
Ponceau-S.  
 
3.3.5. Regulation of PRL1 mRNA levels by hormones 
The Genevestigator microarray database (Zimmermann et al., 2004) was searched to examine thus far 
observed effects of various plant hormones on PRL1 gene expression. The search was restricted to 
experiments performed on wild type Col-0 plants. Microarray data from the following hormone 
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treatments were analyzed: 10 μM ABA for 1h an 3h, 10 μM ACC for 1h and 3 h, 10 nM brassinolide 
(BL) for 1h and 3h, 5ppm ethylene for 3h, 1 μM GA3 for 1h and 3h, 1 μM IAA for 1h and 3h or 5 μM 
for 1h and 2h, 10 μM methyl-jasmonate for 1h and 3 h, 10 μM salicylic acid for 3h and 1 μM zeatin 
for 1h and 3h (Figure 30). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30. Genevestigator microarray data on changes of PRL1 transcript levels in response hormone 
treatments 
Plant microarray data was taken from the Genevestigator database and sorted according to changes in PRL1 
mRNA levels in response to various hormone treatments. 
 
Experimental setups for 6-benzyl-adenine and sugar treatments were not found in the database. 
Comparative analysis of the data indicated that the PRL1 mRNA level was reasonably constant in all 
conditions examined, although a slight decrease in mRNA expression was detected in ABA treated 
samples and an increase of PRL1 transcript levels was observed in sugar treated plant samples.  
 
3.4. Posttranscriptional regulation of PRL1 
3.4.1. Comparison of PRL1 transcript and protein levels in different plant organs 
Preliminary comparison of PRL1 transcript and protein levels in different plant organs suggested 
possible posttranscriptional regulation of PRL1 expression. K. Németh from our laboratory previously 
performed a series of northern hybridization experiments using wild type plants and analyzed PRL1 
mRNA levels in cell suspension, roots, shoots and shoot apex. The results showed that PRL1 
expression levels were largely comparable in all the tissues (Nemeth, 1994). Comparison of PRL1 
mRNA levels based on data obtained from the Genevestigator microarray database is shown in Figure 
31 A. The PRL1 gene is evenly expressed in all plant organs. PRL1 mRNA levels are somewhat 
higher in cell suspension, radicles, carpel, shoot apex, juvenile leaves and lateral roots, but lower in 
cotyledons, stamens and pollen. In order to examine the PRL1 protein levels in plant organs, plants 
carrying the 35S::PRL1cDNA-HiA and native PRL1::PRL1genomic-HA (pPCV002-PRL1-HA) 
construct in prl1 mutant background were analyzed (Figure 31B). Protein extracts were isolated from 
seedlings grown for 2 weeks on MSAR medium, as well as from soil-grown plants, resolved by 12% 
SDS-PAGE gels and subjected to western blotting with anti-HA antibody. In both 35S::PRL1cDNA-
HiA and pPCV002-PRL1-HA transformed plants high levels of PRL1-HA protein were detected in 
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roots and flowers, whereas surprisingly no PRL1-HA protein was detectable in rosette and cauline 
leaves. As PRL1 mRNA levels did not show dramatic differences in the examined organs, the data 
suggested that in leaves the PRL1 protein levels are down-regulated probably as a result of PRL1 
proteolysis. Plans expressing PRL1 both from the CaMV35S and native PRL1 promoters showed 
similar decrease in PRL1 protein level in leaves indicating a posttranscriptional regulatory effect. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31. Comparison of PRL1 mRNA and protein levels in plant organs 
(A) Microarray data from the Genevestigator database showing PRL1 mRNA levels in various plant organs. (B) 
Immunodetection of PRL1-HA protein expressed by the 35S::PRL1cDNA-HiA and PRL1::PRL1genomic-HA 
constructs in prl1 plants. 25 μg of total protein samples were separated on 12% SDS-PAGE gels and subjected to 
western blotting with an anti-HA antibody. 
 
3.4.2. Analysis of PRL1 protein stability 
In order to examine the stability of PRL1 protein, prl1 seedlings carrying the estradiol-inducible 
pER8(Km)-PRL1-cDNA-HA construct tested previously in genetic complementation assay (3.1.4) 
were used. Two weeks old T2 seeds grown on selective plates were transferred into liquid MS medium 
supplemented with 2 μM estradiol to induce PRL1 expression for 24 h. Subsequently, the seedlings 
were washed several times to remove estradiol and then cultured in liquid MS medium. Samples were 
collected 0, 4, 8, 24, 48, 72 and 96 h after removal of estradiol for preparation of protein extracts. 
Samples containing 15 μg of protein were resolved by 12% SDS-PAGE and subjected to western 
blotting followed by immunodetection with anti-HA antibody. Equal loading was checked by staining 
the membranes with Ponceau-S and, after stripping, with immunodetection using an anti-tubulin 
antibody. The results showed that after removal of estradiol, which was used to achieve a high level 
induction of PRL1 gene expression, the PRL1-HA protein level decreased gradually. After 72 h, 
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hardly any PRL1 protein could be detected (Figure 32). This result indicated that the PRL1 protein is 
subjected to degradation with a relatively slow rate. The apparently slow degradation of PRL1 protein 
could be explained by the fact that after estradiol removal the translation of the available mRNA pool 
continued and hence the synthesis of PRL1-HA protein did not stop at 0 time point.  
 
 
 
 
 
 
 
 
 
 
Figure 32. Analysis of PRL1 protein stability 
Seedlings carrying the estradiol-inducible pER8(Km)-PRL1-cDNA-HA construct in prl1 mutant background 
were induced with estradiol for 24 h. After removal of estradiol, seedlings were cultured in liquid MS medium 
and samples were collected at 0, 4, 8, 24, 48, 72 and 96 h. PRL1-HA was detected with anti-HA antibody. Equal 
loading was confirmed by western blotting with anti-tubulin antibody and Ponceau-S staining. 
 
3.4.3. Degradation of PRL1 is inhibited by the proteasome inhibitor MG132  
To assay whether the degradation of PRL1 is proteasome dependent, we examined the effect of 
reversible proteasome inhibitor MG132 on PRL1 protein stability. Seedlings carrying the estradiol-
inducible pER8(Km)-PRL1-cDNA-HA construct in prl1 mutant background were grown for two 
weeks on selective MSAR plates. Subsequently the plants were transferred to liquid MS medium 
containing DMSO, 2 μM estradiol or seedlings treated with estradiol in the presence of 100 μM 
MG132. Samples were collected at 4, 8 and 24 h for preparation of protein extracts, which were 
separated by 12% SDS-PAGE and subjected to immunoblotting with anti-HA antibody (Figure 33).  
 
 
 
 
 
 
 
 
Figure 33. Estradiol induced accumulation of PRL1 protein is enhanced by MG132 proteasome 
inhibitor treatment 
Two-weeks old prl1 seedlings carrying the estradiol-inducible pER8(Km)-PRL1-cDNA-HA construct were 
incubated with DMSO (D), 2 μM estradiol (E) or 2 μM estradiol and 100 μM MG132 (MG) in liquid MS 
medium for 4, 8 and 24 h. After preparation of protein extracts, samples were by 12% SDS-PAGE and the 
PRL1-HA was detected with anti-HA antibody. Equal loading of gel was verified by Ponceau-S staining. 
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Comparison of PRL1-HA levels in samples induced by estradiol in the presence or absence of MG132 
showed that accumulation of PRL1 protein was significantly enhanced by the proteasome inhibitor 
suggesting that PRL1 is a potential substrate for proteasome-dependent degradation in vivo. 
 In order to exclude the possibility that the observed degradation of PRL1 protein was caused 
by its ectopic overexpression by the CaMV35S promoter driven pER8(Km)-PRL1-cDNA-HA 
construct, we have assayed the PRL1 protein stability in cells that expressed a wild type PRL1 gene 
marked with a HA epitope coding sequence in pPCV002-PRL1-HA. At the same time, translation of 
the PRL1 mRNA pool was inhibited in the cells by cycloheximide to block de novo PRL1 protein 
synthesis and thereby only examine the process of PRL1 protein degradation. A light-grown cell 
suspension stably transformed with the pPCV002-PRL1-HA construct was treated three days after 
subculturing with either 50 μM cycloheximide (CHX) or 50 μM cycloheximide and 50 μM MG132 
proteasome inhibitor. From samples collected at 0, 4, 8, 24 and 48 h time points, protein extracts were 
prepared, separated by 8% SDS-PAGE gel and analyzed by western blotting using anti-HA antibody 
(Figure 34). The results showed that slow degradation of the PRL1-HA protein was not accelerated by 
the protein synthesis inhibitor cycloheximide indicating that the slow kinetics of PRL1 degradation did 
not appear result from compensation through de novo translation from a stable mRNA pool but rather 
indicated that PRL1 is a relatively stable protein. As in the previous experiments, MG132 prevented 
degradation of PRL1 also in the presence of cycloheximide confirming that PRL1 is likely degraded 
by the 26S proteasome. 
 
 
 
 
 
 
 
 
Figure 34. Inhibition of translation by cycloheximide does not affect the kinetics of PRL1 degradation 
Light-grown cell suspension stably transformed with pPCV002-PRL1-HA was treated with either 50 μM 
cycloheximide (CHX) or 50 μM cycloheximide and 50 μM MG132 26S proteasome inhibitor. 25 μg of extracted 
protein samples were resolved by 8% SDS-PAGE and the PRL1-HA protein was detected by immunoblotting 
with anti-HA antibody. Equal loading was monitored on the same membrane using an anti-tubulin antibody. 
 
 
3.4.4. Identification and site-specific mutagenesis of a putative destruction-box motif in PRL1  
Sequence analysis revealed that the PRL1 protein contains degradation motives recognized potentially 
by E3 ubiquitin ligase Anaphase Promoting Complex (APC) activating factors. One of the canonical 
APC degron motives is the destruction box (D box), which was first identified in mitotic cyclins. The 
D box is defined by a motif of nine amino acids RxxaLxbxxcxN, where xa is often A or V, xb can be G, 
and xc is frequently I or L). In this motif, amino acids at positions 1 and 4 are conserved in all APC 
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substrates. In addition to the D box, APC substrates may carry KEN-, A- or GxEN boxes. Our analysis 
of the PRL1 protein sequence has identified a perfect D box element in the N-terminal region between 
positions 113-121 (Figure 35).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35. Identification of putative D-box motif in the PRL1 protein sequence 
A D box element was identified in the PRL1 protein sequence between at amino acid positions 113-121 (marked 
with green colour). WD repeats are represented with red boxes and amino acid positions are labelled with 
numbers. 
 
3.4.4.1. Site-directed mutagenesis of the putative PRL1 D box 
As site-specific mutagenesis of the D box has been observed to stabilize APC substrates (for review 
see Peters, 2002), we designed a site-specific mutagenesis experiment for introduction of point 
mutations R113G and L116V at the two highly conserved amino acid positions in the putative D box 
of PRL1. Plasmid pBS-PRL1-2introns-cDNA-GFP was mutated using TransformerTM site-directed 
mutagenesis kit using the STABmut and Sca primers (2.1.6.3). The mutagenesis was verified by DNA 
sequencing and then the PRL1-GFP cassette was isolated as an XhoI-SacII fragment from pBS-PRL1-
2introns-cDNA-GFP, the ends were filled in with T4 DNA polymerase and the fragment was ligated 
into SmaI digested pPCV002-PRL1-PROM-UTR. The obtained pPCV002-STAB-PRL1-GFP 
construct was introduced into green cell suspension, wild type and prl1 mutant plants. 
 
3.4.4.2. Assay of stability of D-box mutant PRL1-GFP protein in cell suspension 
In order to test whether mutation of the D box would affect the stability (i.e., reflected by the 
expression level) of PRL1-GFP protein, light-grown cell suspensions were stably transformed wild 
type and D-box mutant PRL1::PRL1-GFP constructs. From both cell suspensions, protein samples 
were prepared at 1, 3, 7 and 14 days after subculturing, separated by an 8% SDS-PAGE gel and 
immunoblotted with anti-PRL1 antibody (Figure 36). As compared to wild type PRL1-GFP, the levels 
of D-box mutant PRL1-GFP were higher in the cell suspesions at all the time points of the logarithmic 
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growth phase. This result suggested that PRL1 protein may represent a potential APC ubiquitin ligase 
substrate since the only difference between the two constructs was the mutation in the D box element.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36. Assay of levels of wild type and D-box mutant PRL1-GFP proteins in cell suspension 
Samples from light-grown cell suspensions expressing the wild type (WT) and D-box mutant “stabilized” (ST) 
PRL1-GFP proteins from PRL1 promoter driven constructs were collected at 1, 3, 7 and 14 days after 
subculturing. 25 μg of protein samples were size separated on 8% SDS-PAGE gel and immunoblotted with anti-
PRL1 and anti-tubulin antibodies. 
 
As internal control, the anti-PRL1 antibody also detected the levels of intrinsic PRL1 protein, which 
were equal in collected samples. In stationary phase cultures (i.e., 14 days old), the levels of PRL1-
GFP and intrinsic PRL1 proteins showed a notable decrease, which was probably due to partial loss of 
the cells’ viability. 
 
3.4.4.3. Immunodetection of stabilized PRL1-GFP in wild type plants 
The PRL1 promoter driven wild type and D-box mutant PRL1-GFP constructs were also transformed 
into Col-0 wild type Arabidopsis thaliana. For both constructs, seedlings from five independent T2 
families were grown on selective kanamycin plates for 3 weeks and analyzed by immunoblotting with 
anti-PRL1 antibody after separation of protein extracts on 8% SDS-PAGE gel. Despite considerable 
variation of PRL1-GFP levels between the transformants, the assay provided no evidence for higher 
stability of D-box mutant PRL1-GFP protein in seedlings (Figure 37). This observation may correlate 
with the fact that the APC complex is primarily active during the cell cycle from metaphase until S 
phase (i.e., especially, during metaphase anaphase transition and mitotic exit; Harper et al., 2002). 
Since the proportion of the meristematic cells as compared to the number of vegetative cells is small in 
plants, stabilization of D-box mutant PRL1-GFP may not simply detected by assaying for higher 
protein levels. Further analysis of the initiated cell suspensions from these transgenic lines could 
however provide a means for proper analysis of stability of D-box mutant PRL1-GFP protein during 
cell cycle progression using synchronization.  
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Figure 37. Immunodetection of wild type and D-box mutant PRL1-GFP proteins in planta 
From seedlings grown for 3 weeks on selective plates protein extracts were prepared. 25 μg of proteins samples 
was separated on an 8% SDS-PAGE gel and analyzed by western blotting with anti-PRL1 antibody. Equal 
loading was verified by staining the corresponding membrane with Ponceau-S solution. 
 
To test whether overexpression of D-box mutant form of PRL1-GFP protein would cause any 
alteration in the development of wild type plants, the PRL1-GFP coding region was also fused to 
CaMV35S promoter. This was achieved by exchanging the 5’ XhoI-BmgBI fragment of pBS-STAB-
PRL1-2introns-GFP for an XhoI-BmgBI fragment from the pBS-PRL1-cDNA-HA construct. The 
STAB-PRL1-cDNA-GFP cassette was isolated after SacII digestion, T4 DNA polymerase fill-in and 
XhoI digestion and cloned into XhoI-SmaI sites of the binary vector pPAMnptII. A pPAMnptII 
carrying the wild type PRL1-GFP expression cassette was constructed similarly. Both wild type and 
D-box mutant PRL1-GFP expression constructs were transformed into wild type plants and T1 lines 
were selected in the presence of kanamycin. However, in the T2 generation of these plants no 
phenotypic changes were detected (data not shown).  
 
 
3.5. Characterization of PRL1 protein interactions 
3.5.1. Yeast two hybrid assay with AtCDC5 
PRL1 homologs were identified to interact with CDC5 orthologs in spliceosome activating complexes 
in yeast and mammalian cells (see section 1.5). To determine whether this protein interaction is also 
conserved in Arabidopsis, yeast two-hybrid assays were performed with PRL1 and AtCDC5 
(At1g09770). Full-length AtCDC5 cDNA was PCR amplified from a cell suspension cDNA library 
with CDC5-F and CDC5-R primers (2.1.5 and 2.1.6.2). The amplified DNA fragment was digested 
with EcoRI and XhoI and inserted into the pACT2 prey vector in frame with the Gal4 activating 
domain (AD). Y187 and Y190 yeast strains were co-transformed with pACT2-CDC5 in combination 
with pAS2-PRL1, pAS2-PRL2, pAS2-PRL1-N-term (PRL1 sequences between cDNA positions 40 
and 570 bp), pAS2-PRL1-C-term (PRL1 sequences between cDNA positions 1000 and 1500) or the 
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empty pAS2 vector. From the Matchmaker kit (Clontech), we used pVA3-1 (DNA-BD/ murine p53 
protein) and pTD1-1 (AD/ SV40 large T antigen protein) as positive and pLAM5’-1 (DNA BD/ 
human lamin C protein) and pTD1-1 as negative controls. Selected and purified yeast colonies were 
tested by colony lift assay. Full-length PRL1 and PRL2 (i.e., PRL1 homolog) and the N-terminal 
domain of the PRL1 failed to interact with CDC5. However, interaction of AtCDC5 was observed in 
combination with the PRL1 C-terminal domain, which carried the WD-40 repeat region. CDC5 was 
found to interact only with WD-repeats of PRL1 orthologs in yeast and mammals (Ajuh et al., 2002). 
Despite the negative result obtained with full-length PRL1 and PRL2, which carry homologous WD-
40 repeats, we decided therefore to examine interaction of PRL1 with AtCDC5 in vivo.  
 
 
 
 
 
 
 
 
 
 
Figure 38. Yeast two hybrid assays using AtCDC5 as prey 
AtCDC5 was fused to Gal4 activation domain and tested with full-length PRL1 and PRL2 baits, along with 
pAS2 bait vectors coding for N- and C-terminal segments of PRL1. As positive control (+) yeast was co-
transformed with pVA3-1 (DNA-BD/ murine p53 protein) and pTD1-1 (AD/ SV40 large T antigen protein), 
whereas as negative control (-) cells carrying pLAM5’-1 (DNA BD/ human lamin C protein) and pTD1-1 were 
used. As further control, the pAS2-PRL1 bait was transformed with the empty prey vector pACT2. The empty 
bait vector pAS2 alone or in combination with pACT2 showed artificial activation of the LacZ reporter gene as 
described by Durfee et al. (1993), but none of the recombinant pAS2 bait vectors displayed any LacZ activity. 
 
3.5.2. Detection of PRL1-AtCDC5 interaction in vivo 
To detect AtCDC5 in vivo, the 3’-end of full length cDNA was tagged with a HA-epitope coding 
sequence and inserted into an expression vector downstream of a CaMV35S promoter carrying a 
duplicated enhancer domain. The AtCDC5 cDNA was PCR amplified using CDC5-F and CDC5-HA 
primers (2.1.6.2) and upon EcoRI-XbaI digestion the amplified DNA fragment was inserted into 
EcoRI-XbaI sites of the pPAMpat binary vector. After sequencing pPAMpat-CDC5-HA was 
introduced into the Agrobacterium strain GV3101 (pMP90RK) and used for transformation of green 
cell suspension, and wild type (Col-0) and prl1 mutant plants. 
 First, the expression of the CDC5-HA protein in cell suspension was verified by western 
blotting with anti-HA antibody (data not shown). Subsequently, in a scaled up experiment the 
AtCDC5-HA protein was immunoprecipitated from protein extract prepared from light-grown cell 
suspension 7 days after subculturing. The protein extract was incubated with anti-HA IgG, the 
antibody-protein complex was immobilized on protein A/G agarose and then non-specific proteins 
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were removed by stringent washes. The CDC5-HA complex was eluted by HA peptide from the beads 
and then total input and immunoprecipitated protein fractions were analyzed by western blotting using 
anti-HA and anti-PRL1 antibodies (Figure 39). The immunoprecipitated and stringently eluted 
AtCDC5-HA protein pulled down PRL1 from the extract indicating that, despite the detected weak 
interaction in yeast, AtCDC5 and PRL1 interact and occur in a common protein complex in cultured 
Arabidopsis cells.  
 
 
 
 
 
 
 
Figure 39. AtCDC5-HA immunoprecipitates PRL1 from protein extracts prepared from Arabidopsis 
cell suspension. 
Protein extract was prepared from a light-grown cell suspension expressing the AtCDC5-HA protein from a 
CaMV35S promoter-driven expression construct. AtCDC5-HA was immunoprecipitated with anti-HA IgG, 
bound to protein A/G Sepharose matrix, and eluted with HA peptide. Samples from the total input (T) and 
immunoprecipitate (IP) protein fractions were size separated on an 8% SDS-PAGE gel and immunoblotted with 
an anti-HA antibody. After stripping, the same membrane was probed with anti-PRL1 antibody. 
 
3.5.3. AtCDC5-HA is associated with the components of the protein degradation system 
PRL1 was reported to interact with the catalytic α-subunits of SnRK1 class of plant AMP-activated 
protein kinases by Bhalerao et al. (1999). Subsequently, Farras et al. (2001) found a SnRK1α kinase 
subunit in stable association with the proteasome and with common CULLIN 1 and SPK1/ASK1 
subunits of SCF E3 ubiquitin ligase complexes by performing a series of western blotting experiments; 
therefore, we have addressed the question whether AtCDC5 would immunoprecipitate core 
components of the proteasome. In this experiment, the total input and AtCDC5-HA 
immunoprecipitated protein fractions were tested with an anti-20S antibody raised against the α1, α2, 
α3, α5, α6 and α7 subunits of the proteasome 20S core particle and with an antibody detecting the 
Rpn6 regulator non-ATPase subunit of 19S lid of the proteasome. In the AtCDC5-HA 
immunoprecipitated protein fraction the anti-20S antibody detected a protein band displaying the site 
of proteasome α-subunits, whereas similarly the anti-19S antibody cross-reacted with a protein 
corresponding to the site of Rpn6 19S subunit. This data suggested that at least part of AtCDC5-HA 
protein pool is found in proteasomal association (Figure 40).  
 Subsequently, we tested whether some specific components of SCF E3 enzymes or SCF 
regulator COP9 signalosome (CSN) were present in the immunoprecipitated AtCDC5-HA protein 
fraction. Results of the immonoblotting experiments in Figure 40 show that AtCDC5-HA co-
immunoprecipitated with the CSN5 subunit of COP9 signalosome and CULLIN 1 subunit of SCF E3 
ubiquitin ligases. However, remarkably the immunoprecipitated complex did not cross-react with a 
highly specific anti-SKP1/ASK1 antibody suggesting that AtCDC5-HA occurs in a complex with 
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CULLIN 1 that does not contain the SKP1/ASK1 SCF subunit. Finally, western blotting with anti-
ubiquitin antibody detected several unknown ubiquitinated proteins, one of which was present in 
notably high quantity in the AtCDC5-HA immunoprecipitate. In conclusion, these data indicated that 
AtCDC5-HA, alone or in complex with PRL1, interacts with several known components of 
ubiquitination and proteasome-dependent proteolysis pathways. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40. Detection of subunits proteasome, SCF and COP9 complexes in the AtCDC5-HA 
immunoprecipitated protein fraction. 
The total input and immunoprecipitated protein fractions were immunoblotted with anti-Rpn6 (specific to the 
non-ATPase regulator subunit of the 19S lid of the 20S proteasome), anti-20S (raised against α subunits of the 
core particle of the 26S proteasome), anti-CSN5 (COP9 signalosome subunit), anti-CULLIN 1, anti-SKP1 
(ASK1) (detects members of the SCF type E3 ubiquitin ligase complex) and anti-ubiquitin (Ub) antibodies. T: 
total input, IP: immunoprecipitate, Ub: ubiquitin. 
 
3.5.4. Size fractionation of AtCDC5 complex on glycerol gradient 
To estimate the approximate size of AtCDC5 complex, whole cell extract prepared from light-grown 
cell suspension expressing the AtCDC5-HA protein was isolated and size fractionated on 10-40% 
glycerol density gradient (100,000 g, 16h at 4°C). Gradient fractions were separated on SDS-PAGE 
and immunoblotted with anti-HA antibody to follow distribution of CDC5-HA. Subsequently, the 
same membrane was tested with anti-PRL1 antibody. AtCDC5-HA was detected in three separated 
peaks (Figure 41). The monomeric form of AtCDC5-HA was present in fractions 3-13, in a complex 
corresponding to a size of approximately 400 kDa in fractions 18-22, and was also present in a very 
large complex (fraction 36) and insoluble pellet migrating to the bottom of the gradient. 
Immunoblotting of fractions with the anti-PRL1 antibody revealed a similar size distribution of PRL1 
containing protein complexes. Together with the data showing co-immunoprecipitation of AtCDC5-
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HA with PRL1, the analysis of glycerol gradient fractions indicated that PRL1 may co-purify and 
occur in common protein complex(es) with AtCDC5. 
 
 
 
 
 
 
 
 
 
 
Figure 41. Size fractionation of AtCDC5 complex on glycerol density gradient 
Whole cell protein extract was isolated from a light-grown green cell suspension carrying the 
2XCaMV35S::CDC5-HA construct and separated on 10-40% glycerol gradient. 300 μl fractions were collected 
and separated by 8% SDS-PAGE, and analyzed by western blotting with anti-HA antibody. Subsequently, the 
same membrane was probed with anti-PRL1 antibody. A parallel glycerol gradient was run to calibrate the 
resolution of the 10-40% glycerol gradient. The glycerol gradient was calibrated using a high molecular weight 
Gel Filtration Calibration Kit (Amersham) containing albumin (66 kDa), lactate dehydrogenase (140 kDa), 
catalase (232 kDa) and ferritin (440 kDa). 
 
3.5.5. Distribution of AtCDC5 in nuclear and cytoplasmic fractions 
To determine the cellular localization of AtCDC5 protein, nuclear and cytoplasmic protein fractions 
were extracted from the cell suspension carrying the 2XCaMV35S::CDC5-HA construct, size 
separated on SDS-PAGE gels and immunoblotted with anti-HA antibody. Two identical membranes 
were probed with anti-histone H2A and anti-PRL1 antibodies to quality test the preparation and to 
confirm subcellular co-localization of the PRL1 protein. The cell fractionation experiment revealed 
that AtCDC5-HA was present exclusively in the nucleus (Figure 42).  
 
 
 
 
 
 
 
 
 
Figure 42. Biochemical assay of subcellular localization of AtCDC5-HA protein. 
Nuclear and cytoplasmic protein fractions were isolated from AtCDC5-HA expressing green cell suspension 7 
days after subculturing. The protein samples were size separated on either 8% or 16% (for H2A) SDS-PAGE and 
immunoblotted subsequently with anti-HA, anti-histone H2A and anti-PRL antibodies. 
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Analogously, the bulk of PRL1 protein was present in the nuclear extract, but traces of the protein 
were also detected in the cytoplasmic fraction. The data of this subcellular localization experiments 
thus also supported our hypothesis that AtCDC5 and PRL1 are associated in nuclear protein 
complex(es).  
 
3.5.6. Search for protein interactions with the N-terminal domain of PRL1 
In our laboratory, K. Salchert (1997) identified previously 13 putative PRL1-interacting partners 
(PIPs) by performing yeast two-hybrid screens with a pACT2 cDNA library prepared from mRNA 
derived from a dark-grown root-derived cell suspension. In addition, Bhalerao et al. (1998) found that 
the N-terminus of PRL1 interacts specifically with the SnRK1 kinase α-subunits AKIN10 and 
AKIN11. To test whether some of the known PRL1-interacting partners are also found in association 
with PRL1 in vivo, we performed a series of immunoprecipitation experiments. In these studies we 
used analytical tools generated by other members of the group during the characterization of histone 
protein arginine methylase PAM1 (PIP-H, At4g29510), ATAM1 amidase of unknown function (PIP-I, 
At5g07360), AKIN11, and Ufd1 (ubiquitin fusion degradation 1, PIP-K, At4g15420), a CDC48 and 
polyubiquitin binding component of a putative membrane-bound ubiquitin ligase. 
Immunoprecipitation experiments were performed with protein extracts prepared from three weeks old 
seedlings. Seedlings carrying T-DNAs of either pER8-PAM1-cMyc or pER8-AKIN11-HA constructs 
for inducible expression of epitope labelled PAM1-cMyc and AKIN11-HA proteins, respectively, 
were treated for 24h with 2 μM estradiol prior protein extraction. Extract containing the HA-epitope 
labelled  
 
 
 
 
 
 
 
 
Figure 43. Assay of PRL1 co-immunoprecipitation with AKIN11-HA, UFD1-HA and PAM1-cMyc 
baits 
Immunoprecipitations were performed with anti-HA or anti-cMyc IgGs using whole cell protein extracts from 3 
weeks old seedlings. The total input (T) and immunoprecipitated (IP) protein fractions were resolved on 8% 
SDS-PAGE and analyzed by western blotting with anti-HA and anti-cMyc antibodies. The same membranes 
were treated tested subsequently with the anti-PRL1 antibody. 
 
UFD1-HA protein was prepared from plants carrying a CaMV35 promoter driven UFD1-HiA 
construct. Whole cell extracts were immunoprecipitated with either anti-HA or anti-cMyc antibodies 
followed by elution with the appropriate peptide. Aliquots from the total input and 
immunoprecipitated fractions were analyzed by western blotting using anti-HA or anti-cMyc 
antibodies to confirm the presence of bait proteins. Subsequently, the membranes were stripped to 
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perform immunodetection with anti-PRL1 antibody. As shown in Figure 43, PRL1 could not be 
detected in the immunoprecipitates of AKIN11-HA, UFD1-HA and PAM1-cMyc proteins. 
 A similar immunoprecipitation assay was performed with protein extracts prepared also from 
3 weeks old seedlings that carried the pPCV002PRL1-HA construct for expression of an HA-tagged 
form of PRL1 by the full-length native PRL1 promoter in the prl1 mutant background. PRL1-HA was 
immunoprecipitated with anti-HA IgG, the immunocomplex was bound to protein A/G agarose, 
washed several times to remove unspecific proteins and then eluted by HA peptide. The 
immunoprecipitated proteins were subjected to western blotting with anti-HA antibody to detect 
PRL1-HA, as well as with an antibody was raised against the tobacco NPK5 protein that can recognize 
all SnRK1α subunits expressed in Arabidopsis and with an anti-AtATAM1 amidase antibody. 
However, we could reveal no PRL1 association with SnRK1α and ATAM1 amidase proteins (Figure 
44). The immunoprecipitated protein fractions were further tested by immunodetection with anti-19S 
proteasome, anti-20S proteasome, anti-CULLIN 1 and anti-SKP1/ASK1 antibodies, however, these 
also failed to detect co-immunoprecipitation of the corresponding proteins (data not shown). 
 
 
 
 
 
Figure 44. Assay of co-immunoprecipitation of PRL1-HA with SnRK1α and ATAM1 amidase 
proteins. 
Whole cell protein extracts were prepared from 3 weeks PRL1-HA expressing seedlings and immunoprecipitated 
with anti-HA antibody. After HA peptide elution, the immunoprecipitated protein fraction was analyzed by 
western blotting using anti-HA, anti-SnRKα and anti-amidase antibodies. 
 
These negative data were puzzling as our experiment previous experiments clearly demonstrated in 
vivo association of PRL1 with the AtCDC5 protein, which was also found to co-immunoprecipitate 
components of the proteasome, signalosome and CULLIN 1. However, these protein interactions were 
observed in actively dividing cultured cells, whereas the above described co-immunoprecipitation 
assays were performed with plant materials representing mostly leaves. As shown by Figure 44, 
PRL1-HA is significantly degraded in these samples. It is thus possible that in leaves where PRL1 
levels are low, probably due to enhanced degradation, the tested proteins do not interact with PRL1. 
The fact that cDNAs of all PIPs identified in previous yeast two-hybrid interactions were isolated from 
a dark grown cell suspension also suggest that interaction of PRL1 with the tested PIP proteins may 
not occur in leaves, but in other cell types, such as actively dividing cells of shoot or root meristems. 
 One of the most problematic technical aspects of biochemical work with PRL1 (and AtCDC5) 
is the establishment of proper conditions for isolation of intact nuclear protein complexes. As shown in 
Figure 45, size fractionation of protein complexes prepared from purified nuclei of PRL1-HA 
expressing plants yields primarily a peak of non-complexed free PRL1-HA protein, whereas the bulk 
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of PRL1-HA protein migrates to the pellet, indicating a severe solubilization problem. On the other 
hand, glycerol gradient size fractionation of whole cell extract indicates that protein complexes  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 45. Size fractionation of PRL1-HA complexes from nuclear and whole cell protein extracts 
Nuclear and whole cell protein extracts were prepared from three weeks old plants expressing the PRL1-HA 
protein under the control of the native PRL1 promoter of the pPCV002-PRL1-HA construct. The samples were 
size fractionated on 10-40% glycerol gradients. 300 μl fractions were collected and analyzed by 
immunodetection with anti-HA antibody after SDS-PAGE separation and western blotting. In case of whole cell 
extract (total protein); the western blot was stained with Ponceau-S solution. Calibration of the glycerol gradient 
was performed with a HMW Gel Filtration Calibration Kit represented by yellow boxes. P: pellet indicates a 
small aliquot from the poorly solubilised protein fractions that contain high molecular weight protein complexes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 46. Size separation of protein complexes containing putative PRL1 interacting partner 
proteins 
Whole cell extracts from three weeks old plants carrying T-DNA of either pER8-PAM1-c-Myc, 
PRL1::PRL1genomic-HA or 35S::UFD1-HA expression vectors were prepared and size fractionated on 10-40% 
glycerol gradients. 300 μl fractions were collected and analyzed by western blotting using anti-cMyc, anti-
ATAM1 amidase and anti-HA antibodies. Corresponding membranes were stained with Ponceau solution. P: 
pellet. As in Figure 45, in addition to fractions containing monomeric free forms of epitope labelled proteins, 
significant amounts of PAM1 methylase, ATAM1 amidase and UFD1 occur only in the pellet fractions of 
gradients.  
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containing PRL1-HA are distributed through the whole size range of the gradient, which is a clear sign 
for artificial dissociation of large protein complexes. As shown in Figure 46, very similar problems 
were uncovered by size fractionation experiments performed with whole cell extracts containing the 
PAM1-cMyc, ATAM1 amidase and Ufd1-HA proteins, a significant proportion of which is also found 
in insoluble pellets at the bottom of glycerol gradient. These observations indicate that further 
biochemical analysis of PRL1 and AtCDC5 complexes requires the application of better solubilization 
and high-affinity binding technologies for isolation of large protein complexes. 
 
 
3.6. Genetic approaches to functional characterization of PRL1 and its putative 
interacting partners 
3.6.1. Isolation of new prl1 insertion mutant alleles 
In our experiments described above, we showed that AtCDC5 interacts with the C-terminal WD-40 
repeat region of the PRL1 protein. In the first identified prl1-1 mutant allele (Nemeth et al., 1998), the 
T-DNA insertion was localized close to the 3’-end of the PRL1 coding region. Although nearly the 
full-length upstream PRL1 coding sequence is transcribed in the prl1-1 mutant, as Nemeth et al. 
(1998) we also failed to detect the synthesis of a C-terminally truncated protein product in this mutant. 
This observation suggests that C-terminal sequences of PRL1 play a role in either proper folding or 
regulation of stability of the protein, or both. As all public Arabidopsis T-DNA insertion mutant 
collections were generated with T-DNA tags that carry in close vicinity of their left borders various 
strong promoters (i.e., that initiate transcription through the border), we have examined whether any 
currently available T-DNA insertion would promote the expression of a partially functional PRL1 
protein resulting in a phenotype different from that of the prl1-1 mutant.  
 Three prl1 mutant lines were obtained from the SALK T-DNA insertion population. The 
genotypes of individuals in the obtained segregating populations were determined by PCR 
amplification using combinations of gene and T-DNA end specific primers. Seeds were germinated on 
MSAR plates and after 15 days planted in soil for harvesting leaf material for individual plants for 
preparation of template DNAs. Results of PCR genotyping performed in this thesis work are 
summarized briefly below. 
 
3.6.1.1. PCR genotyping of the prl1-2 SALK_008466 line 
PCR analysis of the SALK_008466 line was performed with three sets of primers. The gene specific 
primers (PRL1 5’ and PRL1 3’) located upstream and downstream of PRL1 gene amplified a 3.5 kb 
fragment only when the wild type copy of PRL1 was present. The PRL1 5’ and SALK LB primers 
were specific for the left border and FISH2 and PRL1 3’ for the right border junction of the T-DNA. 
PCR analysis with the gene specific primers indicated that lines 17, 18, 19 and 20 in Figure 47 were 
homozygous, whereas lines 6, 9, 10, 11, 14 and 15 did not carry T-DNA insertion. The T-DNA 
specific primer sets were able to amplify DNA fragments from these samples that verified the 
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presence of the insertion. In case of the FISH2 and PRL1 3’ primers instead of an expected 3 kb 
fragment the PCR reaction resulted in a product of 1.9 kb. The amplified PCR fragments were 
sequenced in order to reveal the exact position of the T-DNA. This showed precisely that the 
SALK_008466 T-DNA insertion occurred in the fifth exon of the PRL1 gene and caused a large 
internal deletion of 1290 bp between exons 5 and 11 (Figure 47). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 47. PCR analysis of prl1-2 SALK_008466 allele 
M3 individuals carrying the prl1-2 SALK-008466 allele were analyzed using gene and T-DNA specific primer 
combinations. Sequencing of amplified PCR fragments indicated that the insertion occurred in exon 5 causing a 
large internal deletion between exons 5 and 11. The sequence of the T-DNA below schematic presentation of the 
PRL1 gene is marked with underlined capital letters, bold letters indicate filler DNA sequences, and letters in 
lower case correspond to PRL1 sequences. WT, wild type control DNA; M: DNA size marker (λ-HindIII). 
 
3.6.1.2. PCR genotyping of prl1-3 SALK_096289 and prl1-4 SALK_039427 lines 
In the analysis of the SALK-039427 prl1 and SALK_096289 mutant alleles the same principle and 
primer combinations were used as described above for SALK_008466. PCR amplification of SALK-
039427 lines with the gene specific primers failed to yield a product for lines 21, 22, 23, 24, 25, 26, 
28, 29, 30, 31 and 32 (Figure 48). Amplification of the T-DNA left and right insert junctions 
confirmed that these lines were indeed homozygous mutants and indicated that lines 1, 2, 5, 6, 7, 10, 
13, 15, 17, 18 and 19 did not carry T-DNA. Sequencing the T-DNA junction fragments showed that 
SALK_008466
PRL1 5’ and PRL1 3’ primers
WT  1   2    3   4    5   6    7    8    9   10 11  12 13 14  15 16 17  18 19 20 M
WT  1 2 3 4 5 6  7    8     9 10  11 12  13  14  15 16  17  18 19  20 M
PRL1 5‘ and SALK LB primers
FISH2 and PRL1 3'primers
M   1  2 3    4    5    6    7    8    9   10 11  12 13  14  15  16  17 18  19 20 
2838
1159
1986
 
 
 
 
 
 
 
 
 
 
 
SALK 008466
tacaggttccACAACAAATTAATGTACACATTGACGC GAACAGATTGTCGTTTCACGTCAAGNTtgtgggatat 
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prl1-3 SALK-039427 allele carried a T-DNA insertion in intron 4 and caused a target site deletion of 
39 bp. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 48. PCR genotyping of prl1-3 SALK_039427 lines 
32 M3 lines were analyzed by PCR amplification using different combinations of gene specific and T-DNA 
specific primers. Homozygous candidates lines were identified using the PRL1 5’ and PRL1 3’ primers 
Amplification with the T-DNA specific and the gene specific primers confirmed indicated the presence of T-
DNA insertion in the PRL1 gene. Sequencing of the amplified border junctions revealed that the T-DNA 
insertion occurred in intron 4. Below the schematic map of the PRL1 gene, T-DNA sequences are marked with 
capital letters, whereas letters in lower case correspond to PRL1 sequences. WT, wild type control, M: DNA size 
marker (λ-HindIII). 
 
In case of prl1-4 SALK_096289 allele, gene specific PRL1 ups and PRL1 3’ primers failed to amplify 
a DNA fragment in line 21 indicating that this line was likely homozygous for the mutation (Figure 
49). PCRs reactions performed with the PRL 3’ and SALK LB primers verified the presence of the T-
DNA insertion confirming that this line was homozygous, and showed that lines 9, 11 and 21 were 
heterozygous for the mutation. No PCR fragment was obtained with the right border specific PRL1 
ups and FISH2 primers, which suggested that the right T-DNA border suffered a larger deletion. The 
WT 1   2  3 4   5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 M
WT 1 2 3 4    5   6   7 8 9  10 11 12 13 14 15 16  17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  M
WT 1   2    3 4    5   6   7   8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 M
PRL1 5’ and PRL1 3’ primers
PRL1 3’ and SALK LB primers
PRL1-5’ and FISH2 primers
SALK_039427 
2322
2027
2322
4361
4361
SALK_039427
aattcggttctcCACTGATAGTT GTCAATTTGTTTAcaccattata
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location of the T-DNA insertion was identified by sequencing of the border junctions and showed that 
the T-DNA was situated in the second intron of the PRL1 gene. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 49. PCR genotyping of the prl1-4 SALK_096289 allele 
From the SALK_096289 allele 21 M3 lines were analyzed by PCR reactions with the PRL1 ups and PRL1 3’ 
gene specific primers, and the PRL1 3’ and SALK LB primer combination. Line 21 was identified to be 
homozygous for the mutation. Sequencing of the amplified T-DNA junction indicated that the T-DNA was 
located in the second intron. Below: the schematic figure of the PRL1 gene, T-DNA sequences are marked with 
capital letters, whereas letters in lower case letters indicate PRL1 sequences. WT, wild type control, M: DNA 
size marker (λ-HindIII). 
 
Phenotypic characterization of seedlings carrying the new prl1 alleles 
The phenotype caused by the new prl1-2 to prl1-4 mutant alleles was compared to that of originally 
isolated prl1-1 mutant (Nemeth et al., 1998) by germination of homozygous M3 seeds in the presence 
of 0.1 and 0.2 μM ABA, 3 and 5% glucose, 5% sucrose and ethylene. In addition, root elongation of 
these mutants was analyzed by growing seedlings on vertically oriented MSAR agar plates containing 
0.5% sucrose and measuring root length of 50 two weeks old seedlings in each case (Figure 50). The 
phenotype of all four newly isolated prl1 alleles was indistinguishable from that of prl1 under all 
conditions examined. Allelism tests performed by C. Koncz with all combinations of prl1 mutant 
alleles also showed no change in the assayed prl1 phenotypic traits.  
 
 
 
 
 
 
 
 
Figure 50. Root elongation phenotype of seedlings carrying the prl1-2 to prl1-4 mutant alleles 
(A) Seeds were germinated on vertically positioned MSAR agar plates containing 0.5% MSAR. (B) Root length 
of 50 individuals was measured two weeks after germination.  
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3.6.2. Isolation of prl2 T-DNA insertion mutations 
The Arabidopsis genome encodes a PRL1 homolog, PRL2. Similarly, other plant species examined 
carry two genes coding for potential PRL1 orthologs, which distinguishes them from all other 
eukaryotes (i.e., including budding and fission yeast, Caenorhabditis elegans, Drosophila 
melanogaster, mouse, rat and humans; Nemeth et al., 1998) that carry only a single gene for PRL1 
ortholog. Although PRL1 and PRL2 carry divergent N-terminal sequences, their WD40 domains show 
very high level of sequence similarity. Inspection of transcript profiling data deposited in the 
Genevestigator database indicated that both PRL1 and PRL2 are expressed in most of the tissues 
(Figure 51). The highest PRL2 mRNA levels were detected in pollen and cell suspensions, whereas 
PRL2 transcript levels are lower in radicles, petals, sepals, and roots. In comparison, PRL1 transcript 
levels were found to be the highest in callus and the shoot apex, and the lowest in the pollen.  
 
 
 
 
 
 
 
Figure 51. Comparison of PRL1 and PRL2 gene expression patterns based on microarray data in the 
Genevestigator database. 
Microarray expression data was obtained from the Genevestigator database to compare PRL1 and PRL2 mRNA 
levels in different plant organs. Dark blue colour indicates high expression level.  
 
Albeit we did not detect any interaction between PRL2 and AtCDC5 in the yeast two-hybrid system, 
the fact that also only a weak interaction was detected between PRL1 and AtCDC5 suggested that this 
assay did not provide completely reliable data. Indeed, subsequently we found that the WD40-repeat 
domain of PRL1 interacts in vivo with AtCDC5. It is therefore plausible that PRL2, as PRL1, may 
interact through its WD40 domain with AtCDC5. If this is the case, PRL1 and PRL2 could perform at 
least partially overlapping functions in the CDC5-related pathways, whereas their N-terminal 
sequences may interact with different signalling factors. To generate genetic tools for further analysis 
of the PRL2 function, we have identified prl2 T-DNA insertion mutants. 
 
3.6.2.1. PCR genotyping of the prl2-1 KONCZ16136 line 
Our mutant collection represented by super-pools with DNA templates from 4000 and 5000 plants was 
screened by PCR with PRL2 gene specific primers to identify a P100 pool carrying T-DNA insertion 
in the PRL2 gene (Rios et al., 2002, data not shown). From this P100 pool DNA was extracted from all 
individual lines to identify a line (Koncz16136-#4) hemizygous for the prl2 mutation. 20 seedlings 
from the M2 progeny of this line were grown on selective medium and PCR genotyped with 
combinations of gene and T-DNA end specific primers (Figure 52). All lines examined were 
heterozygous for the prl2 mutation suggesting that inactivation of the PRL2 gene affects either male or 
PRL2
PRL1
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female transmission. Sequencing the insert junctions showed that the T-DNA tag was located in exon 
9 of the PRL2 gene and that the integration event caused a target site deletion of 51 bp. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 52. PCR analysis of the prl2-1 Koncz16136 (#4) mutant 
20 M2 lines were analyzed by PCR amplification. All primer combinations resulted in PCR products, which 
suggested that there was no homozygous prl2 mutant among these lines. Sequencing the amplified insert 
junctions revealed that the insertion was located in exon 9. Below: the schematic figure of the PRL2 gene, T-
DNA sequences are marked with capital letters, whereas letters in lower case indicate PRL2 sequences. 
Sequences duplicated in the insert junction are underlined. WT, wild type control; M: DNA size marker (λ-PstI 
and λ-HindIII). 
 
3.6.2.2. PCR genotyping of the prl-2-2 GABI 228D02 mutant line 
A second mutant was isolated from the GABI-KAT collection and analyzed by PCR amplification 
(Figure 53). Using the gene specific primer combination PRL2 5’ and PRL2 3’ a PCR product was 
always detected. When PCR was performed with the T-DNA specific primer combinations, the right 
border primer failed to yield any PCR product, but with the PRL2 3’ and left border specific FISH1 
primers the insertion event was verified in the PRL2 gene. Line 7 escaped selection and did not carry 
any T-DNA insertion. As in case of the prl2-1 allele, this PCR screen did not yield either homozygous 
prl2 mutant. Sequencing the left border junction of the insertion site showed that the T-DNA was 
located in the second intron of the gene. 
M   1    2 3    4    5    6    7    8    9   10  11  12  13  14  15 16  17  18  19  20 WT
WT 1    2    3    4 5    6    7    8    9   10 11  12  13  14  15  16  17 18 19 20 M
WT  1    2    3  4    5    6    7    8    9   10  11  12  13 14  15 16  17  18  19 20 M
Koncz #4
PRL2 5’ and PRL2 3’ primers
PRL2 5‘ and FISH1 primers
PRL2 3‘ and FISH1 primers
2838
4507
1700
2838
2027
aatgctgggaAATCTACATGGATCAG ACATGAAGCCATattaattactcttct
PRL2 Koncz #4
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Figure 53. PCR analysis of prl2-2 GABI 228D02 insertion line 
18 M2 plants were analyzed by PCR amplification. Gene specific primers PRL2 5’ and PRL2 3’ amplified a 
DNA fragment of expected size in each line indicating that these lines were not homozygous. The presence of 
the T-DNA insertion was confirmed by PCR amplification with the primer combination PRL2 3’ and FISH1. 
Lines 7 and 16 did not carry any T-DNA. Below: the schematic figure of the PRL2 gene, T-DNA sequences are 
marked with capital letters, whereas letters in lower case indicate PRL2 sequences.  WT, wild type control; M: 
DNA size marker (λ-PstI). 
 
 
prl2-1 HygR HygS PCR  prl2-2 SuR SuS PCR 
#1 156 88 +/-  #1 172 79 +/- 
#2 73 32 +/-  #2 218 98 +/- 
#3 204 90 +/-  #3 131 59 +/- 
#4 108 43 +/-  #4 109 56 +/- 
#5 166 88 +/-  #5 78 37 +/- 
#6 81 40 +/-  #6 189 82 +/- 
#7 96 41 +/-  #7 76 45 -  
#8 145 79 +/-  #8 148 61 +/- 
#9 74 44 +/-  #9 121 66 +/- 
#10 110 51 +/-  #10 68 37 +/- 
#11 66 34 +/-  #11 169 68 +/- 
#12 84 45 +/-  #12 93 49 +/- 
#13 175 97 +/-  #13 175 80 +/- 
#14 157 77 +/-  #14 x x x 
#15 -   - +/-  #15 135 61 +/- 
#16 178 81 +/-  #16 92 45 -  
#17 195 111 +/-  #17 111 41 +/- 
#18 166 83 +/-  #18 214 81 +/- 
#19 207 100 +/-  #19 x x x 
#20 169 99 +/-  #20 116 45 +/- 
Total 1397 727    Total 2414 1090   
         
  χ2 DF      χ2 DF 
Total 10,373 19    Total 18,779 18 
All 0,165 1    All 7,812 1 
Homogeneity 10,208 18    Homogeneity 10,96 17 
P= 93% for 2:1    P= 89% for 2:1 
 
Table 2. Segregation analysis of prl2 mutant lines 
Seed from each PRC analyzed prl2-1 and prl2-2 M2 family was germinated on selective MSAR plates and the 
ratio of resistant versus sensitive seedlings was determined. Hyg: Hygromycin, Su: Sulfadiazine, R: resistant, S: 
sensitive. 
 
 
M   1 2    3    4    5    6    7    8    9   10 11  12  13 - 15 16  17  18    - 20  WT 1   2  3  4    5  6    7    8    9   10  11  12  13    - 15  16  17  18 - 20 M
PRL2 5’ and PRL2 3’ primers PRL2 3‘ and FISH1 primers
GABI 228D02 
2838
4507
GABI 228D02
GCTGATCCATgcttatcacttt
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3.6.2.3. Segregation analysis of prl2-1 and prl2-2 mutants 
To determine the segregation of T-DNA encoded selectable marker genes, seeds of PCR genotyped 
M2 lines were germinated on hygromycin (prl2-1) or sulfadiazine (prl2-2) containing MSAR agar 
plates (Table 2). Both prl2-1/+ and prl2-2/+ mutant lines showed 2:1 segregation ratio indicating that 
plants homozygous for prl2 mutations were non-viable. Examination of siliques of hygromycin and 
sulfadiazine resistant plants transferred into soil from each M2 families revealed segregation of albino 
and aborted embryos suggesting a possible embryo-lethal phenotype for both prl2 mutations. Further 
characterization of this phenotype may help to better understand the function of PRL2 gene. 
 
3.6.3. Generation of prl1 double mutants with mutations in genes coding for putative PRL1 
interacting partners 
As described in section 3.5.6, K. Salchert (1997) in our laboratory has previously identified 13 
putative PRL1-interacting partners (PIPs), most of which showed interaction with the N-terminus of 
the PRL1 protein in yeast two-hybrid screens. All putative PRL1 interacting partners (PIPs) showed 
also specific interaction with PRL1 in protein-binding assays in vitro. Nonetheless, due to reasons 
discussed in section 3.5.6, we failed to confirm interaction in vivo between PRL1 and some of the PIPs 
tested. To develop resources for exploring possible genetic interactions (i.e., synthetic lethality or 
suppression) between the prl1 mutation and mutations affecting the PIP coding genes, C. Koncz and S. 
Schaefer have identified multiple T-DNA insertion mutant alleles of all PIP genes. In this thesis work, 
we initiated the construction of prl1 double mutants with mutations affecting the PIPs listed in Table 
3. The location of these PIP genes in Arabidopsis chromosomes is shown in Figure 54. In crosses with 
the pip mutants, we used either the prl1-1 or prl1-2 mutants (Table 4) in order to take advantage of the 
T-DNA encoded selectable markers in selection for the presence of at least one of the combined 
mutations.  
 
PRL2 At3g16650 PRL1 homolog 
PIP-A At5g19900 Unknown protein 
PIP-C At5g58720 Unknown protein 
PIP-D At3g50530 Putative calcium dependent protein kinase 
PIP-E At1g69830 Alpha-amylase-like protein 
PIP-F At4g01480 Putative inorganic pyrophosphatase 
PIP-H At4g29510 Protein arginine N-methyltransferase 
PIP-I At5g07360 Amidase family protein 
PIP-K At4g15420 Ubiquitin fusion degradation protein UFD1 
PIP-L At1g15730 Cobalamin synthesis protein-like 
CBP20 At5g44200 Cap binding protein 20 (mRNA binding factor) 
 
Table 3. List of PIP genes, in which insertion mutations were isolated and used in crosses with the prl1 
mutant. 
A mutation in the CBP20 gene, encoding the 20 kDa subunit of the mRNA CAP-binding complex, causes ABA 
hypersensitivity similarly to the prl1 mutation (Papp et al., 2004). Therefore, crosses were also performed to test 
potential genetic interaction between cbp20 and prl1.  
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Figure 54. Map positions of PIP genes in the Arabidopsis chromosomes 
The figure was generated using the Chromosome Map Tool of Tair (http://www.arabidopsis.org). 
 
♀ ♂ Status 
1. prl1-1  x prl2-2  Discarded, no prl2 insertion  
2. prl1-2  x prl2-1  prl1/prl1 PRL2/prl2  
3. prl1-1  x pip-a GABI 197C07  Homozygous double mutants 
4. pip-c SALK_010773  x prl1-1 Homozygous double mutants 
5. pip-c SALK_039094  x prl1-1  Homozygous double mutants 
6. prl1-1 x pip-d SAIL 586 H06 M2 did not germinate 
7. prl1-2 x pip-d Koncz38225 Homozygous double mutants 
8. prl1-1 x pip-e SAIL 613 D12 Homozygous double mutants 
9. pip-f SALK_014647  x prl1-1 Pooled sample-further analysis 
10. prl1-1 x pip-f SALK_014647 Not analyzed. 
11. prl1-2  x pip-h KONCZ65425  Pooled sample-further analysis 
12. pip-i SALK_000718  x prl1-1 Homozygous double mutants 
13. pip-i SALK_011213  x prl1-1  Homozygous double mutants 
14. prl1-1 x pip-i GABI 160C01  Homozygous double mutants 
15. prl1-1 x pip-i Wisc446.659-3 Homozygous double mutants 
16. prl1-1 x pip-k SAIL 1284 G09 Pooled sample-further analysis 
17. prl1-2  x pip-k Koncz77621 Homozygous double mutants 
18. prl1-1  x pip-k SAIL 1053 H01 Heterozygous prl1/prl1 PIP-K/pip-k 
19. pip-l SALK_037227  x prl1-1 Homozygous double mutants 
20. prl1 SALK_008466 x pip-l Koncz 22893 Homozygous double mutants 
21. prl1-2 0 x  cpb20 Koncz 372 Homozygous double mutants 
Table 4. List of crosses performed between prl1 and pip mutants  
Current status of double mutant analyses is indicated in the third column. 
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In all insertion mutants derived from the SALK collection, we observed silencing of the selectable 
kanamycin resistance marker gene. From each cross, 10 F1 families were grown to produce F2 seeds. 
From 5 independent F2 families, 20 individuals selected in antibiotics containing media (if it was 
possible) were grown in soil for collecting DNA samples. When it was possible, only F2 plants 
selected for the short root phenotype of prl1 were genotyped for the combined second mutation. The 
PIP-F, PIP-H and PIP-K genes are located in the same chromosome as PRL1, which made the 
isolation of homozygous double mutants more difficult. From these crosses 100 M3 lines were 
analyzed. The collected plant material was pooled (10 independent lines in each pool) and analyzed by 
PCR. The pip-f, pip-h and pip-k T-DNA insertions were detected in the pooled DNA samples and 
these pools are now being further analyzed to identify individual lines containing the combined 
mutations. All thus far identified homozygous double mutants showed the characteristic prl1 root 
elongation defect indicating that PIPs do not affect pathways controlling root elongation. Further 
ongoing assays aim to reveal whether any of the pip mutations affect glucose and hormone 
hypersensitivity responses caused by the prl1 mutation.  
 
3.6.4. Isolation of point mutations in the PRL1 coding region 
The yeast two hybrid and in vitro protein interaction assays performed by K. Salchert (1997) indicated 
that PIP-C, PIP-F, PIP-H, PIP-K, PIP-M and the two SnRK1 α subunits AKIN10 and AKIN11 bound 
to N-terminal sequences of PRL1. By contrast, PIP-A, PIP-B, PIP-D, PIP-E, PIP-G, PIP-I and PIP-L 
were found to interact with C-terminal PRL1 sequences downstream of the sixth WD40-repeat. 
Computer-based structure predictions suggested that the N- and C-terminal ends form a rod-like 
structure sticking out from the cone-like WD40 repeat domain. To search for point mutations causing 
amino acid exchanges in the N-terminus of PRL1 and thereby possible alteration of interactions with 
PIPs, we have screened by TILLING for EMS-induced mutations and developed a site-specific 
mutagenesis approach. 
 
3.6.4.1. Screening for EMS-induced point mutations by TILLING  
A large population of ethylmethanesulfonate (EMS) mutagenised Arabidopsis plants was screened to 
identify point mutations in the PRL1 gene using TILLING (Targeting Induced Local Lesions in 
Genomes) technology and facilities provided by Arabidopsis TILLING project (ATP, 
http://tilling.fhcrc.org:9366; Till et al. 2003). K. Berendzen from our laboratory designed screening 
primers for point mutations in PRL1 sequences encoding the N-terminal domain. 23 point mutations 
were found in this screen. From these EMS mutations, 12 was located in non-coding intron regions, 3 
substitutions did not result in amino acid changes, but in 8 lines the sequenced nucleotide mutations 
induced amino acid exchanges (Table 5). M2 seeds of TILLING lines were germinated on MSAR 
plates to search for prl1-like phenotypic traits, including short root and serrated leaf. The CS87948 
TILLING line, which carried a P22S mutation, segregated 104 wild type and 24 albino plants. Line 
CS93156 carrying a S33L substitutions showed wild type phenotype. Line CS93711 line, containing a 
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P58S substitution, showed a segregation of 21 wild type plants, 3 plants with shorter roots and 8 
albinos.  
 
 Line Nucleotide Effect Genotype 
1. CS87948 C115T P22S hetero 
2. CS93156 C149T S33L hetero 
3. CS90002 C168T L39= homo 
4. CS93711 C223T P58S homo 
5. CS89680 C231T D60= hetero 
6. CS93970 G244A Intron hetero 
7. CS94048 C258T Intron homo 
8. CS89522 G302A Intron hetero 
9. CS87940 C454T Intron hetero 
10. CS89552 C487T Intron hetero 
11. CS87753 C508T Intron hetero 
12. CS89433 C509T Intron hetero 
13. CS88580 G522A Intron hetero 
14. CS92210 G525A Intron homo 
15. CS91910 G613A G77E homo 
16. CS92359 G613A G77E hetero 
17. CS86130 C625T P81L hetero 
18. CS93235 G727A Intron hetero 
19. CS88592 G780A Intron homo 
20. CS85391 G825A G110R homo 
21. CS93290 G833A K112= hetero 
22. CS86061 C900T P135S hetero 
23. CS88018 G933A Intron hetero 
 
Table 5. Identification of EMS-induced mutations in the 5’ coding region of the PRL1 gene by TILLING. 
EMS mutagenized lines were screened for point mutations affecting the N-terminal sequences of PRL1. The 
nucleotide substitutions were confirmed by DNA sequencing and the genotype of identified point mutants is 
indicated.  
 
Line CS92359 harbouring G77E substitution showed a segregation of 48 wild type plants and 8 plants 
with short roots, but showing normal leaf morphology. In the M2 progeny of line CS86130, which 
carried a P81L substitution, 56 wild type seedlings and 11 plants with shorter roots were observed. 
Finally, line CS86061 (P135S substitution) segregated 43 wild type, 11 albino, 2 pale seedlings and 5 
plants with shorter roots. As the root elongation defect appeared to be frequently observed in the 
TILLING lines, further analysis of these mutations in allelism assays with prl1 is necessary. In case of 
line CS92359 (which proved to be identical to line CS91910, which carried a mutation causing G77E 
exchange in homozygous form), we performed a direct assay to test whether the identified mutation 
caused indeed the observed short root phenotype. This mutation was introduced into pPCV002-PRL1-
HA by site-specific mutagenesis and tested in genetic complementation experiment performed with 
the prl1-1 mutant. Briefly, site-directed mutagenesis was performed on pBS-PRL1-HA template DNA 
using the G77E and NotI primers (2.1.6.3). The presence of mutation was confirmed by DNA 
sequencing and then the XbaI-XmaI PRL1 genomic fragment was subcloned into the pPCV002 vector. 
This construct was transferred to Agrobacterium GV3101(pMP90RK) and transformed into the prl1 
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mutant. The phenotype of six transformed T1 plants was analyzed after germination on selective plates 
containing kanamycin and all of them showed wild type phenotype (Figure 55). The expression of the 
PRL1-HA protein in the first three transgenic lines was confirmed by immunodetection using anti-HA 
antibody (data not shown). This result clearly indicated that the G77E point mutation does not affect 
the PRL1 function and thus provided a warning example for avoiding direct phenotypic analysis of 
TILLING lines, instead of performing allelism tests. As confirmation, germination of line CS91910 
that was received later and carried the G77E mutation in homozygous form yielded only wild type 
plants. 
 
 
 
 
 
 
Figure 55. Genetic complementation assays with G77E mutation 
Point mutation causing G77E substitution in PRL1 was introduced into the PRL1::PRL1genomic-HA construct 
by site-specific mutagenesis and assayed in genetic complementation test with the prl1-1 mutant. The 
phenotypes of the soil-grown transgenic plants are shown. Expression of the modified PRL1-HA(G77E) protein 
was detected by Western blotting using anti-HA antibody. 
 
3.6.4.2. Site-directed mutagenesis of the PRL1 gene 
As an alternative approach to genetic mapping functionally important domains in the N- and C-
terminal extensions flanking the WD40-repeats of PRL1 protein, we performed a site-directed alanine 
scanning mutagenesis experiment. Design of the mutagenesis experiment was based on previous two 
dimensional modelling of the PRL1 protein structure. Residues that were predicted to play a potential 
role (such as prolines) in determination of protein structure were not targeted by the mutagenesis. The 
list of point mutations generated is shown in Table 6. Mutagenesis was performed using the 
TransformerTM site-directed mutagenesis kit with different Mut primers in combination with the NotI 
primer on pBS-PRL1-HA (2.1.6.4). The mutations were verified by sequencing, and then an XbaI-
XmaI fragment of pBS-PRL1-HA carrying the modified PRL1-HA gene was inserted into XbaI-XmaI 
sites of pPCV002 vector. Subsequently, prl1 mutant plants were transformed with these constructs and 
the phenotype of T1 transgenic plants was analyzed for complementation of the prl1 root elongation 
defect. Site-directed mutagenesis failed so far with the Mut26 and Mut29 primers. The Mut2 primer 
contained originally three mutations but the only mutation causing a single amino acid exchange was 
recovered. In summary, this experiment generated 28 modified PRL1 sequences, which carried 53 
point mutations, and for each modified PRL1 construct 20 independent T1 plants were analyzed. 
Although the success of the genetic complementation experiment was clearly dependent on the 
expression level and stability of mutagenized versions of the PRL1 protein, the majority of T1 plants 
obtained by transformation of the prl1 mutant with all 28 modified PRL1 genes showed wild type root 
elongation. This suggested that the N- and C-terminal extensions of the PRL1 protein do not play a 
line#1 line#2 line#3 1     2 3
PRL1-HA
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role in the control of this phenotypic trait of the prl1 mutant. Whether these site specific mutations 
affect other phenotypic traits, such as hypersensitivity to ABA, is being clarified by ongoing 
experiments. 
 
Line Mutation Line Mutation Line Mutation 
Mut1 E7A, E9A, E12A Mut11 R49A, S51A Mut21 Q97A, K98A 
Mut2 P10A Mut12 H52A, K53A Mut22 E102A, S103A 
Mut3 K17A, K18A Mut13 K55A, F58A Mut23 S125A, S126A 
Mut4 K22A, K25A Mut14 E62A, S66A Mut24 K128A, S129A 
Mut5 S20A, S23A Mut15 R70A, Q71A Mut25 S138A, S139A 
Mut6 R26A, S27A Mut16 D73A. R74A Mut26 E465A, D466A, E467A 
Mut7 E29A, S32A Mut17 E77A, Q78A Mut27 E472A, H474A 
Mut8 P33A Mut18 S82A, S86A Mut28 K478A 
Mut9 H35A, Q35A Mut19 E91A, S93A Mut29 K481A, E482A 
Mut10 D42A, E44A Mut20 K94A, S95A Mut30 R484A, R485A 
Table 6. Site-directed mutagenesis of the PRL1 gene 
List of mutagenesis primers used and amino acid exchanges generated in site-directed alanine-scanning 
mutagenesis of the PRL1 gene. 
 
The results of site-specific mutagenesis experiment also suggested that the cell elongation and 
polarity-related defects observed in prl1 roots (Figure 56) may be primarily related to the function and 
interacting partners of PRL1 WD40-repeats.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 56. Cytological analysis of prl1 root structure 
The root structure of the prl1 mutant was investigated collaboration with J. Jásik. Longitudinal cross sections of 
roots were prepared from five days old wild type and prl1 plants after embedding in PEG. Although all basic 
layers of the root structure are present in prl1, the well conserved organization of linear cell files is largely 
disturbed. Serious polarity and elongation defects are observed in cells of the elongation zone, the cortex and the 
endodermis cells are swollen and highly vacuolized. The diameter of central cylinder is reduced in prl1. 
Furthermore, prl1 displays ectopic root hair development due to mispositioning of trichoblast mother cells. 
WT prl1
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Interaction of the PRL1 WD-40 repeat region with AtCDC5 and functional conservation of CDC5 in 
eukaryotes suggested that the loss of PRL1 from the AtCDC5 complex in the prl1 mutant could cause 
cell cycle-related defects in addition to influencing potentially spliceosome-assembly or splicing 
related functions. In fact, recent microarray profiling experiments performed by G. Molnar and others 
in our laboratory indicated that a gene encoding cyclin B1;1, which is involved in the control of G2/M 
transition, is upregulated in the prl1 mutant. In order to confirm this observation, we have introduced a 
CycB1;1::GUS reporter gene (Ferreira et al., 1994) into the prl1-1 mutant and monitored its activity 
by histochemical GUS assay (Figure 57).  
 
 
 
 
 
 
 
 
 
 
Figure 57. Histochemical staining of prl1 and wild type plants carrying the CycB1;1::GUS reporter 
gene. 
Wild type and prl1 seedlings grown in MSAR medium for 2 weeks were stained with X-Gluc to monitor the 
expression of GUS reporter enzyme encoded by the CycB1;1::GUS gene. 
 
As compared to wild type plants, in which CycB1;1::GUS expression was only observed in root tips, 
the prl1 mutant displayed overall activation of cyclin B1;1 gene in rosette leaves and other organs of 2 
weeks old seedlings tested in this experiment. Together with the PRL1-AtCDC5 protein interaction 
data, this experiment directs attention to future analysis of potential functions of PRL1 and AtCDC5 in 
the regulation of cell cycle and polarity. 
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4. DISCUSSION 
4.1. Characterization of PRL1 gene expression 
Our studies, focusing on functional characterization of the Arabidopsis PRL1 gene and its nuclear 
WD40 protein product, were initiated by the analysis of temporal and spatial expression pattern of 
PRL1 using reporter constructs. A PRL1 promoter fragment containing a 3.5 kb upstream regulatory 
region, the 5’ UTR, and the first two exons and introns was fused to the GUS reporter gene in frame 
with the third PRL1 exon. Histochemical analysis of the GUS expression pattern revealed that the 
PRL1 promoter is active in most tissues. The PRL1::GUS reporter showed the highest activities in 
shoot and root apical meristems and emerging lateral meristems. However, young hypocotyls and leaf 
primordia were also stained robustly, although during further development PRL1::GUS expression 
became more restricted to the vascular tissues. The strong meristematic activity of the PRL1::GUS 
reporter underlies a potential PRL1 function in cell division or in cell elongation. Such a function is 
also suggested by the prl1 mutant phenotype, as mutant plants have characteristic short roots and the 
elongation of hypocotyl cells are also inhibited. 
Further characterization of subcellular localization and expression pattern of the PRL1 protein 
was performed using indirect immunofluorescence microscopy in collaboration with Dr. J. Jásik. In 
these experiments, a genomic construct driven by the native PRL1 promoter was labelled with HA 
epitope coding sequences, and its expression was studied in prl1 mutant plants. PRL1-HA signal is 
predominantly detected in the nucleus; specifically in the nucleoplasm, but not in the nucleolus. 
Chromosomes were identified by specific DAPI staining and their localization was compared to the 
PRL1-HA subcellular pattern showing that PRL1 is not a chromatin-associated protein during mitosis.  
A third approach focused on the analysis of localization of PRL1::PRL1-GFP expression in 
transgenic plants in vivo using confocal laser scanning microscopy in collaboration with Dr. E. 
Schmelzer. The observed localization pattern of the PRL1-GFP reporter further validates that PRL1 is 
a nuclear protein, although significantly lower levels of GFP signal was also detected in the 
cytoplasm. This data was verified later by biochemical studies, in which nuclear and cytoplasmic 
protein fractions were prepared from plants and cell suspension, and low amount of PRL1 was also 
shown to be present in the cytoplasmic fractions by immunodetection experiments. The cellular 
localization experiments showed that PRL1-GFP is expressed in all cell types analyzed. This data 
explains why the native PRL1 (Nemeth et al. 1998) and PRL::PRL1-HA proteins were detected in all 
plant organs by western blotting and postulates a general role for PRL1 that is necessary in most 
Arabidopsis cell types. In particular, high level expression of PRL1-GFP in meristematic tissues and 
leaf primordia strongly suggests a possible role for PRL1 in the regulation of cell cycle and/or cell 
elongation.  
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4.2. PRL1 gene expression is regulated by intragenic regions 
Previous experiments performed by J. Jásik indicated that PRL1 promoter sequences located 5’-
upstream of the ATG codon are not sufficient to drive transcription of reporter constructs in plants. 
Nemeth et al. (1998) showed that a 7.9 kb genomic fragment containing 3.5 kb upstream sequence and 
the coding region contained all sequences necessary for genetic complementation of the prl1 mutation. 
We have observed that a PRL1 gene segment carrying only 62 bp upstream of the ATG codon of a 
full-length coding region cloned in the estradiol-inducible expression vector pER8 was also sufficient 
to complement the prl1 mutant phenotype and conferred high levels of protein expression even in the 
absence of estradiol induction. In order to examine the stringency of estradiol inducibility of the pER8 
vector, we tested the regulation of a control pER8-GUS reporter gene construct. Histochemical 
analyses detected GUS activities only estradiol-treated plants indicating that the observed activity of 
5’-truncated PRL1 gene was not due to leaky regulation of transcription by the estradiol-inducible 
promoter of pER8. Another control experiment showed that expression of PRL1 cDNA controlled by 
the estradiol inducible pER8 vector was insufficient for complementation of the prl1 mutation and 
synthesis of the PRL1 protein in the absence of estradiol induction. These results clearly indicated that 
an extremely short upstream promoter region containing a TATA-box consensus and transcription 
initiation sequences are required for proper transcriptional regulation of PRL1 gene. This conclusion 
was also supported by the observation that a T-DNA insertion identified in the prl1-5 SAIL-1276G04 
allele at position -85 bp from the PRL1 ATG codon did not result in prl1 mutant phenotype.  
A series of promoter deletion constructs was generated in order to identify the essential 
transcription regulatory region in the 5’-coding region of the PRL1 gene by monitoring the expression 
of GUS reporter in cultured cells and plants. GUS activity was detected when the 3.5 kb full length 
promoter was linked to the first two exons and introns, as well as when a short promoter sequence 
between position -62 and the ATG codon was linked to the first two exons and introns of the coding 
region. GUS expression diminished when the reporter gene was linked to the 3.5 kb PRL1 promoter 
terminating at the ATG, and also when sequences of the second intron were removed from the short 
promoter (i.e. extending from position -62 to the second exon). These experiments proved that 
promoter sequences located upstream of the ATG codon are not sufficient for the PRL1 gene 
expression and that essential transcription regulatory elements are located in a 300 bp intragenic 
region carrying the second intron and short sequences from the second and third exons. The presence 
of essential transcription regulatory sequences in the coding region is not a unique property of the 
PRL1 gene, but appears to be rather common in other genes of Arabidopsis and different plant species. 
For example, expression the AGAMOUS (AG) floral homeotic gene is restricted to the inner two 
whorls of the flower and regulated by positive and negative transcription factors that bind to the 3 kb 
second intron of AG (Sieburth and Meyerowitz, 1997, Busch et al., 1999, Deyholos and Sieburth, 
2000). Comparative analysis of expression patterns of GUS reporters driven by PRL1 promoters 
carrying or lacking sequences 5’-upstream of position -62 show that the intragenic regulatory 
sequences are also fully sufficient for proper tissue specific expression of PRL1. Short promoter 
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driven GUS gene construct displays thus the same expression pattern as reporter constructs driven by 
the long promoter, both showing especially high activities in the apical and lateral meristems. 
Nonetheless, somewhat lower activity of the short promoter suggests that sequences located 5’-
upstream of position -62 contain enhancer elements that quantitatively regulate PRL1 transcription. 
Sequence analysis of the intragenic promoter region suggested that TC-repeats present in the 5’ 
UTR and the second intron might be important in the control of transcription. In the CaMV35S 
promoter sequence downstream of the transcription initiation site a CT-rich region was reported to act 
as an enhancer (Pauli et al., 2004). Specific binding factors for the TC/GA repeat were initially 
identified in Drosophila (Farkas et al., 1994), but found later also in Arabidopsis. These factors are 
represented by the BASIC PENTACYSTEINE (BPC) protein in Arabidopsis (Meister et al., 2004; 
Kooiker et al., 2005) and the barley b recombinant (BBR) protein in barley (Santi et al., 2003). 
However, removal of these sequences did not result in dramatic changes in the activity of PRL1 
promoter.  
Regulatory importance of the second intron was also confirmed by genetic complementation 
assays performed with the prl1 mutant. Constructs carrying the full-length coding region of 3.7 kb in 
fusion with either the 5’-upstream promoter region of 3.5 kb or only the short promoter extending 
from position -62 complemented the prl1 mutant equally well. Similarly, the full-length (i.e., 3.5 kb) 
promoter and the genomic sequence carrying the first two exons and introns fused in frame with exon 
3 sequences of the PRL1 cDNA was sufficient to complement the prl1 mutation. However, the prl1 
phenotype was not complemented by a PRL1 cDNA construct that carried only 5’-upstream promoter 
sequences terminating at the ATG codon. These data verified that in the absence of intragenic 
regulatory sequences the PRL1 promoter region located 5’-upstream of the ATG codon can drive only 
low level of transcription. The results based on monitoring GUS reporter enzyme activities conferred 
by the different promoter constructs were faithfully confirmed by the analysis of expression levels of 
PRL1-HA protein in the complemented prl1 mutant lines. Whereas all complemented prl1 lines 
expressed comparable amounts of the PRL1-HA protein, lines showing no complementation contained 
significantly lower amounts of PRL1-HA protein. Genetic complementation of the prl1 mutation 
appeared to require a critical threshold of PRL1-HA expression, as it was observed in overexpression 
experiments of PRL1-cDNA-HA controlled by the estradiol-inducible pER8 vector.  
Studies of PRL1 promoter deletion constructs clearly indicated that important transcription 
regulatory sequences are located in the area of the second intron, including short sequence elements 
from the second and third exons. These sequences were analyzed by the PlantCARE program (Lescot 
et al., 2002) in order to identify putative plant transcription factor binding sites. However, transcription 
factors suggested by the PlantCare program showed completely different expression patterns, as 
indicated by subsequent analysis of microarray databases, than the PRL1 gene. Therefore, we decided 
to perform a yeast one-hybrid experiment to search for transcription factors that bind to intragenic 
regulatory sequences of PRL1 intron 2 region. In this screen, a plant specific regulator AtNAM (NO 
APICAL MERISTEM, At1g52880) was identified. AtNAM belongs to the NAC (NAM, ATAF1/2, 
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CUC2) family of transcription factors. The protein carries a highly conserved DNA-binding domain at 
the N-terminus and a trans-activation domain at the C-terminus. The target sequence of AtNAM was 
identified in the CaMV35S promoter (Duval et al., 2002), and we found that two potential AtNAM 
binding sites are present in the third exon of the PRL1 coding region. We have analyzed the regulation 
of AtNAM transcription in the Genevestigator database and compared these data with the Northern blot 
data of Duval et al. (2002). A negative correlation was detected between AtNAM and PRL1 expression 
suggesting that AtNAM could be a possible repressor of PRL1 promoter activity. However, we argued 
that the predicted AtNAM-binding site in exon 3, if indeed targeted by AtNAM, is also present in the 
cDNA, which did not confer genetic complementation of the prl1 mutation in the absence of other 
transcription regulatory sequences located in the first and second exons and introns. Alternatively, 
potential negative exonic regulation could also be proposed, however this would not explain the 
behaviour of the studied promoter deletion constructs. Clearly, further analysis of this question is 
required. Preferably, a new yeast one-hybrid screen should be performed using a Gal4-activation 
domain library representing transcripts from different organs. In addition, the 300 bp intron 2-centered 
intragenic regulatory region must be further resolved to precisely map the binding site of AtNAM and 
confirm its possible role in regulation of PRL1 transcription.  
In order to identify the cell layers where PRL1 is active in the apical meristem, a misexpression 
approach was carried out using the genetic complementation test with the prl1 mutant. PRL1 
expression was targeted either to the entire shoot apical meristem (SAM) by the AtKNAT1 and AtSTM 
promoters or to a specific region of SAM by the AtUFO promoter. Using the promoter of 
ASYMMETRIC LEAF 1 (AtAS1) PRL1 was expressed in leaf primordia. As controls, the phloem 
companion cell specific AtSUC2, the xylem specific At4CL1, and the root central cylinder specific 
TobRB7 promoters were used and both PRL1 genomic and cDNA constructs were introduced under 
the control of these promoters into prl1 mutant plants. As the PRL1 genomic fragment carries the short 
promoter region with all essential intragenic regulatory elements, all promoter constructs tested 
complemented the prl1 mutant probably due to PRL1-specific regulation of gene expression. 
However, in case of the cDNA constructs only the AtSUC2 and AtAS1 driven PRL1 expression 
resulted in complementation of the leaf phenotype of the prl1 mutant. On the other hand, none of the 
heterologous promoter driven cDNA constructs restored the root elongation defect of the prl1 mutant. 
These data suggest that during leaf development PRL1 probably does not function in the shoot apical 
meristem, but rather in the leaf primordia and vascular meristem or differentiating phloem. The 
AtSUC2 gene encodes a sucrose-H+ symporter. The AtSUC2 promoter activity pattern was 
characterized using GUS reporter gene fusions (Truernit and Sauer 1995) and localized to the phloem 
vessels throughout the entire plant from the roots to developing fruits. Restoration of prl1 serrated leaf 
phenotype to wild type by the AtSUC2-PRL1 cDNA construct suggests that PRL1 may have a function 
in the phloem in leaves, but not in the roots. The prl1 leaf phenotype was also converted to wild type 
by the AS1 promoter driven cDNA construct. AS1 encodes a Myb family transcription factor and acts 
as a negative regulator of homeotic genes, such as KNAT1 and STM in leaf primordia (for review see 
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Bowman and Eshed, 2000; Baurle and Laux, 2003). In situ hybridization of AS1 during embryo 
development showed that AS1 is predominantly expressed in leaf primordia (Byrne et al 2000). RNA 
hybridization data indicate that AS1 is preferentially transcribed in young and immature plant tissues, 
including roots, stems, leaves, flowers and siliques; whereas fully developed rosette and cauline leaves 
shows low AS1 expression (Sun et al., 2001). Complementation of the prl1 leaf phenotype by the 
AtAS1-PRL1 cDNA construct suggests a potential role for PRL1 during early leaf development. In 
general, data of the PRL1 misexpression experiment also indicate that the PRL1 protein signal is not 
transmittable between plant organs and cells. The failure of complementation in case of AtSTM and 
AtUFO promoter driven constructs may be due to the very low expression levels of PRL1, which is 
probably below the threshold seen in analysis of PRL1 promoter deletion constructs. However, plants 
expressing PRL1 from the AtKNAT1 promoter construct displayed prl1 mutant phenotype despite high 
levels of PRL1 expression.  
 
4.3. PRL1 protein is a potential proteasome substrate 
Comparison of regulation of PRL1 mRNA and protein levels in different plant organs indicated that 
while the amount of PRL1 mRNA is relatively constant in the plant organs, the PRL1 protein levels 
show a remarkable variation. We noted that the PRL1 protein is present at high levels in dividing and 
developing organs, such as roots and flowers, whereas mature rosette and cauline leaves contained 
very low levels of PRL1 protein. These data suggested that the PRL1 protein levels may be 
differentially regulated in diverse plant organs by a posttranscriptional or posttranslational mechanism. 
The stability of PRL1 protein was tested using an estradiol-inducible pER8-PRL1-HA cDNA 
construct. After inducing the transcription of PRL1-HA cDNA by estradiol, the inducer was removed 
and the stability of PRL1-HA protein was monitored in various time points during 96 h. In this 
experiment a linear decrease was detected in the PRL1-HA protein level, and the half life of PRL1-HA 
protein was estimated approximately 8 h. This indicated that the PRL1 protein is probably not 
extremely unstable, although continued translation of the PRL1-HA mRNA after blocking 
transcription by the removal of estradiol was not prevented in this experiment. Also, this experiment 
was performed by expressing the PRL1-HA protein in the prl1 mutant hence there was a possible 
selection for synthesis of functional PRL1 protein.  
To examine whether the stability of the PRL1 protein is regulated through proteasomal 
degradation, we examined the effect of the reversible proteasome inhibitor MG132 in two independent 
experiments. First, we induced the transcription of an estradiol-inducible PRL1-HA expression 
construct in the prl1 mutant background in the presence and absence of MG132 and found that 
MG132 enhances the accumulation of the PRL1 protein. However, this result could well be criticized, 
if the degradation of PRL1 protein was induced by its overproduction. Therefore, in a second 
experiment, we expressed the PRL1-HA protein from a construct, which was transcribed by the native 
PRL1 promoter in cultured cells, and we blocked translation of the PRL1-HA mRNA using 
cycloheximide treatment in the presence or absence of proteasome inhibitor MG132. In the 
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cycloheximide treated samples, the PRL1-HA protein showed the previously observed slow 
degradation, whereas in the MG132 treated samples the protein remained stable throughout 48 to 72 h.  
MG132 is a known blocking agent of the cell cycle (Planchais et al., 2000). Based on 
preferential expression of PRL1 in meristematic tissues, we have hypothesized that degradation of 
PRL1 could be controlled in a cell cycle dependent fashion. Therefore, we examined the PRL1 protein 
sequence for potential motives, which could direct cell cycle dependent regulation of PRL1 
degradation. We have found that the PRL1 carries in its N-terminal region upstream of the WD-40 
repeats a perfect destruction box (D-box), which is known to be recognized by the anaphase 
promoting/cyclosome APC complex and its activators that are involved in the control of cell cycle 
progression from G2 to M phase (for reviews see: Vodermaier, 2004; Peters, 2002; Castro et al., 
2005). In order to test a possible role of D-box in regulation of PRL1 protein stability, we have 
performed a site-specific mutagenesis experiment by exchanging two conserved amino acids of the D 
box motive in a GFP-tagged PRL1 construct and then examined the stability of this protein in cultured 
cells (i.e. in comparison to a wild type PRL1-GFP protein). In logarithmically growing cell culture, 
where the intrinsic PRL1 protein levels were constant, the levels of D-box mutant PRL1-GFP protein 
were significantly higher than those of the wild type PRL1-GFP protein suggesting that mutation of 
the D-box could stabilize PRL1 and hence PRL1 may be targeted to proteasomal degradation by the 
APC E3 ubiquitin ligase. The levels of both wild type and D-box mutant GFP-PRL1 proteins 
decreased significantly in cell suspension after two weeks. Cultured Arabidopsis cells reach a 
stationary phase after approximately seven days, thus upon two weeks without subculturing the cells 
stop dividing and enter a senescent phase accompanied by induction of cell death. As probably many 
other proteins, PRL1 is also quickly degraded in non-dividing senescent cell cultures. In contrast to 
actively dividing cultured cells, we observed no significant difference between the stabilities of wild 
type and D-box mutant PRL1-GFP proteins in seedlings. As in seedlings the proportion of actively 
dividing cells is rather low as compared to the proportion of differentiated cells, the changes in the 
stability of wild type and D-box mutant GFP-PRL1 proteins were probably too small to be detected in 
these experiments. In addition, we noted that expression of the D-box mutated PRL1-GFP under the 
control of either native PRL1 or CaMV35S promoters caused no phenotypic changes in wild type 
plants, indicating that PRL1 is not limiting in dividing cells or at least not efficiently competed by the 
D-box mutant form of GFP-PRL1 fusion protein. Experiments designed for testing the effects of plant 
hormones on the stability of PRL1 protein revealed that during induction of cell death by treatment of 
plants with 50 mM salicylic acid PRL1 undergoes enhanced degradation. Since several distinct PRL1 
proteolysis products were detected by the anti-PRL1 antibody (which was raised against a specific N-
terminal PRL1 peptide), we hypothesized that under cell death inducing condition PRL1 may also be 
degraded by proteases (i.e., instead of the proteasomal pathway).  
 
DISCUSSION   108 
4.4. PRL1 is present in an AtCDC5-associated protein complex 
PRL1 orthologs in budding and fission yeast (McDonald et al., 1999; Ohi and Gould, 2002; Ohi et al., 
2002; Tsai et al., 1999; Hazbun et al. 2003), as well as in human cells (Ajuh et al., 2000), have been 
identified in association with CDC5 in spliceosome activating Prp19/CDC5 protein complexes. As 
both PRL1 and CDC5 orthologs are highly conserved in eukaryotes, we have tested whether AtCDC5 
would bind PRL1 in yeast two-hybrid protein interaction assays. Although we found no interaction of 
full-length PRL1 with AtCDC5, an N-terminally truncated version of PRL1 carrying the WD-40 
repeat region, showed interaction with AtCDC5. As the CDC5-binding region was mapped to the WD-
40 domains of yeast PRL1 orthologs ScCef1p and ScPrp46p (Ohi and Gould, 2002), we decided to test 
interaction of PRL1 with AtCDC5 also in vivo. Using a CaMV35S promoter driven construct, we 
overexpressed an HA-epitope labelled version of AtCDC5-HA protein in a light-grown Arabidopsis 
cell suspension. CDC5-HA was detected in nuclear protein extracts, and observed that the size 
distribution of AtCDC5-HA containing protein complexes on glycerol gradients is similar to those of 
PRL1-containing protein complexes. These data suggested potential co-localization and co-
fractionation of AtCDC5 and PRL1. Therefore, we have tested co-immunoprecipitation of AtCDC5-
HA protein and PRL1, and found that AtCDC5-HA pulled down PRL1 from whole cell protein 
extract. This data suggested that PRL1 is found in association with AtCDC5 in a nuclear protein 
complex that – based on evolutionary conservation of CDC5 interacting factors – may represent a 
Prp19/CDC5-like spliceosome-associated complex also in Arabidopsis.  
As our group has previously demonstrated that PRL1 is a binding partner of SnRK1α AMP-
activated protein kinases, which were found in proteasomal associated SCF E3 ubiquitin ligase 
complexes (Farras et al., 2001), we have tested whether AtCDC5 would also interact with components 
of the proteasomal protein degradation system. In these immunoprecipitation experiments, AtCDC5 
pulled down subunits of 20S core particle and 19S lid of the 26S proteasome, the CSN5 subunit of 
COP9 signalosome, and the CULLIN 1 subunit of SCF E3 ubiquitin ligases. Furthermore, an anti-
ubiquitin antibody detected several distinct protein bands in the protein sample immunoprecipitated by 
AtCDC5-HA suggesting that these ubiquitinated factors may correspond to substrates of the AtCDC5-
HA associated proteasome complex. Our results would excellently support a predicted role for the 
Prp19/Ntc spliceosome activating complex in the proteasome pathway, if further experiments could 
prove that the proteasome-associated AtCDC5-HA complex also contains conserved subunits of the 
Prp19/Cdc5 spliceosomal complex. Namely, Prp19 carries a U-box domain, which has been proved to 
possess ubiquitin ligase activity (Hatakeyama and Nakayama, 2003; Ohi et al., 2003). Moreover, in 
fission yeast Prp19 interacts with the β7 subunit of 20S proteasome core particle both in vitro and in 
vivo (Loscher et al. 2005). However, no specific substrates for the proteasome-associated Prp19 
ubiquitin ligase have been identified thus far. In our experiments, CULLIN 1, a conserved subunit of 
SCF E3 ubiquitin ligases was found to interact with AtCDC5-HA. The apparent contradiction that two 
ubiquitin ligases are present in the same complex may be resolved by accounting that Prp19 was 
proposed to act as an E4 rather than E3 ligase. E4 enzymes represent a recently identified group of 
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ubiquitin ligases, which bind proteins marked with one to three ubiquitin molecules and catalyze 
further conjugation of ubiquitins together with the canonical E1, E2 and E3 complex (for review see 
Hoppe, 2005). In yeast, several transcription factors are known to become activated by covalent 
attachment of ubiquitin molecules and degraded later upon further addition of ubiquitins (Muratani 
and Tansey, 2003). UFD2, a U-box family member is one of the best characterised examples of E4 
ligases. So far, SKP1 as another core component of SCF type E3 ligases was not detected in our 
AtCDC5-HA immunoprecipitation experiments. If SKP1 is indeed not associated to the AtCDC5-
CULLIN 1 complex than probably this complex contains another members of the Arabidopsis 
SKP1/ASK1 protein family, which contains 19 proteins. However, ongoing experiments performed 
with a cell line carrying the PRL1::PRL1-HA expression construct indicate that PRL1-HA 
immunoprecipitated protein samples cross-react with anti-19S proteasome, anti-CULLIN 1, anti-SKP1 
and anti-ubiquitin antibodies. However, when performing similar immunoprecipitation experiments 
with protein extracts prepared from three weeks old seedlings we could not detect association of PRL1 
with SCF and proteasome subunits. These results, together with data showing degradation of PRL1 in 
leaves, suggest that PRL1 is only found in complex with AtCDC5, proteasome and other components 
of ubiquitination-dependent proteasome pathway in actively dividing cells, such as cell suspensions 
and meristems. This assumption is also supported by our failure to detect any in vivo interaction of the 
PRL1 protein with several previously identified PRL1-interacting partners (PIPs), including the 
SnRK1α protein kinases, in seedlings and mature plants. 
 Of course, the above discussed data also raise the question how a splicing related complex can 
influence the regulation of sugar signalling. A week indication was found for that ScCdc5p/Cef1p 
interacts in yeast two-hybrid assays with the Met30p F-box protein (Hazbun et al., 2003; 
http://www.yeastrc.org/unknown_orfs). Major target of the SCFMet30 E3 enzyme is a bZIP transcription 
factor, Met4p, which is responsible for the expression of genes involved in methionine biosynthesis 
and activated by low intracellular S-adenosylmethionine levels and oxidative stress (Kuras et al., 
2002). It was reported that in yeast Met4p is activated by the attachment of a single ubiquitin 
molecule, however, this modification does not lead to immediate degradation of Met4p (Flick et al., 
2004). Destabilization of Met4p could for example be accelerated by an E4 ligase, such as Prp19. 
Unfortunately, as compared to the 21 predicted F-box proteins in yeast, the Arabidopsis genome codes 
for approximately 700 putative F-box factors. Moreover, a clear homologue of Met4p was not yet 
identified from plants. 
 
4.5. Genetic approaches to functional characterization of PRL1 interactions 
To enhance functional dissection of the regulatory domain of the PRL1 protein, we have isolated 
three additional T-DNA insertion mutations in the PRL1 gene. As all T-DNA tags in the currently 
available T-DNA insertion mutant collections carry plant promoters close to their left borders, we 
wished to test whether any of the newly identified T-DNA insertion mutant alleles would allow 
expression of an N-terminally truncated PRL1 protein, which could have helped to study more 
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specifically the function of the WD40-repeat region. The three new T-DNA insertion mutants carrying 
the prl1-2 SALK_008466, prl1-3 SALK_039427 and prl1-4 SALK_096289 however did not show 
any phenotypic difference as compared to the originally characterized prl1-1 mutant, including block 
of root elongation and hypersensitivity to glucose, sucrose, and plant hormones ABA and ethylene. 
Pair-wise interallelic complementation test also revealed prl1 phenotype, which correlated with our 
observation that none of the available prl1 mutants contained detectable amounts of PRL1 protein. 
Although we failed to detect interaction between AtCDC5 and the PRL2 homolog of PRL1 in 
our yeast two-hybrid assays, the fact that these two proteins carry nearly identical WD40-repeats 
suggests that PRL2 may turn out to interact also with AtCDC5 in vivo. To facilitate later analysis of 
the PRL2 function, we have also searched for T-DNA insertion mutations inactivating the PRL2 gene. 
Two alleles, prl2-1 Koncz16136 and prl2-2GABI_228D02 were identified. As we failed to identify 
homozygous prl2 mutant lines, we performed a detailed segregation analysis for both mutant alleles. 
This analysis revealed a 2:1 segregation of T-DNA tagged prl2 alleles and observation of embryo 
lethality in the siliques suggested that the PRL2 is probably required for proper female gametogenesis. 
Nonetheless, high level of PRL2 transcription in the pollen indicated by transcript profiling data also 
suggests that the prl2 mutation could also affect male instead of female transmission. This should be 
clarified by the ongoing reciprocal crosses between wild type and prl2 mutants. 
To facilitate further analysis of potential genetic interactions between the prl1 mutation and 
mutations isolated in genes coding for some previously identified PRL1 interacting partners (PIPs), we 
have initiated the construction of double mutant lines. This collection of double mutants will be 
particularly useful, if further biochemical experiments would confirm in vivo association of PIPs with 
PRL1 in actively dividing cells. As all PIPs identified earlier by yeast two-hybrid screens performed 
with a cDNA library prepared from dark-grown cell suspension interact with N- and C-terminal 
extensions flanking the WD-40 repeat region in the PRL1 protein, there is a need for identification of 
specific point mutations that destroy binding of PIPs to these protein domains. In order to identify 
such mutations, we have exploited the public TILLING service and identified several point mutations 
causing amino acid exchanges in the N-terminus of the PRL1 protein. However, direct phenotypic 
analysis of TILLING EMS mutants is greatly disturbed by high number of background mutations, 
which frequently cause altered root elongation and serrated leaf phenotypes that are also characteristic 
for the prl1 mutant. At least in case of one point mutation causing a G77E amino acid exchange in the 
N-terminus of PRL1, we have demonstrated that the mutation was not linked to the short root and 
serrated leaf phenotypes. To develop an alternative approach, we performed site-directed alanine 
mutagenesis of N- and C-terminal extensions of the PRL1 protein. Altogether 28 modified PRL1 
protein carrying 53 amino acid exchanges were tested for complementation of the prl1 phenotype. The 
fact that all these mutations complemented the root elongation defect of the prl1 mutant strongly 
suggests that the N- and C-terminal domains of PRL1 do not play a role in regulation of cell division 
and/or cell elongation in roots. Based on the observation of the AtCDC5-PRL1 interaction, we 
hypothesize that this effect is associated to the function of PRL1 WD40-repeats. Nonetheless, the 
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availability of point mutations causing amino acid exchanges in the N- and C-terminal domains of 
PRL1 offer now useful tools for mapping the potential binding domains of several known PRL1 
interacting proteins. In addition, these mutations may also be useful to test whether individual 
regulatory domains of PRL1 would control different phenotypic traits caused by the prl1 null 
mutations, including hypersensitivity to sugar and plant hormones.  
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